|
Presenter
|
Presentation
|
|
|
TRANSCRIPTOMIC AND GENETIC STUDIES IDENTIFY IL-33 AS A CANDIDATE GENE FOR ALZHEIMER'S DISEASE
|
|
AAVANI, T.
|
EFFECTS OF ABETA(1-40) AND ABETA(1-42) ACCUMULATION IN THE DORSAL RAPHE NUCLEUS ON T-MAZE ALTERNATION TASK AND PASSIVE AVOIDANCE LEARNING
|
|
ABELIOVICH, A.
|
MICRORNAS IN NEURON FUNCTION AND NEURODEGENERATION
|
|
ADACHI, Y.
|
ABERRANT SPLICING VARIATIONS OF PARKIN MRNA WITH ALU SEQUENCE
|
|
ADAMCZYK, A.
|
ALPHA-SYNUCLEIN ALTERS NMDA RECEPTOR-DEPENDENT SIGNAL TRANSDUCTION
|
|
ADLARD, P.
|
8-HYDROXY QUINOLINE EFFECTS ON NEURONAL PLASTICITY
|
|
AGARWAL, S.
|
REDUCED GEPHYRIN LEVELS MAY CAUSE INDIRECT EXCITOTOXICITY IN ALZHEIMER'S DISEASE
|
|
ÁGUEDA-GÓMEZ, B.
|
SEARCHING FOR THE GENE RESPONSIBLE FOR FAMILIAR PROGRESSIVE SUPRANUCLEAR PALSY: ANALYSIS OF FAM5C
|
|
AGUILERA, J.
|
IS TETANUS TOXIN THE SOLUTION OF PARKINSON´S DISEASE?
|
|
AISA, B.
|
INVOLVEMENT OF PLASTICITY CHANGES IN EARLY-LIFE STRESS EFFECTS ON CHOLINERGIC NEURONS VULNERABILITY AND COGNITION
|
|
AITKEN, A.
|
PROTEIN INTERACTIONS AND DRUG DISCOVERY IN PARKINSON'S DISEASE
|
|
AKIN, A.
|
QUANTIFICATION OF BRAIN ASYMMETRY IN AGING BY FUNCTIONAL NEAR INFRARED SPECTROSCOPY
|
|
AKINYEMI, R.
|
NON- MOTOR SYMPTOMS IN NIGERIAN AFRICANS WITH PARKINSON'S DISEASE: A PRELIMINARY REPORT
|
|
AKINYEMI, R.
|
COGNITIVE DYSFUNCTION IN NIGERIANS WITH PARKINSON'S DISEASE
|
|
AL JARRAH, M.
|
ENDURANCE EXERCISE TRAINING PROMOTES ANGIOGENESIS IN THE BRAIN OF CHRONIC/PROGRESSIVE MOUSE MODEL OF PARKINSON´S DISEASE
|
|
ALAFUZOFF, I.
|
THE BRAAK STAGE AND THE MCKEITH CATEGORY OF ALPHA-SYNUCLIEN PATHOLOGY AND THEIR CLINICAL RELEVANCE
|
|
ALDUNATE, R.
|
DELETION OF THE METHIONINE SULPHOXIDE REDUCTASE GENE INCREASES THE NEUROTOXICITY OF AΒ1-42 IN CAENORHABDITIS ELEGANS
|
|
ALEGRE ABARRATEGUI, J.
|
DEVELOPING NOVEL CELLULAR MODELS FOR PARKINSON´S DISEASE BY ENGINEERING GENOMIC DNA EXPRESSION VECTORS OF THE LEUCINE-RICH REPEAT KINASE 2 GENE
|
|
ALEXANDRESCU, A.
|
ROLE OF CHARGES IN THE CONFORMATIONAL TRANSITIONS OF AMYLOID-BETA AND Α-SYNUCLEIN
|
|
ALEXANDRU, A.
|
AGE-DEPENDENT HIPPOCAMPAL CELL LOSS AND GLIOSIS IN A NOVEL TRANSGENIC MOUSE MODEL OF PGLU-AΒ-INDUCED NEUROTOXICITY
|
|
ALI, A.M.
|
MICROHETEROGENEITY OF SOME SERUM GLYCOPROTEINS IN NEURODEGENERATIVE DISEASES
|
|
ALMEIDA, A.
|
CYCLIN-DEPENDENT KINASE-5 (CDK5) PHOSPHORYLATES CDH1 LEADING TO CYCLIN B1 ACCUMULATION DURING EXCITOTOXIC NEURODEGENERATION
|
|
ALOE, L.
|
NERVE GROWTH FACTOR EYE APPLICATION PROTECTS CHEMICALLY INJURED RAT FOREBRAIN CHOLINERGIC NEURONS IN RATS
|
|
ALPAR, A.
|
DEPRIVATION-INDUCED DENDRITIC SHRINKAGE IS OPPOSITELY AFFECTED BY THE EXPRESSION OF WILD-TYPE AND MUTATED HUMAN AMYLOID PRECURSOR PROTEIN
|
|
ALVAREZ, A.
|
MODULATORY EFFECTS OF CEREBROLYSIN ON TNF-ALPHA AND IGF-I IN ALZHEIMER'S DISEASE
|
|
ALVAREZ, A.
|
STI571 PREVENTS APOPTOSIS, TAU PHOSPHORYLATION, AND BEHAVIORAL IMPAIRMENTS INDUCED BY ALZHEIMER'S Β-AMYLOID DEPOSITS
|
|
ALVAREZ, A.
|
INFLAMMATORY BIOMARKERS ARE ASSOCIATED WITH LOW IGF-I LEVELS AND DISABILITY IN ALZHEIMER'S DISEASE
|
|
ALVAREZ, A.
|
CEREBROLYSIN, DONEPEZIL AND A COMBINATION THERAPY IN ALZHEIMER'S DISEASE: RESULTS OF A DOUBLE-BLIND CLINICAL TRIAL
|
|
ALVAREZ, H.
|
VERBAL FLUENCY IN AMNESTIC MILD COGNITIVE IMPAIRMENT: A PATTERN CHARACTERISTIC OF ALZHEIMER´S TYPE DEMENTIA
|
|
AMADIO, M.
|
NEURONAL ELAV PROTEINS AS A NEW TARGET FOR BETA-AMYLOID: IMPLICATIONS FOR ALZHEIMER'S DISEASE
|
|
AMADORO, G.
|
ENDOGENOUSLY OVERPRODUCED AΒ CAUSES CELL DEATH IN NGF-DEPRIVED HIPPOCAMPAL NEURONS VIA EARLY TAU HYPERPHOSPHORYLATION
|
|
AMES, D.
|
THE BIMODALITY OF HEALTHY AGEING: HOW DO THE DIFFERING PROFILES OF HEALTHY CONTROLS COMPARE TO PATIENTS WITH MILD COGNITIVE IMPAIRMENT?
|
|
AMES, D.
|
CORRELATES OF CAREGIVER BURDEN BY HENRY BRODATY, KARYN BOUNDY, MICHAEL WOODWARD, DAVID AMES AND THE PRIME RESEARCH GROUP
|
|
AMICI, S.
|
PLASMA LEVELS OF DIFFERENT ISOFORMS OF VITAMIN E AND COQ10 AND BRAIN ATROPHY: RESULTS FROM THE ADDNEUROMED STUDY
|
|
AMORES GUEVARA, F.
|
INTRUSION AND PERSEVERATION AS A FRONTAL ERRORS IN ALZHEIMER'S DISEASE
|
|
AN, S.
|
DIAGNOSING AD BY DETECTING OLIGOMERIC FORM OF BETA-AMYLOID (AΒ) IN BLOOD
|
|
ANAND, V.
|
ENZYMOLOGICAL AND CELLULAR CHARACTERIZATION OF LRRK2 AND ITS ROLE IN PARKINSON'S DISEASE
|
|
ANDERSON, T.
|
COGNITIVE IMPAIRMENT AND DEMENTIA IN PARKINSON'S DISEASE: MONTREAL COGNITIVE ASSESSMENT AND PROGRESSIVE HIPPOCAMPAL VOLUME REDUCTION.
|
|
ANDERSON, T.J.
|
ARTERIAL SPIN LABELING PERFUSION MRI IN THE CHARACTERIZATION OF ABNORMAL PERFUSION PATTERNS IN EARLY, DRUG-NAÏVE PARKINSON'S DISEASE
|
|
ANDERSSON, L.C.
|
INVOLVEMENT OF STANNIOCALCIN-1 IN NEURODEGENERATION
|
|
ANDERSSON, M.
|
THE COGNITIVE PROFILE AND CSF BIOMARKERS IN DEMENTIA WITH LEWY BODIES AND PARKINSON'S DISEASE DEMENTIA
|
|
ANDERSSON, M.E.
|
THE NRF2 GENE NFE2L2 IS ASSOCIATED TO RISK AND AGE AT ONSET FOR SPORADIC PD
|
|
ANDREADIS, A.
|
REGULATION OF TAU SPLICING BY FACTORS LOCATED ON CHROMOSOME 21
|
|
ANDREOLI, V.
|
GENETIC SCREENING OF ALZHEIMER´S DISEASE GENES IN ITALIAN SAMPLES YIELDS NOVEL MUTATIONS IN PRESENILIN-ENHANCER 2
|
|
ANG, E.-T.
|
IRON TRANSPORTER DMT1 TRANSGENIC MOUSE AS A MODEL FOR OXIDATIVE STRESS: IMPLICATIONS FOR NEURODEGENERATIVE DISEASE
|
|
ANICHTCHIK, O.
|
EFFECTS OF ENDOGENOUS ALPHA-SYNUCLEIN ON DOPAMINERGIC CELLS NUMBER IN SUBSTANTIA NIGRA OF WILD TYPE AND TRANSGENIC MICE
|
|
ANTONINI, A.
|
LEVODOPA AND 3-OMD LEVELS IN PARKINSON PATIENTS TREATED WITH DUODOPA
|
|
ANZOLA, G.
|
EARLY DYSAUTONOMIC DYSFUNCTION REVEALED BY CEREBROVASCULAR RESERVE TESTING IN MCI: A TRANSCRANIAL DOPPLER STUDY
|
|
APOSTOLOVA, L.
|
3D MAPPING OF HIPPOCAMPAL, CAUDATE AND VENTRICULAR CHANGES IN PARKINSON'S DISEASE WITH AND WITHOUT DEMENTIA
|
|
ARENA, M.G.
|
DOES GLUTEN SENSITIVITY PLAY A ROLE IN ALZHEIMER´S DISEASE?
|
|
ARIAS, C.
|
AGE-DEPENDENT Β-AMYLOID TOXICITY CORRELATES WITH CHANGES IN ANTIOXIDANT COMPETENCE IN SYNAPTOSOMES
|
|
ARIAS, C.
|
MODIFICATION OF WNT SIGNALING DURING AGING AND ITS ROLE ON GSK-3Β-INDUCED TAU PHOSPHORYLATION
|
|
ARISI, I.
|
MICRORNA GENE EXPRESSION PROFILE IN THE BRAIN OF AN ANTI-NGF TRANSGENIC MOUSE MODEL OF ALZHEIMER'S LIKE NEURODEGENERATION
|
|
ARMATO, U.
|
AMYLOID-BETA PEPTIDE INDUCES HIF TRANSCRIPTION FACTOR AND VEGF EXPRESSION IN CULTURED NORMAL ADULT HUMAN ASTROCYTES
|
|
ARMENTERO, M.-T.
|
DIFFERENTIAL ALTERATIONS OF KEY REGULATORY KINASES IN PERIPHERAL BLOOD LYMPHOCYTES OF PATIENTS WITH PARKINSON´S OR ALZHEIMER´S DISEASE
|
|
ASANO, S.
|
EFFECTS OF DONEPEZIL IN PATIENTS WITH VARIOUS TYPE OF DEMENTIA
|
|
ATTAR, A.
|
RATIONALLY DESIGNED SMALL MOLECULE INHIBITOR OF AMYLOID-BETA-PROTEIN ASSEMBLY RESCUES SPATIAL WORKING MEMORY DEFICITS IN A MOUSE MODEL OF ALZHEIMER'S DISEASE
|
|
ATTEMS, J.
|
SECRETAGOGIN AND NEUROPROTECTION (TAU) IN ALZHEIMER´S DISEASE; HUMAN AND TRANSGENIC MOUSE (P301L) STUDIES
|
|
AYTON, S.
|
THE AMYLOID PRECURSOR PROTEIN PROTECTS AGAINST 1-METHYL-4-PHENYL-1,2,3,6-TETRQHYDROPYRIDINE (MPTP) TOXICITY
|
|
BABA, Y.
|
LUMBER BACK PAIN IN PARKINSON DISEASE: RELATION TO DA AGONISTS?
|
|
BABALOLA, K.S.
|
ALZHEIMER´S DISEASE AND PARKINSON´S DISEASE
|
|
BABUSIKOVA, E.
|
EFFECT OF ISCHEMIA INJURY ON THE METABOLISM OF THE AMYLOID PRECURSOR PROTEIN
|
|
BACHERYKOV, A.
|
CRANIOCEREBRAL HYPOTHERMIA IN TREATMENT ALZHEIMER`S DESEASE
|
|
BAGNOLI, S.
|
ASSOCIATION STUDY BETWEEN VASCULAR ENDOTHELIAL GROWTH FACTOR GENE (VEGF) AND ITALIAN SPORADIC ALZHEIMER'S DISEASE
|
|
BAJIC, N.
|
PROTEASOME DYSFUNCTION AS A MODEL OF DEMENTIA WITH LEWY BODIES AND PARKINSON'S DISEASE DEMENTIA
|
|
BALASH, Y.
|
SUBJECTIVE MEMORY COMPLAINTS AS A MANIFESTATION OF DEPRESSION IN COGNITIVELY NORMAL AND IMPAIRED ELDERS
|
|
BALASH, Y.
|
SUBJECTIVE MEMORY DECLINE IN HEALTHY COMMUNITY DWELLING ELDERS
|
|
BALÁŽ, M.
|
THE EFFECT OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON COGNITIVE EVENT RELATED POTENTIALS FROM THE SUBTHALAMIC NUCLEUS IN PARKINSON'S DISEASE
|
|
BALDUCCI, C.
|
SYNTHETIC AB1-40 OLIGOMERS SPECIFICALLY INDUCE COGNITIVE DEFICITS IN RECOGNITION MEMORY IN MICE
|
|
BAMMENS, L.
|
CHARACTERIZATION OF THE PEN-2 KNOCK OUT MOUSE
|
|
BAMMENS, T.
|
Α-SYNUCLEIN-INDUCED CELL DEATH IN AGED YEAST REQUIRES FUNCTIONAL MITOCHONDRIA
|
|
BANDOPADHYAY, R.
|
PHOSPHO-ALPHA-SYNUCLEIN EXPRESSION IN LRRK2 G2019S MUTATED POST-MORTEM BRAINS
|
|
BANERJEE, P.
|
MEMANTINE LOWERS Β-AMYLOID LEVELS: EVIDENCE FROM PRECLINICAL STUDIES
|
|
BANIHANI, S.
|
CROSSING OF NEURONAL PATHWAYS
|
|
BARBOV, I.
|
THE PHENOMENOLOGY OF THE BEHAVIORAL DISTURBANCES IN THE ALZHEIMER´S AND VASCULAR DEMENTIA
|
|
BARTNIK, D.
|
CHARACTERIZATION OF SMALL D-ENANTIOMERIC PEPTIDES FOR DIAGNOSIS AND THERAPY OF ALZHEIMER´S DISEASE
|
|
BARTOŠ, A.
|
A POTENTIAL NEW BIOMARKER OF ALZHEIMER DISEASE: COMPLEX OF MITOCHONDRIAL ENZYME 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 10 AND AMYLOID BETA PEPTIDES
|
|
BARTOVA, P.
|
TRANSCRANIAL SONOGRAPHY IN PARKINSON´S DISEASE DIAGNOSTICS
|
|
BARZILAY, R.
|
LENTIVIRAL DELIVERY OF LMX1A ENHANCES DOPAMINERGIC PHENOTYPE IN DIFFERENTIATED HUMAN BONE MARROW MESENCHYMAL STEM CELLS
|
|
BASKYS, A.
|
RAMELTEON (ROZEREM) IN THE TREATMENT OF SLEEP DISTURBANCES ASSOCIATED WITH PARKINSON´S DISEASE
|
|
BASKYS, A.
|
GENE EXPRESSION ANALYSIS OF PERIPHERAL BLOOD IN PATIENTS WITH ALZHEIMER´S DISEASE
|
|
BATELLI, S.
|
DEVELOPMENT OF A MOUSE MODEL OF DOPAMINERGIC DEGENERATION USING 6-HYDROXYDOPAMINE AND TAT-FUSED ALPHA-SYNUCLEIN
|
|
BATTAGIRI, P.
|
IMPROVING SHORT-TERM MEMORY LOSS IN PATIENTS WITH ALZHEIMER'S DEMENTIA USING SMARTPHONE APPLICATION FOR CAPTURING DAILY LIFE MOMENTS
|
|
BAUMANN, C.
|
VIGILANCE IMPAIRMENT AND ITS ASSOCIATION WITH SEVERITY OF MOTOR SYMPTOMS, DEPRESSION, COGNITION, AND DOPAMINERGIC TREATMENT IN IDIOPATHIC PARKINSON'S DISEASE
|
|
BAZZINI, E.
|
CALCIUM HOMEOSTASIS IS DYSREGULATED IN PARKINSONIAN PATIENTS WITH L-DOPA INDUCED DYSKINESIAS
|
|
BECKER, T.
|
THE ROLE OF PHOSPHOLIPID TRANSFER PROTEIN (PLTP) AT THE BLOOD-BRAIN BARRIER (BBB) AND IN THE BRAIN
|
|
BECKETT, T.L.
|
EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) ON AMYLOID PATHOLOGY IN MUSCLE
|
|
BEDARD, C.
|
DOPAMINERGIC AND SEROTONINERGIC STRIATAL SYSTEMS ARE SIMILARLY ALTERED IN PARKINSON'S DISEASE AND HUNTINGTON'S CHOREA
|
|
BEECHAM, G.W.
|
GENOME-WIDE ASSOCIATION OF COPY NUMBER ABERRATIONS IN LATE-ONSET ALZHEIMER DISEASE
|
|
BELANGER JASMIN, S.
|
PCSK9 GENETIC VARIANTS AND ALZHEIMER'S DISEASE RISK
|
|
BELYAEV, N.
|
DE-REPRESSION OF THE NEPRILYSIN GENE BY HISTONE DEACETYLASE INHIBITORS AS A POSSIBLE THERAPEUTIC STRATEGY IN ALZHEIMER'S DISEASE
|
|
BENITEZ, M.L.
|
TRAFFICKING, PROCESSING AND SIGNALING OF APOER2 IN NIEMANN-PICK TYPE C DISEASE MODELS
|
|
BENSENY-CASES, N.
|
ALZHEIMER'S PEPTIDE AΒ(1-28) AND PRION PROTEIN FRAGMENT PRP(185-208) FIBRIL FORMATION - IMPORTANCE OF ELECTROSTATIC AND AROMATIC STACKING INTERACTIONS
|
|
BERGER, Z.
|
BIOCHEMICAL ANALYSIS OF LRRK2 CONFORMATIONS AND ACTIVITY
|
|
BERGLUND, P.
|
IMPROVEMENT AND HALTED DEVELOPMENT OF FATIGUE AND ASTENO-EMOTIONAL SYNDROME IN PARKINSON´S DISEASE AFTER DEEP BRAIN STIMULATION
|
|
BERKOWITZ, L.
|
RATER TRAINING: EVALUATION OF TWO DIFFERENT TRAINING METHODOLOGIES
|
|
BERKOWITZ, L.
|
RATER TRAINING ON UNIFIED PARKINSON´S DISEASE RATING SCALE (UPDRS ) MOTOR SECTION (PART III)
|
|
BERKOWITZ, L.
|
RATER TRAINING ON UPDRS (PART III) MOTOR SECTION
|
|
BERMAN, D.
|
THE ROLE OF PIP2 PHOSPHATASE SYNAPTOJANIN 1 IN ALZHEIMER´S DISEASE-LINKED SYNAPTIC AND NEUROBEHAVIORAL DYSFUNCTION
|
|
BERSON, A.
|
ACETYLCHOLINESTERASE SPLICE VARIANTS EXERT INVERSE EFFECTS ON ALZHEIMER´S NEUROPATHOLOGY
|
|
BERTI, V.
|
BRAIN METABOLIC CORRELATES OF DOPAMINERGIC DEGENERATION IN DE NOVO IDIOPATHIC PARKINSON'S DISEASE PATIENTS
|
|
BETTENS, K.
|
GENETIC VARIABILITY AT MIRNA SITES WITHIN THE 3´ UTR OF APP AND BACE1 HAS NO MAJOR ROLE IN ALZHEIMER´S DISEASE
|
|
BEZPROZVANNY, I.
|
EVALUATION OF DIMEBON IN CELLULAR MODEL OF HUNTINGTON'S DISEASE
|
|
BHALLA, P.
|
PROTECTIVE ROLE OF LITHIUM IN ALUMINIUM-INDUCED STRUCTURAL AND FUNCTIONAL ALTERATIONS
|
|
BHAT, A.
|
CHARACTERIZATION OF MICROGLIAL CELL DYNAMICS AROUND BETA-AMYLOID PLAQUES IN A TRANSGENIC MICE
|
|
BIANCHI, F.
|
BIOINFORMATIC IDENTIFICATION AND EXPERIMENTAL CARACTHERIZATION OF HSP47 AS A NOVEL FUNCTIONAL PARTNER OF APP
|
|
BICA, L.
|
METAL-BIS (THIOSEMICARBAZONATO) COMPLEXES INCREASE EXPRESSION OF SYNAPTIC PROTEIN AND MODULATE NEURITE OUTGROWTH IN NEURONAL CELL CULTURES
|
|
BIRKMANN, E.
|
SINGLE PARTICLE DETECTION AS TOOL FOR DIAGNOSIS AND MONITORING OF DISEASES ASSOCIATED WITH PROTEIN AGGREGATION
|
|
BITAN, G.
|
RATIONALLY DESIGNED INHIBITORS OF AMYLOID ß-PROTEIN ASSEMBLY AND TOXICITY
|
|
BLAAS, E.
|
HIGH-CONTENT SCREENING OF CANDIDATE GENES FOR PARKINSON'S DISEASE
|
|
BLANC, F.
|
COGNITIVE DYSFUNCTIONS IN PRIMARY SJÖGREN SYNDROME
|
|
BLANDINI, F.
|
FUNCTIONAL AND NEUROCHEMICAL CHANGES OF THE GASTROINTESTINAL TRACT IN A RODENT MODEL OF PARKINSON'S DISEASE: RELEVANCE TO THE HUMAN DISEASE
|
|
BLOUKI ASLI, S.
|
ASTROCYTES PROTECT NT2 NEURONS AGAINST OXIDATIVE STRESS-INDUCED AMYLOID Β BY NRF2 DEPENDENT MECHANISM
|
|
BOCHE, D.
|
ACTIVATION OF MICROGLIA IN ALZHEIMER'S DISEASE FOLLOWING AΒ42 IMMUNISATION: GOOD OR BAD?
|
|
BODDEN, M.
|
RELATIONSHIP BETWEEN THEORY OF MIND AND EXECUTIVE FUNCTIONS IN PARKINSON'S DISEASE
|
|
BOGDANOV, R.
|
TIME PARAMETERS OF SACCADIC EYE MOVEMENTS AS ADDITIONAL MARKERS OF DIFFERENTIAL DIAGNOSTICS OF EXTRAPYRAMIDAL DISORDERS
|
|
BOLOGNIN, S.
|
EFFECTS OF BETA AMYLOID-METAL COMPLEXES ON SH-SY5Y NEUROBLASTOMA CELLS: GENE EXPRESSION PROFILE ANALYSIS
|
|
BONANNI, L.
|
P300 RESPONSE IN EARLY DLB AND AD PATIENTS
|
|
BONNE HERNANDEZ, R.
|
DEVELOPMENT NEUROTOXICOLOGICAL RISK ASSESSMENT OF THE MANGANESE (DNTRAM): ROLE OF CHEMICAL SPECIATION AND CELL TYPE
|
|
BONTE, F.
|
REDUCING DISTRESS FACED BY CAREGIVER OF PATIENTS WITH DEMENTIA, IN PSYCHOGERIATRIC DAYCARE HOSPITAL
|
|
BORAH, A.
|
SALICYLIC ACID AND MELATONIN PROTECT AGAINST STRIATAL GENERATION OF 6-OHDA IN RODENTS TREATED WITH L-DOPA AND MPTP
|
|
BORDJI, K.
|
EXTRASYNAPTIC NMDA RECEPTORS ACTIVATION MEDIATES SPECIFIC APP PROCESSING AND INCREASE NEURONAL Β-AMYLOID PRODUCTION
|
|
BOSCO, D.
|
PATHOLOGICAL GAMBLING RELATED TO DOPAMINERGIC THERAPY IN PARKINSON´S DISEASE: IT IS ALWAYS A REVERSIBLE EFFECT?
|
|
BOSTRÖM, F.
|
CSF T-TAU PREDICTS SURVIVAL IN DEMENTIA WITH LEWY BODIES
|
|
BOUMAN, L.
|
OPPOSING EFFECTS OF CYTOSOLIC AND ER STRESS PATHWAYS ON THE TRANSCRIPTIONAL REGULATION OF PARKIN
|
|
BOWTHORPE, J.
|
LYMPHOPENIA IN IDIOPATHIC PARKINSONISM: AN AETIOLOGICAL CLUE
|
|
BOZSÓ, Z.
|
THE SYNTHESIS AND STRUCTURAL STUDY OF ISO-Aß(1-42)
|
|
BRAITHWAITE, S.
|
AUTOPHOSPHORYLATION OF JNK3: POTENTIAL ROLES IN TAU PHOSPHORYLATION AND DYNAMICS
|
|
BRAUN, R.
|
MECHANISTIC DISSECTION OF CELL DEATH PATHWAYS IN A YEAST MODEL FOR NEUROTOXICITY IN FTD/AD
|
|
BRAUNER, D.
|
CHARACTERIZING THE ADVOCATE IN THREE PERSON DECISION-MAKING DISCOURSE FOR PATIENTS WITH DEMENTIA
|
|
BRAVO-ZEHNDER, M.
|
MEMORY IMPAIRMENT BY AUTOANTIBODIES RELATED TO NEUROPSIQUIATRIC LUPUS
|
|
BROADSTOCK, M.
|
BIOCHEMICAL CHARACTERISATION OF A TRANSGENIC MOUSE (JACKSON) MODEL OF ALZHEIMERS FED A PRO-OXIDANT DIET (I)
|
|
BROADSTOCK, M.
|
BIOCHEMICAL CHARACTERISATION OF A TRANSGENIC MOUSE (TASTPM) MODEL OF ALZHEIMERS FED A PRO-OXIDANT DIET (II)
|
|
BROERSEN, K.
|
RISK FACTORS FOR ALZHEIMER´S DISEASE FURTHER EXPLORED: THE EFFECT OF PEPTIDE LENGTH AND LIPIDS ON BETA AMYLOID TOXICITY
|
|
BROMBERG, E.
|
CONTEXTUAL MEMORY AND COGNITIVE RESERVE IMPAIRMENT IN EARLY STAGES OF PARKINSON DISEASE
|
|
BROOKS, D.J.
|
AN OPEN-LABEL, ADAPTIVE PET STUDY TO ASSESS ADENOSINE A2A BRAIN RECEPTOR OCCUPANCY OF BIIB014 IN HEALTHY MALE VOLUNTEERS
|
|
BROUGHTON, E.
|
COMPARING A BEDSIDE TIMED MOTOR ASSESSMENT TOOL (BT-MAT) WITH THE UPDRS-III TO MEASURE CLINICAL FEATURES AND L-DOPA RESPONSE IN PARKINSON'S DISEASE
|
|
BROUILLETTE, J.
|
INTERACTION BETWEEN TOXIC AMYLOID-BETA OLIGOMERS AND TAU IN THE INDUCTION OF ALZHEIMER PHENOTYPE
|
|
BROUWERS, N.
|
NO MAJOR ROLE FOR TARDBP IN ALZHEIMER GENETIC ETIOLOGY
|
|
BROWN, B.
|
THE ROLE OF PHYSICAL ACTIVITY ON BLOOD BIO-MARKERS RELATED TO ALZHEIMER'S DISEASE
|
|
BROWN, D.
|
METAL BINDING TO SYNUCLEINS AND ITS CONSEQUENCES
|
|
BROWNE, S.
|
TIME COURSE OF A PROGRESSIVE MOTOR PHENOTYPE IN THE MITOPARK MOUSE MODEL OF PD
|
|
BRUECKNER, M.K.
|
THE PHYSIOLOGICAL LINK BETWEEN METABOLIC RATE DEPRESSION AND TAU PHOSPHORYLATION: WHAT HIBERNATING ANIMALS CAN TEACH US ABOUT ALZHEIMER'S DISEASE
|
|
BRUGG, B.
|
RETROGRADE PROPAGATION OF APOPTOTIC SIGNALS IN CNS NEURONS: STUDY IN MICROFLUIDIC CULTURE CHAMBERS
|
|
BRUINSMA, I.
|
SMALL HEAT SHOCK PROTEINS INHIBIT THE AGGREGATION OF Α-SYNUCLEIN
|
|
BRUINSMA, I.
|
HIGHLY SULPHATED GLYCOSAMINOGLYCANS ARE IMPORTANT IN THE INTERACTION WITH THE AMYLOID Β PROTEIN
|
|
BRUNI, A.C.
|
WORLDWIDE DISTRIBUTION OF PSEN1 MET146LEU MUTATION: A LARGE VARIABILITY FOR A FOUNDER MUTATION
|
|
BUCHHAVE, P.
|
SOLUBLE TNF RECEPTORS ARE ASSOCIATED WITH AΒ METABOLISM AND CONVERSION TO DEMENTIA IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT
|
|
BUCK, K.
|
CONTINUOUS DOPAMINERGIC STIMULATION USING PRAMIPEXOLE IS EFFECTIVE TO TREAT EARLY MORNING AKINESIA IN ANIMAL MODELS OF PARKINSON'S DISEASE
|
|
BUGOS, O.
|
SEX DOES NOT INFLUENCE THE LOAD OF NEUROFIBRILLARY TANGLES IN THE BRAIN OF TRANSGENIC RAT MODEL OF HUMAN NEURODEGENERATIVE TAUOPATHY
|
|
BULBARELLI, A.
|
PIN1 INVOLVEMENT IN MODULATION OF TAU PHOSPHORYLATION IN A CELLULAR MODEL OF ALZHEIMER DISEASE
|
|
BULET, P.
|
AN INTEGRATED RESEARCH PLATFORM FOR NEURODEGENERATIVE DISORDERS' STUDIES: THE BIOPARK OF ARCHAMPS
|
|
BURDULADZE, I.
|
RESTLESS LEG SYNDROME IN NEUROLOGICAL CLINIC PATIENTS
|
|
BURG, V.
|
MECHANISTIC LINK BETWEEN CHOLESTEROL METABOLISM AND APP PROCESSING
|
|
BURGOS, J.
|
NST0021, AN EFFICIENT MOLECULE TO PREVENT THE NEURODEGENERATION IN AN ALZHEIMER´S DISEASE MOUSE MODEL
|
|
BURLAKOVA, E.
|
THE CHANGES IN THE LIPID PHASE OF BRAIN CELL MEMBRANES IN MICE BEARING EXPERIMENTAL ALZHEIMER'S-LIKE DISEASE
|
|
BÜTTNER, S.
|
Α-SYNUCLEIN KILLS AGED YEAST DEPENDING ON MITOCHONDRIAL FUNCTION
|
|
BYKANOVA, M.
|
MOTOR AND NON MOTOR FLUCTUATIONS AT MEN AND WOMEN WITH PARKINSON DISEASE
|
|
CAGNIN, A.
|
A HAPLOTYPE OF THE MTHFR GENE IS PROTECTIVE AGAINST ALZHEIMER'S DISEASE
|
|
CAIXETA, L.
|
NEUROANATOMIC CORRELATIONS IN DEMENTIA IN THE PRESENCE OR ABSENCE OF EXTRAPYRAMIDAL SYMPTOMS
|
|
CALLER, T.
|
DEEP BRAIN STIMULATION OF THE SUBTHALAMIC NUCLEUS VERSUS GLOBUS PALLIDUS FOR PARKINSON´S DISEASE: A SYSTEMATIC REVIEW
|
|
CAMINS, A.
|
COMPLEX II INHIBITION INDUCES CELL CYCLE ACTIVATION IN STRIATAL NEURONS FROM RATS
|
|
CAMOZZATO, A.L.
|
IMPLEMENTATION OF THE BRAZILIAN GUIDELINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
|
CAMOZZATO, A.L.
|
PREDICTORS OF TWELVE-YEAR MORTALITY IN ELDERLY FROM A CATCHMENT AREA IN THE CITY OF PORTO ALEGRE, SOUTHERN BRAZIL
|
|
CAMOZZATO, A.L.
|
DETECTION VALIDITY OF THE BRAZILIAN PORTUGUESE ALFI-MMSE TELEPHONE VERSION FOR ALZHEIMER'S DISEASE
|
|
CANKURTARAN, M.
|
CORRELATION BETWEEN INTRAERYTHROCYTE IRON LEVELS AND COGNITIVE FUNCTIONS IN ELDERLY PATIENTS
|
|
CANNEVA, F.
|
A NOVEL TRANSGENIC RAT MODEL WITH A FULL ALZHEIMER'S-LIKE AMYLOID PATHOLOGY DISPLAYING INTRACELLULAR AΒ-ASSOCIATED COGNITIVE IMPAIRMENT
|
|
CANZONIERO, L.M.T.
|
BRAIN PROTEIN ANALYSIS IN 3XTG-AD MICE BY A 2D-E AND BLUE NATIVE-PAGE COMBINED APPROACH
|
|
CAPPAI, R.
|
DOPAMINE AND THE DOPAMINE OXIDATION PRODUCT 5,6-DIHYDROXYLINDOLE PROMOTE DISTINCT ON AND OFF-PATHWAY AGGREGATION OF Α-SYNUCLEIN IN A PH DEPENDENT MANNER
|
|
CARAMELLI, A.
|
AUTOIMMUNE PARKINSONISM: A CASE REPORT
|
|
CARBALLO-CARBAJAL, I.
|
MUTATIONS IN LEUCINE-RICH REPEAT KINASE-2 (LRRK2) CAUSE A DELAY IN THE ACTIVATION OF EXTRACELLULAR SIGNAL-REGULATED KINASES (ERK)
|
|
CARDONA, F.
|
IN SILICO ANALYSIS OF PINK1 PARKINSON RELATED KINASE - PHYLOGENETIC AND STRUCTURAL APPROACHES
|
|
CARLSON, A.
|
PROGRANULIN AS A POTENTIAL BIOMARKER FOR ALZHEIMER´S DISEASE AND RELATED DISORDERS
|
|
CARNEVALE, D.
|
A MURINE MODEL OF ARTERIAL HYPERTENSION TO STUDY THE ASSOCIATION BETWEEN SPORADIC ALZHEIMER'S DISEASE AND CARDIOVASCULAR RISK FACTORS
|
|
CARRANO, A.
|
NEUROPATHOLOGICAL CHARACTERISTICS OF CAPILLARY CEREBRAL AMYLOID ANGIOPATHY WITH DYSHORIC CHANGES
|
|
CARRO, E.
|
BENEFICIAL EFFECTS OF A TACRINE-MELATONIN HIBRID IN EXPERIMENTAL MODELS OF ALZHEIMER DISEASE
|
|
CARSON, R.
|
GENETIC VARIATION IN BACE1 INTERACTING PROTEINS (RTN3 AND PPIL2) DOES NOT INFLUENCE SUSCEPTIBILITY TO ALZHEIMER´S DISEASE
|
|
CATER, M.
|
CHARACTERIZATION OF THE FERROXIDASE ACTIVITY OF THE AMYLOID PRECURSOR PROTEIN (APP)
|
|
CATTEPOEL, S.
|
ANTIBODIES AND ANTIBODY FRAGMENTS AS THERAPEUTIC TOOLS IN TRANSGENIC MOUSE MODELS OF BRAIN AMYLOIDOSIS
|
|
CAZZANIGA, E.
|
CHANGES IN MEMBRANE PHOSPHOLIPIDS COMPOSITION AFFECT ABETA PEPTIDE TOXICITY ON NEURONAL CELL
|
|
CECCANTI, M.
|
EFFECTS OF ACUTE AND CHRONIC ALCOHOL INTAKE ON CORTICAL EXCITABILITY
|
|
CENINI, G.
|
EFFECTS OF OXIDATIVE AND NITROSATIVE STRESS ON P53 PRO-APOPTOTIC PROTEIN IN BRAIN FROM AMNESTIC MILD COGNITIVE IMPAIRMENT AND ALZHEIMER DISEASE
|
|
CENINI, G.
|
DIFFERENT OXIDATIVE PROFILES INDUCED BY OVEREXPRESSION OF MUTANT AND WILD-TYPE APP IN HEK CELLS
|
|
CENTE, M.
|
HUMAN TRUNCATED TAU PROTEIN INDUCES MITOCHONDRIAL DAMAGE AND OXIDATIVE STRESS IN A RODENT MODEL OF TAUOPATHY
|
|
CHALIMONIUK, M.
|
SERUM HUMAN TYPE IIA SECRETORY PHOSPHOLIPASE A2 AND PROINFLAMMATORY CYTOKINE CONCENTRATIONS ARE INCREASED IN PATIENTS WITH ATYPICAL AND IDIOPATHIC PARKINSONISM
|
|
CHALON, S.
|
FOLLOW-UP OF DOPAMINERGIC NEURON LOSS AND MICROGLIAL ACTIVATION IN A RAT MODEL OF PARKINSON´S DISEASE
|
|
CHANDRA, G.
|
DISRUPTION OF INTRANEURONAL CALCIUM HOMEOSTASIS BY NEUROLATHYRISM TOXIN, B-N-OXALYL AMINO-L-ALANINE (L-BOAA)
|
|
CHANG, M.-H.
|
EYE OF THE TIGER-LIKE MRI IN PARKINSONIAN VARIANT OF MULTIPLE SYSTEM ATROPHY
|
|
CHANG, N.-S.
|
TGF-B1 INDUCES TIAF1 SELF-ASSOCIATION THAT PROMOTES NEURONAL DEATH: PRESENCE OF TIAF1 AGGREGATES IN AD HIPPOCAMPI
|
|
CHANG, R.C.C.
|
WOLFBERRY POLYSACCHARIDE PROTECTS PRIMARY CORTICAL NEURONS FROM HOMOCYSTEINE-INDUCED NEUROTOXICITY
|
|
CHANG, Y.
|
ENCEPHALITIS LETHARGICA SYNDROME WITH MALIGNANT CATATONIA
|
|
CHANSON, J.-B.
|
COGNITIVE FUNCTIONS IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
|
|
CHATURVEDI, R.
|
ZUCKERKANDL´S ORGAN IMPROVES LONG-TERM SURVIVAL AND FUNCTION OF NEURAL STEM CELL DERIVED DOPAMINERGIC NEURONS IN PARKINSONIAN RATS
|
|
CHAVANT, F.
|
EFFECT OF AN INHIBITION OF TNFΑ ON COGNITIVE DEFICITS IN AN ANIMAL MODEL OF ALZHEIMER'S DISEASE
|
|
CHAVES, M.L.
|
CROSS-CULTURAL EFFECTS ON VERB RESPONSES IN FRENCH AND BRAZILIAN PORTUGUESE NATIVE SPEAKERS ALZHEIMER'S DISEASE PATIENTS
|
|
CHAVES, M.L.
|
TWO-YEAR SEVERITY PROGRESSION OF ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA IN BRAZILIAN PATIENTS
|
|
CHAVES, M.L.
|
SERUM LEVELS OF S100B IS ASSOCIATED TO FUNCTIONAL CONDITION AND OF NSE TO MORPHOLOGICAL STATUS IN ALZHEIMER'S DISEASE
|
|
CHECHIK, N.
|
MECHANISMS OF VASCULAR DEMENTIA
|
|
CHEN, C.-D.
|
THE ANTI-AGING PROTEIN KLOTHO IN NORMAL AGING, ALZHEIMER'S DISEASE AND CANCER
|
|
CHEN, C.-M.
|
INCREASED OXIDATIVE DAMAGE IN PERIPHERAL BLOOD CORRELATES WITH SEVERITY OF PARKINSON'S DISEASE
|
|
CHEN, S.-D.
|
THE PROTECTION OF CURCUMIN ON MPTP-INDUCED NIGRAL DOPAMINERGIC NEURONS INJURY
|
|
CHETSAWANG, B.
|
MELATONIN ATTENUATES INDUCTION OF BAX- AND CASPASE-DEPENDENT DEATH SIGNALING IN METHAMPHETAMINE-TREATED HUMAN NEUROBLASTOMA SH-SY5Y CULTURED CELLS
|
|
CHIBA, T.
|
ABETA CAUSES MEMORY IMPAIRMENT BY DISTURBING THE JAK2/STAT3 AXIS IN HIPPOCAMPAL NEURONS
|
|
CHO, H.
|
ANOSOGNOSIA IN ALZHEIMER DISEASE
|
|
CHO, J.
|
NONCLINICAL SAFETY AND PHARMACOKINETIC PROFILE OF AAD-2004 AS A PUTATIVE DISEASE-MODIFYING DRUG FOR NEURODEGENERATIVE DISEASES
|
|
CHO, Y.H.
|
NON SPATIAL TEMPORAL MEMORY DEFICITS IN APP/PS1, APP AND PS1 MICE
|
|
CHRISTENSEN, D.Z.
|
INTRACELLULAR AΒ CORRELATES WITH NEURON LOSS IN ALZHEIMER´S DISEASE
|
|
CHUGH, R.
|
PREVALENCE OF DEMENTIA AMONG INPATIENTS IN A UK DISTRICT GENERAL HOSPITAL
|
|
CHUMBURIDZE, S.
|
EFFICACY AND SAFETY OF LONG-TERM ATORVASTATIN TREATMENT IN PATIENTS WITH ALZHEIMER'S DISEASE
|
|
CHUN, W.
|
ACTIVATION OF GLYCOGEN SYNTHASE KINASE 3B INHIBITS AUTOPHAGIC DEGRADATION OF TAU
|
|
CHUNG, E.J.
|
USEFULNESS OF DIFFUSION WEIGHTED MRI FOR DIFFERENTIATION BETWEEN PD AND MSA-P
|
|
CICCOCIOPPO, F.
|
AMYLOID Β1-42 STIMULATED T CELLS EXPRESS PROTEIN KINASE C-Δ AND/OR PROTEIN KINASE C-Ζ IN ALZHEIMER DISEASE
|
|
CIOBICA, A.S.
|
SOME ASPECTS CONCERNING THE INTERACTION BETWEEN THE CHOLINERGIC AND NORADRENERGIC SYSTEMS IN LEARNING AND MEMORY PROCESSES IN RATS
|
|
CIOBICA, A.S.
|
CHANGES IN THE ACTIVITY OF THE ANTIOXIDANT ENZYMES IN 6-HYDROXYDOPAMINE-INDUCED RAT MODEL OF PARKINSON'S DISEASE
|
|
CIOBICA, A.S.
|
COGNITIVE DISORDERS IN 6-HYDROXYDOPAMINE-INDUCED RAT MODEL OF PARKINSON'S DISEASE
|
|
CLARK, C.
|
TEST-RETEST REPRODUCIBILITY OF PET AMYLOID IMAGING WITH 18F -AV-45
|
|
CLARK, C.
|
LUMBAR AND VENTRICULAR CONCENTRATIONS OF AD BIOMARKERS AND CORRELATION WITH HISTOPATHOLOGY IN PATIENTS WITH NORMAL PRESSURE HYDROCEPHALUS
|
|
CLARK, C.
|
CSF TAU AND AMYLOID Β1-42 IN AUTOPSY CONFIRMED PATIENTS WITH LATE-LIFE DEMENTIA - DIAGNOSTIC PERFORMANCE USING XMAP TECHNOLOGY
|
|
CLARK, C.
|
A COMPARISON OF MULTIPLEX XMAP LUMINEX AND ELISA AS CSF PATHOLOGICAL PEPTIDE ASSAYS FOR DIAGNOSIS OF ALZHEIMER´S DISEASE
|
|
CLAVERO, P.
|
COGNITIVE IMPAIRMENT IN PARKINSON´S DISEASE: A MRI VOXEL BASED MORPHOMETRY AND FDG-PET STUDY
|
|
COLAO, R.
|
FRONTOTEMPORAL DEMENTIA SPORADIC CASE ASSOCIATING TWO NOVEL TAU MUTATIONS. PART ONE: CLINICO - PATHOLOGICAL STUDY
|
|
COLOMBO, A.
|
JNK INFLUENCES APP PROCESSING, DEGRADATION AD AΒ FRAGMENTS PRODUCTION IN A IN VITRO AD MODEL
|
|
CORONA, C.
|
BENEFICIAL EFFECTS OF DIETARY SUPPLEMENTATION OF ZINC IN TRIPLE TRANSGENIC AD MICE
|
|
CORZO, L.
|
INFLUENCE OF VASCULAR RISK FACTORS ON COGNITIVE STATUS
|
|
COSTA, A.
|
THEORY OF MIND AND EXECUTIVE ABILITIES IN PATIENTS WITH PARKINSON'S DISEASE
|
|
COSTA, J.
|
PROTEOMICS OF PLASMA FROM PORTUGUESE PATIENTS WITH FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS
|
|
COSTA, R.O.
|
ROLE OF N-METHYL-D-ASPARTATE RECEPTORS IN ENDOPLASMIC RETICULUM STRESS INDUCED BY AMYLOID-BETA OLIGOMERS
|
|
COSTANTINI, L.
|
GENOTYPE-SPECIFIC THERAPEUTIC RESPONSES IN ALZHEIMER'S DISEASE
|
|
CRNEK-KUNSTELJ, V.
|
MODIFIED EMBRYO ORGAN CULTURE MODEL SYSTEM FOR PRECLINICAL STUDIES OF GROWTH FACTORS-INDUCED NEURAL TISSUE DIFFERENTIATION IN MAMMALS
|
|
CROZIER, R.
|
DISSOCIATION OF SYNAPTIC DYSFUNCTION AND BEHAVIOR IN A TAUOPATHY MOUSE MODEL (PRP-MAPT) OF ALZHEIMER'S DISEASE
|
|
CUETOS, F.
|
ACTION NAMING IS IMPAIRED IN PARKINSON DISEASE PATIENTS
|
|
CULLEN, V.
|
CATHEPSIN D EXPRESSION AFFECTS Α-SYNUCLEIN PROCESSING, AGGREGATION, AND TOXICITY IN VIVO
|
|
CZARNECKI, M.
|
PATTERN OF HIPPOCAMPAL MR SPECTROSCOPY IN PATIENTS WITH ALZHEIMER'S DISEASE
|
|
CZVITKOVICH, S.
|
EFFECTS OF DIFFERENT SECRETASE INHIBITORS ON APP PROCESSING IN PRIMARY CULTURES OF CHICKEN CORTICAL NEURONS
|
|
DARBY, D.
|
COMMUNITY SCREENING FOR EARLY SIGNS OF DEMENTIA
|
|
DARNAUD, T.
|
FAMILY IMPACT OF THE ALZHEIMER'S DISEASE, THE EMERGENCE OF A MODEL
|
|
DAUMAS, S.
|
AGE-INDEPENDENT IMPAIRMENT IN FORGETTING OF SPATIAL MEMORY IN PDAPP MICE (LINE 2613) AND ITS RELATIONSHIP TO BETA-AMYLOID LEVELS
|
|
DAVIS, A.
|
MUSCARINIC ACETYLCHOLINE RECEPTOR REGULATION OF AMYLOID PRECURSOR PROTEIN PROCESSING IN PRIMARY NEURONAL CULTURE
|
|
DE LEONNI STANONIK, M.
|
SELF TEST II: AN ENHANCED INSTRUMENT FOR THE DETECTION OF EARLY AD AND MCI -REQUIRING MINIMAL NON-PROFESSIONAL SUPERVISION
|
|
DE MAURO, S.
|
THE POLYMORPHIC REGION OF THE SEROTONIN TRANSPORTER GENE IS A RISK FACTOR FOR PARKINSON'S DISEASE AND RELATED DEPRESSION IN ITALY
|
|
DECAMP, E.
|
EFFECT OF THE PHOSPHODIESTERASE 4 INHIBITOR, HT-0712, ON DISCRIMINATION LEARNING AND LONG TERM RETRIEVAL IN AGED NON HUMAN PRIMATES
|
|
DECKER, M.
|
TACRINE/NO HYBRID MOLECULES SHOW IMPROVED ACTIVITIES IN VITRO COMPARED TO TACRINE, EXHIBIT PRO-COGNITIVE PROPERTIES IN VIVO, AND LACK TACRINE´S HEPATOTOXICITY
|
|
DECRAEMER, H.
|
IMPROVING ANALYTICAL PERFORMANCE OF MULTIPLEX TAU/PHOSPHO-TAU ASSAY IN PLASMA USING MAGPLEX™ MICROSPHERES
|
|
DEKUNDY, A.
|
INFLUENCE OF SUBTYPE 5 METABOTROPIC GLUTAMATE RECEPTOR (MGLUR5) ANTAGONISTS ON L-DOPA EFFECTS IN MODELS OF PARKINSON'S DISEASE AND L-DOPA-INDUCED DYSKINESIA
|
|
DELAY, C.
|
SYNPHILIN-1 ENHANCES Α-SYNUCLEIN AGGREGATION AND TOXICITY IN A YEAST MODEL FOR PARKINSON'S DISEASE
|
|
DEOGAONKAR, M.
|
ACCURACY OF TARGETING USING A FRAMELESS STEREOTACTIC TARGETING SYSTEM FOR DEEP BRAIN STIMULATION SURGERY
|
|
DEOGAONKAR, M.
|
ROLE OF FETAL DORSAL MESENCEPHALON AS A 'CONTROL' FOR INTRANIGRAL GRAFTS IN HEMIPARKINSONIAN RATS WITH DUAL TRANSPLANTS
|
|
DESIRE, L.
|
EHT 0202: A NEUROPROTECTIVE AND PROCOGNITIVE ALPHA-SECRETASE STIMULATOR TARGETED TOWARDS ALZHEIMER'S DISEASE THERAPY
|
|
DEXTER, D.
|
NEUROPROTECTIVE EFFECT OF THE MGLUR4 ALLOSTERIC POTENTIATOR PHCCC AND THE MGLUR8 AGONIST DCPG IN THE 6-OHDA RAT MODEL OF PARKINSON'S DISEASE
|
|
DEXTER, D.
|
STRESS IN MALES, BUT NOT FEMALES, MAY RENDER THE NIGROSTRIATAL SYSTEM SUSCEPTIBLE TO TOXIC INSULTS
|
|
DI CESARE, F.
|
A CLINICAL METHOD TO EVALUATE MEMORY AND SEMANTIC ORGANISATION IN CLINICAL RESEARCH
|
|
DIAZ, M.
|
ALTERED LIPID COMPOSITION IN LIPID RAFTS FROM ALZHEIMER´S DISEASE BRAIN CORTEX
|
|
DICKSTEIN, D.L.
|
CHANGES IN SPINE MORPHOLOGY BUT NOT SPINE DENSITY OCCUR WITH AGE IN TG2576 AD MICE
|
|
DIDIC - HAMEL COOKE, M.
|
AMNESTIC MCI PATIENTS FAILING ON A VISUAL RECOGNITION MEMORY TASK: A MULTIMETHODOLOGICAL NEUROMAGING PROFILE OF PREDEMENTIA AD
|
|
DIMANT, H.
|
MODULATION OF ALPHA SYNUCLEIN AGGREGATION BY FILAMENTOUS PHAGES IN A CELLULAR MODEL OF PARKINSON´S DISEASE
|
|
DINAMARCA, M.
|
IS NEUROLIGIN THE POSTSYNAPTIC RECEPTOR TARGET FOR AMYLOID-Β OLIGOMERS ?
|
|
DOBBS, R.J.
|
IMMUNO-INFLAMMATORY ACTIVATION AS A CAUSE OF INCREASED SERUM HOMOCYSTEINE CONCENTRATION IN IDIOPATHIC PARKINSONISM
|
|
DOBBS, S.
|
TIME TRENDS IN FACETS OF IDIOPATHIC PARKINSONISM DISSOCIATE FOLLOWING HELICOBACTER ERADICATION: AN EXPLANATION FOR HYPOKINESIA- AND RIGIDITY-PREDOMINANT SYNDROMES
|
|
DOBOS, N.
|
INDOLEAMINE 2,3 DIOXYGENASE AS A LINK BETWEEN NEUROINFLAMMATION AND DEPRESSION IN ALZHEIMER'S DISEASE?
|
|
DOBROTA, D.
|
INFLUENCE OF ISCHEMIA AND REPERFUSION ON AMYLOID PRECURSOR PROTEIN IN RAT HIPPOCAMPUS
|
|
DOHM, C.
|
BAG1 MEDIATED NEUROPROTECTION IN IN VIVO AND IN VITRO MODELS OF PARKINSON'S DISEASE
|
|
DOMINGUES, S.C.
|
THE ALZHEIMER'S AMYLOID PRECURSOR PROTEIN INTERACTS WITH THE RAN BINDING PROTEIN RANBPM
|
|
DOPPLER, E.
|
CEREBROLYSIN IN VASCULAR DEMENTIA: IMPROVEMENT OF CLINICAL OUTCOME IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL
|
|
DORMANN, D.
|
PROTEOLYTIC PROCESSING AND AGGREGATION OF TAR DNA BINDING PROTEIN-43 AFTER CASPASE ACTIVATION
|
|
DORSZEWSKA, J.
|
ASYMMETRIC DIMETHYLARGININE IN THE PLASMA OF PATIENTS WITH ALZHEIMER'S AND PARKINSON'S DISEASES
|
|
DRUKARCH, B.
|
TISSUE TRANSGLUTAMINASE (TTG): FRIEND OR FOE FOR NEURONAL SURVIVAL IN PARKINSON´S DISEASE?
|
|
DU, J.-R.
|
Z-LIGUSTILIDE PROTECTS AGAINST AMYLOID B-INDUCED CYTOTOXICITY IN SH-SY5Y CELLS
|
|
DU, J.-R.
|
PROTECTIVE EFFECT OF Z-LIGUSTILIDE AGAINST AMYLOID B-INDUCED NEUROTOXICITY IS ASSOCIATED WITH ANTI-NEUROINFLAMMATION IN RATS
|
|
DUBENKO, A.
|
DEMENTIA AND DEPRESSION IN ELDERLY - DIFFERENTIAL DIAGNOSTIC AND COMORBIDITY
|
|
DUCE, J.
|
ALZHEIMER´S DISEASE ß-AMYLOID PROTEIN PRECURSOR IS A FERROXIDASE THAT PROMOTES IRON EXPORT
|
|
DUPUIS, M.
|
DISAPPEARANCE OF ESSENTIAL TREMOR AFTER STROKE
|
|
EBERT, S.
|
RECURRENT SYSTEMIC INFECTIONS WITH STREPTOCOCCUS PNEUMONIAE DO NOT AGGRAVATE THE COURSE OF EXPERIMENTAL NEURODEGENERATIVE DISEASES
|
|
ECKERT, A.
|
TRANSGENIC MOUSE MODELS OF ALZHEIMER'S DISEASE: FROM PROTEOMICS TO FUNCTIONAL ASSAYS OF MITOCHONDRIA
|
|
EDLAND, S.D.
|
MITOCHONDRIAL SUBHAPLOGROUP H4 ASSOCIATION WITH ALZHEIMER´S DISEASE
|
|
EDWARDS-INGRAM, L.
|
METABOLIC STATUS AND YEAST ENDOGENOUS LOCI AFFECT RECOMBINANT Γ-SECRETASE ACTIVITY DERIVED FROM 4 CORE COMPONENTS
|
|
EFTEKHARZADEH, B.
|
STABILIZATION OF NRF2 BY TBHQ PREVENT OXIDATIVE STRESS-INDUCED AMYLOID Β FORMATION IN NT2 NEURONS
|
|
EISELE, Y.S.
|
EXOGENOUS INDUCTION OF PROTEIN AGGREGATION IN MOUSE MODELS OF DIFFERENT NEURODEGENERATIVE DISEASES
|
|
EKHOLM PETTERSSON, F.
|
AMYLOID-BETA PROTOFIBRILS ARE PRESENT IN ALZHEIMER DISEASE BRAIN AND LINKED TO EARLY COGNITIVE IMPAIRMENT IN APP TRANSGENIC MICE
|
|
EL MOUTAWAKIL, B.
|
DEMENTIA IN YOUNG PATIENTS
|
|
EL SAFTY, A.
|
PREVALENCE OF PARKINSONISM AMONG HEAVY METAL EXPOSED WORKERS
|
|
ELLAM, R.
|
MEMORY PROFILES AS PREDICTORS OF GLOBAL COGNITIVE DECLINE IN NONDEMENTED PATIENTS WITH PARKINSON´S DISEASE
|
|
ELLIS, K.
|
THE AIBL STUDY: BASELINE DATA FROM A MULTI-CENTRE, PROSPECTIVE LONGITUDINAL STUDY OF AGEING IN 1100 VOLUNTEERS
|
|
EMELYANOV, A.
|
DECREASED ALPHA-SYNUCLEIN LYMPHOCYTES LEVEL IN PATIENTS WITH LRRK2-ASSOCIATED PARKINSON'S DISEASE
|
|
EMRE, M.
|
A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 6-MONTH STUDY OF THE EFFICACY AND SAFETY OF MEMANTINE IN PATIENTS WITH PDD OR DLB
|
|
ENDO, T.
|
INCREASED BISECTING AND CORE FUCOSYLATED N-GLYCANS ON MUTANT HUMAN AMYLOID PRECURSOR PROTEINS
|
|
ENDRES, K.
|
THE EFFECTS OF ALPHA-SECRETASE ADAM10 ON THE PROTEOLYSIS OF NEUREGULIN-1
|
|
ENGBER, T.
|
EFFICACY AND STRIATAL ADENOSINE A2A RECEPTOR OCCUPANCY BY BIIB014 IN THE RAT HALOPERIDOL-INDUCED CATALEPSY MODEL
|
|
ENGELBORGHS, S.
|
IMPROVED DISCRIMINATION OF ALZHEIMER'S DISEASE (AD) FROM NON-AD DEMENTIAS USING CSF P-TAU181P
|
|
ENGELBORGHS, S.
|
RELATION BETWEEN FRONTAL LOBE SYMPTOMS AND DEMENTIA SEVERITY WITHIN AND ACROSS DIAGNOSTIC DEMENTIA CATEGORIES
|
|
ENGLUND, H.
|
LOWERING OF AMYLOID-Β42 IN ALZHEIMER CSF IS PARTLY DUE TO OLIGOMERIZATION - AΒ AGGREGATION COMPLICATES NON-DENATURING ANALYSES
|
|
ERMAK, G.
|
RCAN1-1L PROTECTS AGAINST POLYGLUTAMINE-HUNTINGTIN TOXICITY
|
|
ESMER, C.
|
ATTITUDES TOWARD GENETIC TESTING AMONG UNAFFECTED RELATIVES OF ALZHEIMER´S DISEASE PATIENTS FROM MEXICO
|
|
ESPAÑA AGUSTÍ, J.
|
INTRANEURONAL AΒ ACCUMULATION IN THE BASOLATERAL AMYGDALA ENHANCES FEAR AND ANXIETY IN TRANSGENIC MODELS OF ALZHEIMER'S DISEASE
|
|
ESPOSITO, L.
|
SYNUCLERE: DEVELOPMENT OF A NOVEL SMALL MOLECULE THAT EFFECTIVELY REDUCES ALPHA-SYNUCLEIN AGGREGATION AND IMPROVES MOTOR DYSFUNCTION
|
|
FABELO, N.
|
CHARACTERIZATION OF LIPID COMPOSITION IN LIPID RAFTS FROM HUMAN BRAIN CORTEX
|
|
FALCONER, H.
|
INHIBITORS OF THE INTERACTIONS BETWEEN 14-3-3 AND PARKIN
|
|
FANG, W.-S.
|
NATURAL PRODUCTS DERIVED Β-SECRETASE (BACE1) INHIBITORS: DISCOVERY, STRUCTURE-ACTIVITY RELATIONSHIP, AND BINDING SITE MAPPING
|
|
FELDMAN, A.L.
|
RISK OF DEMENTIA IN CO-TWINS OF PARKINSON´S DISEASE CASES
|
|
FENG, T.
|
COMPARISON OF CEREBRAL GLUCOSE METABOLISM BETWEEN ALZHEIMER'S DISEASE AND DEMENTIA WITH LEWY BODIES
|
|
FENG, T.
|
THE CORRELATION OF METABOLISM BETWEEN GLUCOSE AND DOPAMINE TRANSPORTER IN PATIENTS WITH PARKINSON'S DISEASE
|
|
FERNANDEZ-NOVOA, L.
|
POLYGENIC RISK FACTORS IN ALZHEIMER DISEASE: CALCULATION OF A GENETIC PREDISPOSITION SCORE (GPS)
|
|
FERNÁNDEZ-NOVOA, L.
|
IMMUNE STUDIES IN PERIPHERAL BLOOD OF PATIENTS WITH ALZHEIMER'S DISEASE
|
|
FERNÁNDEZ-NOVOA, L.
|
LOGISTIC REGRESSION AS A USEFUL TOOL TO EXPLAIN GENETIC RISK OF STROKE
|
|
FERNÁNDEZ-NOVOA, L.
|
CYP2D6, CYP2C19, CYP2C9 AND CYP3A5 POLYMORPHISMS IN THE SPANISH POPULATION
|
|
FERRAO SANTOS, S.
|
EXPRESSION OF HUMAN AMYLOID PRECURSOR PROTEIN IN RAT CORTICAL NEURONS INHIBITS CALCIUM OSCILLATIONS
|
|
FERRARI-TONINELLI, G.
|
MICROTUBULE-STABILIZING EFFECT OF NOTCH ACTIVATION IN PRIMARY CORTICAL NEURONS
|
|
FERREIRA, D.
|
COGNITIVE IMPAIRMENT CHARACTERIZATION AND FOLLOW-UP IN AMNESTIC MILD COGNITIVE IMPAIRMENT MULTIDOMAIN (AMCI-MD)
|
|
FERREIRO, E.
|
MITOCHONDRIAL DEPENDENCY FOR ER STRESS-MEDIATED CELL DEATH INDUCED BY THE AMYLOID-BETA PEPTIDE
|
|
FERRETTI, M.T.
|
INFLAMMATORY REACTION ASSOCIATED WITH INTRANEURONAL AΒ-OLIGOMERS AND COGNITIVE IMPAIRMENT PRIOR TO PLAQUE DEPOSITION IN A NEW ALZHEIMER'S TRANSGENIC MODEL
|
|
FETT, M.E.
|
A NOVEL VERTEBRATE MODEL TO STUDY THE FUNCTION OF PARKIN
|
|
FIGUEIREDO-PEREIRA, M.
|
PROSTAGLANDIN J2: A PRODUCT OF INFLAMMATION THAT CAUSES ALZHEIMER'S- AND PARKINSON'S-LIKE PATHOLOGY
|
|
FILIPKOWSKI, R.
|
MICE WITH ALZHEIMER'S DISEASE (APP.V717I) LEARN IN SOCIAL CONTEXT
|
|
FILLIT, H.
|
MEMANTINE DISCONTINUATION DUE TO NON-MEDICAL REASONS IS ASSOCIATED WITH HEALTH STATUS DECLINE IN NURSING HOME RESIDENTS WITH ALZHEIMER'S DISEASE
|
|
FIORE, M.
|
PRENATAL EXPOSURE TO ETHANOL BUT NOT RED WINE CAUSES AGE-RELATED DEFICITS IN RODENTS
|
|
FIORENTINI, A.
|
LITHIUM EFFECTS ON ADULT NEUROGENESIS IN THE DENTATE GYRUS OF AN APP TRANSGENIC MOUSE MODEL
|
|
FISCHER, A.
|
EPIGENETIC CHANGES DURING THE PATHOGENESIS OF ALZHEIMER'S DISAEASE
|
|
FLACHBARTOVA, Z.
|
MULTIFACETED FOLDING OF PHF CORE TAU AFTER BINDING TO MONOCLONAL ANTIBODIES: IMPLICATIONS FOR PHF FORMATION
|
|
FLAX, J.
|
THE SAMPLE REGISTRY: SERIAL ALZHEIMER'S AND MCI PROSPECTIVE LONGITUDINAL EVALUATION
|
|
FONSECA, L.
|
BASAL GANGLIA DISORDERS AND STREPTOCOCCAL INFECTION
|
|
FORSTER, L.
|
VARIABLES ASSOCIATED TO MISDIAGNOSIS AMONG FRONTOTEMPORAL DEMENTIA (FTD) PATIENTS BEFORE EVALUATION BY A SPECIALIST
|
|
FOULDS, P.
|
CORRELATING PLASMA TDP-43 LEVELS WITH POST-MORTEM IMMUNOHISTOPATHOLOGY IN PATIENTS WITH ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION
|
|
FRANK, G.
|
IMPACT OF APOE EPSILON4 ON MEDIAL TEMPORAL LOBE ACTIVATION IN COGNITIVELY INTACT INDIVIDUALS AND PATIENTS WITH MILD COGNITIVE IMPAIRMENT
|
|
FROSINI, D.
|
NIGRO-STRIATAL DYSFUNCTION IN DIFFERENT CLINICAL PHENOTYPE OF PARKINSON'S DISEASE
|
|
FUH, J.-L.
|
VERBAL FLUENCY WAS RELATED TO THE CHANGES OF BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA IN PATIENTS WITH ALZHEIMER'S DISEASE
|
|
FUJIMAKI, H.
|
STIMULATING SIGNALING PATHWAY LEADING TO CREB-MEDIATED TARGET GENE TRANSCRIPTION RELATED TO LEARNING AND MEMORY IN HIPPOCAMPUS OF TOLUENE-EXPOSED MICE
|
|
FUJIOKA, T.
|
A TRADITIONAL CHINESE HERBAL MEDICINE YOKU-KAN-SAN AMELIORATES HALLUCINATIONS IN PARKINSON'S DISEASE
|
|
FUNG, H.-C.
|
STRUCTURAL STUDY OF MAPT IN ASIAN POPULATION AND POSITIVE ASSOCIATION OF MAPT WITH TAIWANESE ALZHEIMER'S PATIENTS
|
|
FUSARI, A.
|
IMPAIRED COGNITIVE PROCESSES IN ODOR TASKS: EFFECTS OF PARKINSON´S DISEASE
|
|
FUSARI, A.
|
ODOUR TASKS IN FORENSIC ASSESSMENT PREDICT NEUROLOGICAL DISORDERS
|
|
GABRYELEWICZ, T.
|
THE FREQUENCY OF PREVIOUS DIAGNOSIS OF MILD COGNITIVE IMPAIRMENT IN ALZHEIMER'S DISEASE PATIENTS: RESULTS FROM AN OBSERVATIONAL POLISH ABC-ADL-10 STUDY
|
|
GAINETDINOV, R.
|
POTENTIAL ROLE OF TRACE AMINE ASSOCIATED RECEPTOR 1 (TAAR1) IN MOVEMENT CONTROL
|
|
GAMA, M.J.
|
EFFECT OF PROTEASOME INHIBITION ON MPP+-INDUCED GSTP1 EXPRESSION IN SH‑SY5Y CELLS
|
|
GARCÍA-MARTÍN, A.
|
PATTERN OF EPISODIC MEMORY IN “DE NOVO” PARKINSON´S DISEASE
|
|
GARCIA-MIRALLES, M.
|
CHARACTERIZATION OF LRRK2 TRANSGENIC MICE
|
|
GARCÍA-RODRÍGUEZ, B.
|
EFFECTS OF AGING AND DEMENTIA ON IMPLICIT MEMORY FOR EMOTIONAL FACIAL EXPRESSIONS
|
|
GARCÍA-YAGÜE, Á.J.
|
REGULATION OF THE NUCLEAR LOCALIZATION AND PROTEASOMAL DEGRADATION OF NURR1
|
|
GARNER, B.
|
BIOACTIVE LIPIDS AND ATP-BINDING CASSETTE TRANSPORTERS AS MODULATORS OF EXTRACELLULAR AMYLOID-BETA CONCENTRATION
|
|
GAVILAN, M.P.
|
ACTIVATION OF THE UNFOLDED PROTEIN RESPONSE FOLLOWING PROTEASOME INHIBITION IS AFFECTED IN AGED RAT HIPPOCAMPUS
|
|
GAVRILOVA, S.
|
PLATELET CYTOCHROME C-OXIDASE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
|
|
GAVRILOVA, S.
|
GALANTAMINE IN THE TREATMENT OF BEHAVIOURAL AND PSYCHOTIC SYMPTOMS OF ALZHEIMER'S DISEASE IN PATIENTS WITH SEVERE DEMENTIA
|
|
GAWEDA-WALERYCH, K.
|
POSSIBLE INFLUENCE OF MITOCHONDRIAL TRANSCRIPTION FACTOR A VARIANTS ON THE RISK OF PARKINSON'S DISEASE
|
|
GEORGE, S.
|
Α-SYNUCLEIN TRANSGENIC MICE TREATED WITH ROTENONE HAVE ENHANCED Α-SYNUCLEIN EXPRESSION AND A MILD MOTOR DEFICIT
|
|
GEORGOPOULOS, S.
|
RAG-1 DEFICIENCY ENHANCES AMYLOID PLAQUE FORMATION IN AN ALZHEIMER TRANSGENIC MOUSE MODEL
|
|
GEPPERT, A.
|
PROTEIN S 100 IN AD AND VAD PATIENTS WITH MILD DEMENTIA
|
|
GERARD, M.
|
THE EFFECT OF FK506 BINDING PROTEINS ON Α-SYNUCLEIN AGGREGATION AND NEUROTOXICITY IN HUMAN NEUROBLASTOMA CELLS USING A HIGH-CONTENT ASSAY
|
|
GETOVA, D.
|
EFFECTS OF CHOLINESTERASE INHIBITOR GALANTAMINE ON SOME MODELS OF IMPAIRED MEMORY
|
|
GHANIMA, A.
|
INFLUENCE OF CHRONIC INHALATION OF MINE WASTES ON THE CENTRAL NERVOUS SYSTEM
|
|
GHAREEB, D.
|
EFFICACY OF NATURAL EXTRACTS AS ACETYLCHOLINESTERASE INHIBITORS, COMPARATIVE STUDY WITH ARICEPT® EFFECT
|
|
GHAREEB, D.
|
TOXIC EFFECTS OF LEAD EXPOSURE ON THE BRAIN OF RATS: THE BENEFICIAL ROLE OF FLAXSEED EXTRACT
|
|
GHIDONI, R.
|
THE NOVEL FAD-LINKED T719P APP MUTATION CLOSED TO THE Ε-CLEAVAGE SITE UNBALANCES THE RELATIVE PROPORTION OF C-TERMINALLY TRUNCATED AMYLOID-Β PEPTIDES
|
|
GHOLIZADEH, S.
|
THE ANXIOGENIC EFFECTS OF ABETA (1- 40) AND ABETA (1-42) IN THE DORSAL RAPHE NUCLEUS IN NON-TRANSGENIC MALE RATS
|
|
GIESERT, F.
|
GENERATION AND ANALYSIS OF THE R1441C-LRRK2 KNOCK-IN MOUSE MODEL
|
|
GIGI, A.
|
ERROR RATE AND SEQUENCE LEARNING IN PARKINSON´S DISEASE
|
|
GILANI, A.-H.
|
CURCUMINOIDS AFFECT MULTIPLE GENE EXPRESSION IN AMYLOID INFUSED MODEL OF ALZHEIMER'S DISEASE
|
|
GIL-BEA, F.
|
CHARACTERIZATION OF THIOREDOXIN-80 IN THE BRAIN ANT ITS RELEVANCE IN ALZHEIMER´S DISEASE
|
|
GILBERT, J.
|
VITAMIN D RECEPTOR: A GENETIC RISK FACTOR FOR ALZHEIMER DISEASE?
|
|
GILSTER, S.
|
QUALITY CARE FOR INDIVIDUALS WITH ALZHEIMER'S DISEASE TAKES AND ORGANIZATIONAL APPROACH: A 22 YEAR REVIEW AND REPORT
|
|
GILSTER, S.
|
BENEFITS OF AN ALZHEIMER´S DISEASE RESEARCH PROGRAM IN A LONG-TERM CARE FACILITY
|
|
GILSTER, S.
|
ORGANIZATIONAL MODEL RESEARCH RESULTS IN IMPROVED SUCCESS IN ALZHEIMER'S PROGRAMS AND LONG-TERM CARE
|
|
GIORGI, L.
|
SYMPTOM CONTROL IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE RECEIVING ADJUNCTIVE ROPINIROLE PROLONGED RELEASE VERSUS ROPINIROLE IMMEDIATE RELEASE: THE PREPARED STUDY
|
|
GLÖCKNER, P.
|
VIRAL GENE TRANSFER TO SLOW DOWN PROGRESSIVE NEURODEGENERATION
|
|
GLOECKNER, F.
|
APOLIPOPROTEIN E DEFICIENCY ENHANCES TAU HYPERPHOSPHORYLATION IN P301L MUTANT HUMAN TAU MICE
|
|
GODEMANN, R.
|
IDENTIFICATION OF FRAGMENT INHIBITORS OF Β-SECRETASE (BACE1)
|
|
GODINHO, C.
|
PREDICTORS OF COGNITIVE DYSFUNCTION AMONG COMMUNITY DWELLING ELDERLY IN SOUTHERN BRAZIL
|
|
GODINHO, C.
|
FUNCTIONAL DECLINE CONCOMITANT TO MENTAL STATUS STABILITY IN A 12-YEAR FOLLOW-UP OF BRAZILIAN HEALTHY ELDERLY
|
|
GODINHO, C.
|
COMPARISON OF COGNITIVE PERFORMANCE AND DEPRESSIVE SYMPTOMS BETWEEN HIGH CARDIOVASCULAR RISK AND HEALTHY COMMUNITY ELDERLY GROUPS
|
|
GOŁĄB-JANOWSKA, M.
|
IDENTIFICATION OF I213L MUTATION IN PSEN1 GENE IN A POLISH FAMILY
|
|
GOLDRING, K.
|
NEUROPATHOLOGICALLY AND CLINICALLY CHARACTERISTED PARKINSON´S, PARKINSON´S-LIKE DISORDER AND CONTROL BRAIN TISSUE AVAILABLE FOR A WIDE RANGE OF RESEACH PURPOSES
|
|
GOMES FRAGA, H.
|
MILD COGNITIVE IMPAIRMENT; RISK FACTORS AND ASSOCIATED DISEASES
|
|
GÓMEZ-SUAGA, P.
|
LRRK2 KINASE ACTIVITY INDUCES AUTOPHAGY IN CULTURED CELLS
|
|
GONZÁLEZ, M.F.
|
COMPARISON OF COGNITIVE FUNCTIONS BETWEEN ALZHEIMER'S AND PARKINSON'S DISEASE DEMENTIA PATIENTS IN LATE STAGES: A PILOT STUDY
|
|
GOSPODINOV, M.
|
CORRELATION AND PREDICTOR CHARACTERISTICS OF STATO-KINESI-COORDINO-METRY IN PATIENTS WITH PARKINSON'S DISEASE
|
|
GOSPODINOV, M.
|
DIFFERENTIAL INFORMATIVENESS OF CHRONOMETRICAL CHARACTERISTICS OF HIERARCHIC-COMPLICATED MOVEMENTS IN PATIENTS WITH PARKINSON'S DISEASE, ESSENTIAL OR PSYCHOGENIC TREMOR
|
|
GRAHAM, C.
|
INFLUENCE OF COGNITIVE STATUS IN PARKINSON´S DISEASE ON REFLEXIVE AND PREDICTIVE SACCADES
|
|
GRAHAM, S.M.
|
MEMANTINE TREATMENT IN PATIENTS WITH ALZHEIMER'S DISEASE: NEUROPSYCHOLOGICAL RESULTS FROM AN OPEN-LABEL, MULTI-CENTER BRAIN IMAGING TRIAL
|
|
GRANIC, I.
|
TNF EXPRESSING STEM CELLS SURROUNDING THE THIRD VENTRICLE OF AGED MOUSE AND HUMAN BRAIN WITH ALZHEIMER'S DISEASE PATHOLOGY
|
|
GRANIC, I.
|
Β-AMYLOID-DERIVED PENTAPEPTIDE LPYFD IS NEUROPROTECTIVE AGAINST AΒ-INDUCED TOXICITY AND MEMORY IMPAIRMENT
|
|
GREMBECKA, B.
|
HIGH FREQUANCY STIMULATION OF THE SUBTHALAMIC NUCLEUS EFFECTS ON LYMPHOCYTE POPULATIONS IN RATS DIFFERING IN SOCIAL POSITION
|
|
GRENIER, K.
|
DIRECT SEQUENCING OF CANDIDATE GENES FOR PARKINSON'S DISEASE
|
|
GRIFFIOEN, G.
|
FIRST-IN-CLASS DRUGS WITH NEUROPROTECTIVE POTENTIAL AGAINST PD (AND AD) IDENTIFIED THROUGH BIOLOGY-DRIVEN DISCOVERY APPROACH
|
|
GRIGOLETTO, J.
|
PROTECTIVE EFFECT OF TAT-PARKIN ON NEURONAL CELLS
|
|
GRILLI, M.
|
SHORT TERM MEMORY DEFECTS AND DISREGULATED NEUROGENESIS IN NF-KAPPAB P50 KNOCK OUT MICE
|
|
GRINBERG, L.T.
|
PRECISE NATURE OF THE WHITE MATTER HYPERINTENSITIES: AN EXACT POINT-TO-POINT POSTMORTEM, PRE-AUTOPSY MRI WITH COMPREHENSIVE NEUROPATHOLOGY
|
|
GRINBERG, L.T.
|
THE DORSAL RAPHE NUCLEUS ALWAYS SHOWS PHOSPHO-TAU CYTOSKELETAL CHANGES BEFORE THE TRANSENTORHINAL REGION IN AD. A NEW (OR EARLIER) BEGINNING?
|
|
GROHM, J.
|
THE BID-INHIBITOR BI-6C9 PREVENTS MITOCHONDRIAL FISSION AND CELL DEATH IN NEURONS EXPOSED TO OXIDATIVE STRESS
|
|
GRÖSGEN, S.
|
ALTERATIONS IN SPHINGOLIPID METABOLISM LINKED WITH ALZHEIMER'S DISEASE
|
|
GROSSI, C.
|
CLIOQUINOL REDUCES AΒ PLAQUE LOAD AND GLIA REACTION AND IMPROVES COGNITIVE DEFICITS IN AN APP TRANSGENIC MOUSE MODEL
|
|
GRUNDKE-IQBAL, I.
|
ENHANCEMENT OF NEUROGENESIS AND COGNITION WITH NEUROTROPHIC PEPTIDES
|
|
GUADAGNA, S.
|
RELATIONSHIP BETWEEN TAU PHOSPHORYLATION STATUS AND AGITATION AND AGGRESSION IN ALZHEIMER'S DISEASE
|
|
GUERINI, F.R.
|
THE CCR5D32 GENOTYPE IS SIGNIFICANTLY INCREASED IN FEMALE ALZHEIMER'S DISEASE PATIENTS WITH EARLY DISEASE ONSET
|
|
GUIDI, M.
|
MILD COGNITIVE IMPAIRMENT IN PARKINSON'S DISEASE
|
|
GUMUCIO GATICA, A.
|
BEHAVIOURAL STUDIES ON TRANSGENIC APP-ARCSWE-MICE
|
|
GÜNTERT, A.
|
DISCOVERY AND VALIDATION OF MARKERS FOR ALZHEIMER´S DISEASE USING ISOBARIC PROTEIN TAGGING
|
|
GUO, L.
|
REGULATION OF SYNAPTIC FUNCTION BY LRRK2
|
|
GUPTA, R.
|
ANTIDEMENTIC MEMANTINE OR SPIN TRAPPING PBN PROTECTS ACHE INHIBITOR-INDUCED OXIDATIVE STRESS AND ENERGY METABOLISM IMPAIRMENT IN BRAIN
|
|
GUSTAFSON, D.
|
ADIPOSITY AND DEMENTIA OVER 32 YEARS IN SWEDEN
|
|
GUTIÉRREZ, R.
|
CODEPENDENCE IN RELATIVES OF AN ALZHEIMER'S DISEASE PATIENT
|
|
HA, T.-Y.
|
ALTERED GENE EXPRESSION PROFILES IN APPV717I-CT100 TRANSGENIC MICE
|
|
HAASS, C.
|
MODELING FTD AND FTLD-U IN ZEBRAFISH AND CULTURED CELLS
|
|
HÄBIG, K.
|
LRRK2 INTERACTS WITH KEY MEDIATORS OF CYTOSKELETON SIGNALLING
|
|
HABUCHI, C.
|
CLINICAL SYMPTOMS AND NEUROPATHOLOGY OF DIFFUSE NEUROFIBRILLARY TANGLES WITH CALCIFICATION
|
|
HAINES, J.L.
|
HIGH-DENSITY LINKAGE SCREEN IDENTIFIES POTENTIAL DEMENTIA AND PARKINSON DISEASE LOCI IN THE AMISH
|
|
HALLIDAY, G.
|
COMPARABLE NEUROTOXICITY OF OLIGOMERIC AΒ40 AND AΒ42 IN A HUMAN IN VITRO MODEL
|
|
HAMILTON, J.
|
BASELINE VISUOSPATIAL DEFICITS PREDICT DEVELOPMENT OF VISUAL HALLUCINATIONS IN PATHOLOGY-CONFIRMED DEMENTIA WITH LEWY BODIES BUT NOT ALZHEIMER´S DISEASE
|
|
HAN, S.-H.
|
PROVERBS COMPREHENSION AND EXECUTIVE FUNCTIONS IN ALZHEIMER'S DISEASE
|
|
HAN, Y.
|
NOVEL ANTI-ALZHEIMER´S DIMER BIS(7)-COGNITIN: CELLULAR AND MOLECULAR MECHANISMS OF NEUROPROTECTION THROUGH MULTIPLE TARGETS
|
|
HANDZUSOVA, M.
|
HIGH-YIELD PURIFICATION OF FETAL TAU PRESERVING ITS STRUCTURE AND PHOSPHORYLATION PATTERN
|
|
HANSSON, O.
|
LONGITUDINAL CHANGES OF CSF BIOMARKERS IN PATIENTS WITH ALZHEIMER'S DISEASE
|
|
HAO, W.
|
MYD88-DEFICIENT BONE MARROW CELLS ATTENUATE AΒ DEPOSITS IN AN AD MOUSE MODEL
|
|
HARRISON, J.
|
LEARNING AND VISUOSPATIAL WORKING MEMORY IN MILD COGNITIVE IMPAIRMENT-AMNESTIC SUBTYPE
|
|
HASHIMOTO, M.
|
DOCOSAHEXAENOIC ACID ATTENUATES IN VITRO AΒ FIBRILLATION WITH CONCOMITANT DECREASES OF AΒ PEPTIDE LEVELS IN BRAIN OF AD MODEL RATS
|
|
HATIP-AL-KHATIB, I.
|
BETA SHEET BREAKER PEPTIDES DECREASE MEMORY IMPAIRMENT AND REACTIVITY OF AΒ40 IN SERUM FOLLOWING MICROINJECTION INTO RATS AMYGDALOID NUCLEUS
|
|
HAYAT, S.
|
STRUCTURAL AND DYNAMIC PROPERTIES OF WATER AROUND AMYLOID BETA PEPTIDES
|
|
HEEMAN, B.
|
GENERATION AND CHARACTERIZATION OF TRANSGENIC PINK1 KNOCK-DOWN MICE USING LENTIVIRAL VECTORS
|
|
HELISALMI, S.
|
LOCI AND GENES CONFERRING AN INCREASED GENETIC RISK IN FINNISH ALZHEIMER´S DISEASE COHORT
|
|
HEMBURY, A.
|
ENDOTHELIN 1 REDUCES P-GLYCOPROTEIN TRANSPORT ACTIVITY IN A HUMAN ADULT IN VITRO BLOOD BRAIN BARRIER MODEL
|
|
HEMSLEY, K.
|
EXAMINING THE CASCADE OF PATHOLOGY IN A MOUSE MODEL OF THE NEURODEGENERATIVE LYSOSOMAL STORAGE DISORDER, MUCOPOLYSACCHARIDOSIS IIIA
|
|
HENCHCLIFFE, C.
|
MAGNETIC RESONANCE SPECTROSCOPIC IMAGING FOR IN VIVO ASSESSMENT OF CEREBRAL MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
|
|
HENNEMAN, W.
|
MRI CORRELATES OF COGNITIVE FUNCTION IN ALZHEIMER'S DISEASE: MARKERS OF ATROPHY AND VASCULAR PATHOLOGY
|
|
HENRIKSEN, G.
|
SYNTHESIS AND EVALUATION OF IMPROVED TRACERS FOR IN VIVO IMAGING OF Β-AMYLOID PLAQUES
|
|
HENRIQUES, A.G.
|
ACCUMULATION OF INTRACELLULAR SAPPΑ FRAGMENT AT CYTOSKELETON ASSOCIATED STRUCTURES - AN AΒ-INDUCED MECHANISM
|
|
HERRMANN, L.
|
HOOK PROTEINS ARE ASSOCIATED WITH TAU PATHOLOGY OF ALZHEIMER`S DISEASE AND MODULATE INTRACELLULAR TRANSPORT
|
|
HETTIARACHCHI, N.
|
INTRACELLULAR CA2+ SIGNALLING IN SH-SY5Y CELLS CARRYING PS-1 MUTATIONS
|
|
HEURTAUX, T.
|
AΒ PEPTIDE CONFORMATION-DEPENDENT ACTIVATION OF MICROGLIA
|
|
HIERZER, M.
|
PROGRESSION OF BRAIN PATHOLOGY AND BEHAVIOURAL DISTURBANCE IN A MOUSE MODEL (TMHT) OVER-EXPRESSING MUTATED HUMAN TAU
|
|
HILL, A.
|
UPREGULATION OF ALPHA-SYNUCLEIN IN PRION INFECTED CELLS: A ROLE FOR ALPHA-SYNUCLEIN IN PRION DISEASES?
|
|
HILL, M.
|
PROGRESSIVE MPTP-NON HUMAN PRIMATE MODELS THAT RECAPITULATE NON-MOTOR SYMPTOMS OF PARKINSON'S DISEASE
|
|
HILLIS, A.
|
ACTION VERSUS OBJECT NAMING IN FRONTOTEMPORAL LOBAR DEGENERATION AND SUBCORTICAL DEMENTIA VERSUS ALZHEIMER´S DISEASE
|
|
HO, J.W.-M.
|
CHARACTERIZATION OF THE PROMOTER REGION OF HUMAN NEURONAL UNCOUPLING PROTEIN-4 (UCP4) AND ITS NEUROPROTECTIVE ROLE IN PARKINSON'S DISEASE
|
|
HO, P.W.-L.
|
SYNERGISTIC ROLE OF NEURONAL UNCOUPLING PROTEIN HOMOLOGUES, UCP4 AND UCP5, IN NEUROPROTECTION AGAINST MITOCHONDRIAL DYSFUNCTION IN PARKINSON'S DISEASE
|
|
HOEGLUND, K.
|
LONGITUDINAL STABILITY OF BIOMARKERS IN CEREBROSPINAL FLUID AND PLASMA FROM PATIENTS WITH ALZHEIMER'S DISEASE
|
|
HOFBAUER, R.K.
|
MEMANTINE TREATMENT WITH ALZHEIMER´S DISEASE IS ASSOCIATED WITH A SLOWER RIGHT HIPPOCAMPAL VOLUME LOSS: AN OPEN-LABEL MULTI-CENTER TRIAL
|
|
HOLBACK, S.
|
INCREASED EXPRESSION OF THE APP BINDING PROTEIN FE65 IN RESPONSE TO NEURONAL DIFFERENTIATION
|
|
HOLLER, C.J.
|
BACE1 AND BACE2 ENZYMATIC ACTIVITIES ARE OPPOSED IN ALZHEIMER'S DISEASE
|
|
HOMMES, J.
|
ROLE OF Γ-SECRETASE IN THE CELLULAR MEMBRANE-LIPID COMPOSITION
|
|
HONG, J.T.
|
MUTANT PRESENILIN 2(N141I) INCREASES BETA-SECRETASE ACTIVITY THROUGH INCREASE OF ERK PATHWAY DEPENDENT HYDROGEN PEROXIDE GENERATION
|
|
HONG, N.
|
DEVELOPMENT OF THE KOREAN QUALITY OF LIFE SCALE FOR ELDERLY WITH DEMENTIA
|
|
HONG, S.
|
NOVEL NEUROPROTECTIVE EFFECT OF A COGNITION-ENHANCING HERB, ALPINAE OXYPHYLLAE, ON GLUTAMATE NEUROTOXICITY
|
|
HONG, Y.-R.
|
GSKIP, A NEGATIVE REGULATOR OF GSK3Β ACTIVITY, MEDIATES N-CADHERIN-BOUND B-CATENIN POOL IN RETINOID ACID-INDUCED DIFFERENTIATION OF SH-SY5Y CELLS
|
|
HOOZEMANS, J.
|
THE UNFOLDED PROTEIN RESPONSE IS ACTIVATED IN PRETANGLE NEURONS IN ALZHEIMER'S DISEASE HIPPOCAMPUS
|
|
HORNICK, A.
|
THE ROLE OF NO IN M1ACHR INDUCED STRIATAL AND PREFRONTAL OXIDATIVE STRESS
|
|
HORNICK, A.
|
EFFECTS OF SCOPOLETIN ON LEARNING AND MEMORY, ON RELEASE OF ACETYLCHOLINE FROM BRAIN SYNAPTOSOMES AND ON LONG-TERM POTENTIATION IN HIPPOCAMPUS
|
|
HORVATH, A.
|
BEHAVIOURAL CHARACTERISATION OF A TRANSGENIC MOUSE MODEL OVER-EXPRESSING THE NEUROTROPHIN RECEPTOR P75
|
|
HOUGH, M.
|
NAMING PATTERNS IN "TYPICAL" AGING: BEHAVIORAL MARKERS FOR NEUROGENERATIVE DISEASE?
|
|
HOUGH, M.
|
GENERATIVE NAMING AND CATEGORIZATION IN DEMENTIA OF THE ALZHEIMER´S TYPE AND TYPICAL AGING
|
|
HRITCU, L.
|
ROLE OF THE SEPTOHIPPOCAMPAL PATHWAY IN LEARNING AND MEMORY PROCESSES OF RATS
|
|
HRITCU, L.
|
UNILATERAL LESION OF SUBSTANTIA NIGRA INDUCED CHANGES ON IMMUNE RESPONSIVENESS IN A RAT MODEL OF PARKINSON'S DISEASE
|
|
HRITCU, L.
|
EFFECTS OF CHRONIC NICOTINE TREATMENT ON PERFORMANCE IN RADIAL ARM-MAZE TASK IN RATS
|
|
HSU, W.-C.
|
THE USE OF CHOLINESTERASE INHIBITORS AND MEMANTINE FOR THE PATIENTS WITH ALZHEIMER DISEASE IN A DEMENTIA CLINIC IN TAIWAN
|
|
HUANG, X.
|
DEVELOPING A NEAR INFRARED MOLECULAR IMAGING PROBE WITH DUAL FLUOROCHROMES FOR ALZHEIMER'S BIOMARKERS- BACE-1 AND CATHEPSIN D
|
|
HUEBBE, P.
|
APOLIPOPROTEIN E GENOTYPE MODULATES AMYLOID PRECURSOR PROTEIN METABOLISM AND CELL CYCLE REGULATION
|
|
HUNG, C.W.
|
A DECREASE IN N-ACETYLASPARTATE IN THE POSTERIOR CINGULATE GYRUS IS ASSOCIATED WITH AGITATION IN ALZHEIMER´S DISEASE
|
|
HURTT, M.
|
123I-ALTROPANE SPECT NEUROIMAGING DIFFERENTIATES BETWEEN TREMOR IN PARKINSON AND NON-PARKINSON SYNDROME (PS)
|
|
IHL, R.
|
IMPROVEMENT OF NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA BY A ONCE-DAILY FORMULATION OF GINKGO BILOBA EXTRACT EGB 761®
|
|
IRACE, G.
|
THE EFFECT OF GLYCOSAMINOGLYCANS (GAGS) ON AMYLOID FORMATION AND AGGREGATE TOXICITY OF TWO DIFFERENT AMYLOIDOGENIC PROTEINS
|
|
IRITANI, S.
|
CASE REPORT: AN ATYPICAL AUTOPSY CASE OF LEWY BODY DISEASE WITH DIAGNOSED MAJOR DEPRESSION CLINICALLY
|
|
ISIK, A.T.
|
GALANTAMİNE HAS NO EFFECT ON ELECTROPHYSIOLOGY OF HEART IN PATIENTS WITH LATE ONSET ALZHEIMER DISEASE
|
|
ISLAM, F.
|
REGULATION OF STEM CELLS IN THE COGNITIVE IMPAIRMENTS BY FIBROBLAST GROWTH FACTOR-2 AND NARDOSTACHY JATAMANSI
|
|
IVANOVOVA, N.
|
TRUNCATED TAU INDUCES HYPERPHOSPHORYLATION IN TRANSGENIC RAT MODEL OF HUMAN TAUOPATHY
|
|
IWASAKI, K.
|
A TRADITIONAL CHINESE MEDICINE YI-GAN SAN FOR THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS AND ACTIVITIES OF DAILY LIVING IN DEMENTIA PATIENTS
|
|
JACOBSEN, K.
|
DIFFERENT SIGNALING PATHWAYS REGULATE THE PROCESSING OF THE APP FAMILY
|
|
JACOBSON, L.
|
EFFECT OF THE BACE INHIBITOR NB-216 ON AΒ AND APP PROCESSING IN TRANSGENIC AND NON-TRANSGENIC RODENT MODELS
|
|
JANKOVICOVA, B.
|
FIRST STEPS IN DEVELOPMENT OF MAGNETICALLY ACTIVE MINIATURIZED ANALYTICAL SYSTEM FOR DIAGNOSIS OF ALZHEIMER DISEASE
|
|
JANSEN, D.
|
EFFECTS OF CHOLESTEROL AND DHA DIETS ON COGNITION, Β-AMYLOID DEPOSITION AND SYNAPTIC DENSITY IN 8- AND 15-MONTH-OLD APP/PS1 ALZHEIMER MICE
|
|
JASINSKA-MYGA, B.
|
DEPRESSION FOLLOWING DIAGNOSIS OF PARKINSON DISEASE - TIME-FRAMES AND PREDICTORS FROM A SURVIVAL ANALYSIS
|
|
JAYADEV, S.
|
PRESENILIN 2 MODULATES MICROGLIA ACTIVATION
|
|
JELCIC, N.
|
EFFECTIVENESS OF A LEXICAL SEMANTIC THERAPY ON COGNITIVE FUNCTIONS IN ALZHEIMER'S DISEASE
|
|
JENNINGS, D.
|
THE PARS (PARKISNON ASSOCIATED RISK SYNDROME) STUDY: EVALUATING PRE-CLINICAL PARKINSON DISEASE
|
|
JEON, N.L.
|
MICROFLUIDIC-BASED HIGH CONTENT DRUG SCREENING PLATFORM FOR QUANTITATIVE ANALYSIS OF AXONAL TRANSPORT IN NEURODEGENERATIVE DISEASE MODELS
|
|
JIMÉNEZ-CABALLERO, P.E.
|
DO NEW DRUG FORMULATIONS IMPROVE CAREGIVER'S SATISFACTION WITH TREATMENT OF ALZHEIMER DISEASE? THE CASE OF DONEPEZIL ORAL DISINTEGRATING TABLETS (ODT)
|
|
JIMÉNEZ-CABALLERO, P.E.
|
CURRENT TREATMENT OF ALZHEIMER DISEASE: ARE MAIN CAREGIVERS SATISFIED WITH THE DRUG TREATMENT RECEIVED BY THEIR PATIENTS?
|
|
JOHANSON, C.
|
ENHANCED EXPRESSION OF RAGE AT THE BLOOD-BRAIN BARRIER: CONGRUENCE BETWEEN ALZHEIMER´S DISEASE AND THE AGING RAT MODEL
|
|
JOHANSSON, A.-S.
|
DEMETALLATION OF MONOMERIC AND DIMERIC SUPEROXIDE DISMUTASE 1 RENDERS THE PROTEIN TOXIC IN CULTURED NEURONAL CELLS
|
|
JOHNSTON, J.A.
|
BACE1 MRNA EXPRESSION IN ALZHEIMER'S DISEASE POST MORTEM BRAIN TISSUE
|
|
JOHNSTONE, T.
|
DUAL MODULATORS OF GABAA AND Α7 NICOTINIC RECEPTORS FOR ALZHEIMER'S DISEASE
|
|
JOKI, H.
|
MANAGEMENT OF SEVERE PSYCHOTIC SYMPTOMS ASSOCIATED WITH PARKINSON DISEASE THAT NEEDED A TREATMENT IN THE PSYCHIATRIC WARD
|
|
JOKINEN, P.
|
IMPAIRED COGNITIVE PERFORMANCE IN PARKINSON'S DISEASE IS RELATED TO CAUDATE DOPAMINERGIC HYPOFUNCTION AND HIPPOCAMPAL ATROPHY
|
|
JOO, Y.
|
A POSSIBLE ROLE FOR AMYLOID PRECURSOR PROTEIN-BINDING PROTEIN 1 (APP-BP1) IN NEUROGENESIS
|
|
JOSHI, H.
|
PHYTOPHARMACOLOGICAL APPROACH FOR MANAGEMENT OF ALZHEIMER'S AND PARKINSON'S DISEASE USING PHARMACOPHORES FROM SIDDHA MEDICINAL PLANTS - A NOVEL INDIAN APPROACH
|
|
JOST, M.
|
CHANGES OF THE PROLIFERATION MARKER PSA-NCAM DUE TO OVEREXPRESSION OF HAPP, ALPHA-SYNUCLEIN AND TAU441 - COMPARING AD AND PD MODELS
|
|
JUENEMANN, K.
|
CHARACTERIZATION OF AN N-TERMINAL CLEAVAGE REGION IN HUNTINGTIN DETERMINING CYTOTOXICITY AND AGGREGATION
|
|
JUNG, B.
|
CEREBRAL VOLUME AND COGNITIVE FUNCTIONS IN NEUROMYELITIS OPTICA
|
|
JURI, C.
|
METABOLIC MAPPING OF MPTP INDUCED PARKINSONISM IN NON-HUMAN PRIMATES - AN 18F-FDG PET STUDY
|
|
KAETHER, C.
|
QUALITY CONTROL OF GAMMA-SECRETASE ASSEMBLY IN THE ER
|
|
KALAITZAKIS, M.
|
PARKINSONISM VERSUS PARKINSON'S DISEASE: A CLINICO-PATHOLOGICAL STUDY OF 100 CASES
|
|
KALEV, O.
|
EARLY ONSET FAMILIAL ALZHEIMER-TYPE DEMENTIA ASSOCIATED WITH NEUROFIBRILLARY DEGENERATION AND SUBCORTICAL GLIAL TAU PATHOLOGY
|
|
KALITA, J.
|
CSF CATECHOLAMINE AND ITS METABOLITES IN ENCEPHALITIS PATIENTS WITH AND WITHOUT MOVEMENT DISORDERS
|
|
KANAZIR, S.
|
DIETARY RESTRICTION MODULATES AGE RELATED CHANGES OF CHOLESTEROL CONTENT AND CYP46 EXPRESSION IN THE RAT HIPPOCAMPUS
|
|
KANDIAH, N.
|
VASCULAR RISK FACTORS AS PREDICTORS OF COGNITIVE DECLINE IN PARKINSON'S DISEASE
|
|
KANG, D.
|
GENETIC ASSOCIATION OF RANBP9, AN LRP BINDING SCAFFOLDING PROTEIN, WITH LATE-ONSET ALZHEIMER'S DISEASE
|
|
KANG, H.W.
|
TWO DINSTICT MECHANISMS TO PREVENT CASPASE ACTIVATION AFTER RELEASE OF CYTOCHROME C IN MITOCHONDRIAL COMPLEX I INHIBITOR-INDUCED DOPAMINERGIC NEURONAL DEATH
|
|
KANG, J.H.
|
OLFACTORY IDENTIFICATION DEFICITS IN CADASIL
|
|
KANGYONG, L.
|
THERAPEUTIC EFFECT AND PROBABLE MECHANISIM OF RAPAMYCIN ON MPTP - INDUCED PARKINSONISM IN MICE
|
|
KANGYONG, L.
|
DIFFERENT TYPES OF ALPHA-SYNUCLEIN ARE DEGRADED BY AUTOPHAGIC PATHWAY
|
|
KANGYONG, L.
|
AUTOPHAGIC PATHWAY AND PROBABLE MECHANISM IN THE DEGRADATION OF MUTANT Α-SYNUCLEIN IN PC12 CELLS
|
|
KANNINEN, K.
|
DIRECT INTRAHIPPOCAMPAL GENE TRANSFER OF A LENTIVIRAL VECTOR EXPRESSING NRF2 IMPROVES SPATIAL LEARNING IN A MOUSE MODEL OF ALZHEIMER´S DISEASE
|
|
KARAFIN, A.
|
MONITORING OF AMYLOID-Β FIBRILLIZATION USING AN IMPROVED FLUORIMETRIC METHOD
|
|
KARDOS, J.
|
CONTRARY EFFECT OF DIFFERENT AΒ(1-42) AGGREGATES ON THE EXCITABILITY OF PIRAMIDAL CELLS IN THE RAT HIPPOCAMPUS IN VIVO
|
|
KARELSON, E.
|
REMARKABLE EXPRESSION DIFFERENCES OF SOD1 AND SOD2 IN ALZHEIMER´S AND SWEDISH FAMILIAL ALZHEIMER´S BRAIN
|
|
KARUNAKARAN, S.
|
REDOX DRIVEN APOPTOTIC SIGNALING UNDERLIES 'SELECTIVITY VULNERABILITY' IN ANIMAL MODEL OF PARKINSON'S DISEASE
|
|
KATAYAMA, S.
|
COMPARISON OF COGNITIVE FUNCTION AND BRAIN ATROPHY AMONG AMNESTIC MCI, EARLY ALZHEIMER'S DISEASE AND DEMENTIA WITH LEWY BODIES
|
|
KATSOURI, L.
|
ROLE OF PERIPHERAL APOE IN THE PATHOGENESIS OF AD IN A TRANSGENIC MOUSE MODEL
|
|
KAWAMURA, M.
|
COGNITIVE, EMOTIONAL, AND AUTONOMIC SIGNS IN PATIENTS WITH RBD
|
|
KAZANTSEVA, N.
|
TREATMENT OF ALS BY MEANS OF MINIMIZED CURATIVE COMPRESSION IN THE CHAMBER WITH CYCLOSPORINE A
|
|
KAZMIERCZAK, A.
|
MOLECULAR MECHANISMS UNDERLYING ALPHA-SYNUCLEIN (ASN) AND NAC PEPTIDE NEUROTOXICITY IN PC12 CELLS
|
|
KERR, F.
|
DIET AND OXIDATIVE STRESS IN THE NEUROPATHOLOGY OF ALZHEIMER'S DISEASE IN DROSOPHILA
|
|
KERRIGAN, T.L.
|
MODULATION OF 'A'-TYPE K+ CHANNELS FOLLOWING DECREASED AMYLOID Β CATABOLISM
|
|
KHAN, M.
|
IDENTIFYING A HIDDEN PROBLEM-DEMENTIA- IN ELDERLY PEOPLE LIVING IN OLD-AGE HOMES
|
|
KHAN, M.M.
|
RESVERATROL PREVENTS 6-HYDROXYDOPAMINE-INDUCED DOPAMINE DEPRESSION IN RAT MODEL OF PARKINSON'S DISEASE
|
|
KHANNA, P.
|
BEHAVIOR AND NEUROTOXIC CONSEQUENCES OF ALUMINUM ON RAT BRAIN FOLLOWED BY RECOVERY
|
|
KHODAGHOLI, F.
|
CHITOSAN PROTECTS NEURAL CELL AGAINST H2O2-INDUCED NEUROTOXICITY VIA NRF2/ARE PATHWAY
|
|
KHUWAJA, G.
|
NEUROPROTECTIVE EFFECT OF CURCUMIN, IN 6OHDA MODEL OF PARKINSONIAN RATS
|
|
KIČIĆ, D.
|
MULTIMODAL ELECTROPHYSIOLOGICAL MAPPING OF CORTICAL EXCITABILITY IN PARKINSONIAN PATIENTS USING AN OFFLINE RTMS APPROACH
|
|
KIEBURTZ, K.
|
THE SAFETY AND EFFICACY OF DIMEBON IN MILD-TO-MODERATE HUNTINGTON'S DISEASE: A MULTICENTER, PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL (DIMOND)
|
|
KIELY, A.
|
DEFECTS IN PINK1 OCCUR IN ALZHEIMER'S DISEASE AND ASSOCIATE WITH PTEN DYSFUNCTION
|
|
KILANDER, L.
|
ALZHEIMER´S DISEASE DIAGNOSIS IN CORRELATION TO AMYLOID BURDEN MEASURED IN CSF, PLASMA AND WITH PET PIB
|
|
KIM, H.
|
PRESENILIN-1 AND P190RHOGEF REGULATE DELTA-CATENIN-INDUCED DENDRITIC MORPHOGENESIS
|
|
KIM, H.-J.
|
WHAT IS NORMAL OR WHAT IS ABNORMAL WITH AGING PROCESSES: THE HANYANG BRAIN PROJECT FOR GRAYING SOCIETY
|
|
KIM, J.A.
|
FLUOXETINE STIMULATES PROLIFERATION AND DIFFERENTIATION OF FETAL NEURAL STEM CELLS
|
|
KIM, M.J.
|
INHIBITION OF PDMP REDUCES APOPTOSIS IN PC 12 CELLS INDUCED BY PROTEASOMAL INHIBITOR
|
|
KIM, W.C.
|
EFFICACY OF OXACARBAZEPINE IN THE TREATMENT OF PAIN IN PATIENTS WITH IDIOPATHIC PARKINSON´S DISEASE
|
|
KIM, Y.-H.
|
INHIBITORY EFFECT OF CBIO2008 ON THE AΒ-INDUCED MEMORY DEFICIENCY AND NEURONAL CELL DEATH
|
|
KIMURA, K.
|
COGNITIVE FUNCTION FOLLOWING BILATERAL SUBTHALAMIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE PATIENTS: A STUDY OF ONSET AGE AND DISEASE DURATION
|
|
KINGERY, L.
|
SAMPLE SIZE ESTIMATES AND POWER OF NEUROPSYCHOLOGICAL OUTCOME MEASURES: A COMPARISON OF THE ADAS-COG, NTB, AND CNTB
|
|
KISTSEN, V.
|
POSTUROGRAFY OF HEMISHERIC STROKE PATIENTS WITH COGNITIVE DISORDERS
|
|
KISTSEN, V.
|
P300 PARAMETERS AFTER RTMS IN POSTSTROKE COGNITIVE DISORDERS
|
|
KITAMOTO, S.
|
IMMUNE RESPONSE INDUCED BY AΒ1-42 FIBRIL MIMIC PEPTIDES
|
|
KITAYAMA, M.
|
ASSOCIATION OF VISUAL HALLUCINATIONS WITH REDUCTION OF MIBG CARDIAC UPTAKE IN PARKINSON'S DISEASE
|
|
KJELVIK, G.
|
NEUROIMAGING OF OLFACTION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT (MCI)
|
|
KLAFKI, H.
|
MAP KINASE ERK1/2 IN CSF CORRELATES WITH TOTAL-TAU AND PHOSPHO-TAU LEVELS IN PATIENTS WITH NEUROPSYCHIATRIC DISORDERS
|
|
KLIMKOWICZ-MROWIEC, A.
|
PARAOXONASE 1 GENE PROMOTER -161 CT POLYMORPHISM AND THE RISK OF ALZHEIMER DISEASE IN A POLISH POPULATION
|
|
KLONIECKI, M.
|
ANALYSIS OF AΒ1-40 PEPTIDE OLIGOMERS USING SYNAPT HDMS SYSTEM
|
|
KLUCKEN, J.
|
THE AUTOPHAGY-LYSOSOMAL PATHWAY (ALP) REGULATES ALPHA-SYNUCLEIN AGGREGATION IN PARKINSON'S DISEASE
|
|
KNUESEL, I.
|
REDUCED REELIN EXPRESSION ACCELERATES CONTEXTUAL MEMORY IMPAIRMENTS AND BETA-AMYLOID PLAQUES FORMATION IN AN ANIMAL MODEL OF ALZHEIMER'S DISEASE
|
|
KOBAYASHI, N.
|
THE PREVENTION OF Α-SYNUCLEIN AMYLOID FORMATION USING PQQ-MODIFIED PARTIAL PEPTIDE FRAGMENTS: FOR TARGET SPECIFIC PREVENTION OF THE AMYLOID FORMATION
|
|
KÖGEL, D.
|
ENHANCED GENERATION OF SAPPΑ IS REQUIRED FOR THE NEUROPROTECTIVE EFFECTS OF THE OMEGA 3 FATTY ACID DHA
|
|
KOIVUNEN, J.
|
PET AMYLOID LIGAND [11C]PIB UPTAKE AND CEREBROSPINAL FLUID BETA-AMYLOID IN MILD COGNITIVE IMPAIRMENT
|
|
KOK, E.
|
ASSOCIATION OF GENETIC VARIATION OF CRP WITH ALZHEIMER'S DISEASE-RELATED SENILE PLAQUES AND NEUROFIBRILLARY TANGLES
|
|
KONIETZKO, U.
|
MASS SPECTROMETRY OF APP-INTERACTING PROTEINS IN VIVO IDENTIFIES A PROTEIN NETWORK INVOLVED IN SYNAPTIC VESICLE TURNOVER
|
|
KOONTZ, J.
|
ANTIOXIDANT CONSUMPTION, CHILDHOOD SES, AND DIFFERENTIAL RATES OF COGNITIVE DECLINE IN SWEDISH TWINS
|
|
KOONTZ, J.
|
AN ALZHEIMER´S DISEASE PREDICTION SYSTEM FOR ADAMS/ HRS DATA USING LOGISTIC AND CART TECHNIQUES
|
|
KORABECNY, J.
|
SYNTHESIS AND EVALUATION OF BIS‑7‑MEOTA COMPOUNDS AS REVERSIBLE ACETYLCHOLINESTERASE INHIBITORS
|
|
KORECKA, J.A.
|
GENE EXPRESSION PROFILING OF RETINOIC ACID DIFFERENTIATED HUMAN NEUROBLASTOMA SH-SY5Y CELLS
|
|
KOVACECH, B.
|
MONOCLONAL ANTIBODY DC40 REVEALS THE DIRECT INTERACTION BETWEEN THE PRO-RICH REGION AND THE MICROTUBULE BINDING DOMAIN OF TAU
|
|
KOVACS, G.
|
WHITE MATTER TAUOPATHY WITH GLOBULAR GLIAL INCLUSIONS (GGIS) IS A DISTINCT ENTITY OF SPORADIC FRONTOTEMPORAL LOBAR DEGENERATION
|
|
KOVACS, G.
|
THE MESSAGE OF DOPAMINE-TRANSPORTER IMMUNOHISTOCHEMISTRY FOR NEUROIMAGING STUDIES
|
|
KOVACS, N.
|
ROUTINE NEUROPHYSIOLOGIC TREMOR ANALYSIS AS A DIAGNOSTIC TOOL FOR PARKINSONIAN TREMOR
|
|
KOWA, H.
|
HYPERHOMOCYSTEINEMIA AND COGNITIVE DYSFUNCTION IN PARKINSON'S DISEASE
|
|
KRAJCIOVA, G.
|
PREVENTION OF NON-NATIVE DISULPHIDE BRIDGES FORMATION IN TAU PROTEIN WITHOUT THE USE OF REDUCING AGENT
|
|
KRUZEL, M.
|
EFFECT OF SYNTHETIC PEPTIDES ON DEGRADATION AND CLEARANCE OF BETA AMYLOID IN HUMAN NEURONAL CELLS
|
|
KUCA, K.
|
IN VITRO EVALUATION OF TWO ALZHEIMER´S DISEASE DRUGS TACRINE AND 7-METHOXYTACRINE USING ELECTROCHEMICAL BIOSENSOR WITH IMMOBILIZED ACETYLCHOLINESTERASE
|
|
KUCHENBECKER, J.
|
BIDIRECTIONAL LINK BETWEEN PLASMALOGEN METABOLISM AND APP PROCESSING
|
|
KUDO, L.
|
OVEREXPRESSION OF HUMAN PUROMYCIN-SENSITIVE AMINOPEPTIDASE (PSA) ATTENUATES ACCUMULATION OF PHOSPHORYLATED TAU
|
|
KUDO, T.
|
APPLICATION OF "PROTEASOME TOLERANCE" TO A NOVEL THERAPY FOR NEURODEGERATIVE DISEASES
|
|
KUHN, P.-H.
|
BEPRIDIL AND AMIODARONE SIMULTANEOUSLY MODULATE BETA- AND GAMMA-SECRETASE
|
|
KUIPERIJ, H.B.
|
TDP-43: A PUTATIVE BIOMARKER FOR NEURODEGENERATIVE DISEASES
|
|
KULISEVSKY, J.
|
EARLY DIAGNOSIS IN PARKINSON'S DISEASE AND INITIATION OF TREATMENT - THE RATIONALE
|
|
KULJIŠ, R.
|
FAÑANÁS' GLIAL CELLS DEVELOP CYTOPLASMIC ACCUMULATION OF AMYLOID PROTEIN IN PATIENTS WITH ALZHEIMER'S DISEASE
|
|
KUMAR, P.
|
MEMBRANE ASSOCIATED NEURONAL MARKERS IN DIABETES AND AGING
|
|
KUPERSTEIN, I.
|
LIPIDS REVERT INERT ABETA AMYLOID FIBRILS TO NEUROTOXIC PROTOFIBRILS THAT AFFECT LEARNING IN MICE
|
|
KURZAWA, M.
|
NUCLEAR-MITOCHONDRIAL INTERACTIONS IN DEMENTIA WITH LEWY BODIES AND PARKINSON'S DISEASE
|
|
KURZAWA, M.
|
GLUCOCEREBROSIDASE - INVESTIGATION INTO POSSIBLE CANDIDATE GENE FOR LEWY BODY DISORDERS
|
|
KUSSMAUL, L.
|
IDENTIFICATION OF DIFFERENT Aß-OLIGOMER POPULATIONS IN SOLUTION ASSESSED BY AFM
|
|
KUSSMAUL, L.
|
INSULIN RESISTANCE IN ALZHEIMER´S DISEASE: IS TAU PHOSPHORYLATION A DOWNSTREAM TARGET OF THE INSULIN RECEPTOR PATHWAY?
|
|
KUZNICKI, J.
|
MUTATIONS IN PRESENILIN 1 AFFECT BOTH EXPRESSION OF STIM PROTEINS AND CCE IN LYMPHOCYTES OF PATIENTS WITH FAMILIAL ALZHEIMER'S DISEASE
|
|
KWON, J.
|
24-WEEK DONEPEZIL TRIALS FOR EFFICACY ON COGNITIVE FUNCTION IN BINSWANGER TYPE SUBCORTICAL VASCULAR DEMENTIA
|
|
KWON, O.D.
|
APOE E4 ALLELE MAY NOT BE A RISK FACTOR OF IDIOPATHIC PARKINSON´S DISEASE: AN ASIAN STUDY
|
|
L. C. ESTEVES, S.
|
CHR9ORF75, A NOVEL PP1 INTERACTING PROTEIN IN HUMAN BRAIN
|
|
LAFFITA-MESA, J.
|
LOSS OF CAA INTERRUPTION IN LARGE SCA2 ALLELES IS A RISK FACTOR TO ATXN2 GENE INSTABILITY
|
|
LAI, E.
|
THE INITIAL INTELLECTUAL IMPAIRMENT IN PATIENTS WITH PARKINSON'S DISEASE IS CORRELATED WITH ACTIVITIES OF DAILY LIVING AND MOTOR ABNORMALITIES
|
|
LANNI, C.
|
CONFORMATIONALLY ALTERED P53: A PUTATIVE PREDICTIVE MARKER FROM MCI TO ALZHEIMER'S DISEASE?
|
|
LANZILLOTTA, A.
|
CHF5074 REDUCES BRAIN B-AMYLOID BURDEN IN A MOUSE MODEL OF ALZHEIMER'S DISEASE BY MODULATING APP AND PS1 INTERACTION
|
|
LARNER, A.J.
|
ADDENBROOKE'S COGNITIVE EXAMINATION-REVISED: CROSS-SECTIONAL AND LONGITUDINAL USE FOR COGNITIVE ASSESSMENT
|
|
LARSEN, K.
|
THREONINE53 IN ALPHA-SYNUCLEIN IS NOT AN EVOLUTIONARY ADAPTATION IN LONG-LIVING ANIMALS
|
|
LE BASTARD, N.
|
ADDED DIAGNOSTIC VALUE OF CSF BIOMARKERS IN DIFFERENTIAL DEMENTIA DIAGNOSIS
|
|
LE BASTARD, N.
|
NO CORRELATION BETWEEN TIME-LINKED PLASMA AND CSF AΒ LEVELS
|
|
LE BASTARD, N.
|
PLASMA AΒ FORMS IN ALZHEIMER'S DISEASE AND NON-ALZHEIMER'S DISEASE PATIENTS
|
|
LE MESSURIER, M.B.
|
SONGSCONNECT ARCHIE & ETHEL - DEPRESSION AND ANTIPSYCHOTIC DRUGS
|
|
LECANU, L.
|
BRAIN REPAIR STRATEGY: ARE MALE AND FEMALE NEURAL STEM CELLS EQUIVALENT?
|
|
LEDÓCHOWSKI, P.
|
INTERHEMISPHERIC MODULATION OF THE MOTOR FUNCTION IN THE SUBTHALAMIC REGIONS
|
|
LEE, A.Y.
|
AUTONOMIC DYSFUNCTION & COGNITION IN PARKINSON'S DISEASE
|
|
LEE, C.W.
|
DISTURBED BRAIN GLUCOSE METABOLISM INDUCES ALZHEIMER´S DISEASE-LIKE PATHOLOGIES
|
|
LEE, J.
|
SPROUTING OF DOPAMINE TERMINALS AND ALTERED DOPAMINE RELEASE AND UPTAKE IN PARKINSONIAN DYSKINESIA
|
|
LEE, J.H.
|
THE DEVELOPMENT OF PET IMAGING AGENTS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE
|
|
LEE, K.-S.
|
THE INFLUENCE OF WHITE MATTER HYPERINTENSITIES ON THE COGNITION OF PATIENTS WITH PARKINSON´S DISEASE
|
|
LEE, P.H.
|
CHANGES IN CEREBRAL GLUCOSE METABOLISM IN PATIENTS WITH PARKINSON'S DISEASE WITH DEMENTIA AFTER CHOLINESTERASE INHIBITOR THERAPY
|
|
LEE, S.-H.
|
ENHANCED DOPAMINE NEURON SURVIVAL AND PHENOTYPE MAINTENANCE BY SUSTAINED NURR1 PROTEIN STABILITY
|
|
LEMMENS, M.
|
THE ROLE OF UBB+1 IN A NOVEL TRIPLE TRANSGENIC MOUSE MODEL FOR ALZHEIMER'S DISEASE
|
|
LENERS, J.-C.
|
EPIDEMIOLOGICAL DATAS FOR PATIENTS WITH ALZHEIMER´ DISEASE IN LUXEMBOURG AND QUALITY OF LIFE RELATED TO THEIR SPECIFIC CARE ENVIRONMENT
|
|
LERCHNER, A.
|
MACROCYCLIC BACE INHIBITORS ACUTELY REDUCE ABETA IN BRAIN AFTER P.O. APPLICATION
|
|
LEUTHAEUSER-JASCHINSKI, K.
|
TRANSCRIPTOMIC ANALYSIS REVEALS DISTURBED INFLAMMATORY AND APOPTOTIC RESPONSE IN LIPID-LADEN HUMAN NIEMANN-PICK DISEASE TYPE C MACROPHAGES
|
|
LEV, N.
|
DJ-1 REGULATES VESICULAR MONOAMINE TRANSPORTER-2 EXPRESSION: IMPLICATIONS FOR NEUROPROTECTION
|
|
LEVITES, Y.
|
EFFECTS OF ANTI-GENERIC AMYLOID SINGLE CHAIN FRAGMENTS ON ABETA DEPOSITION IN APP MOUSE MODELS
|
|
LEWCZUK, P.
|
AMYLOID Β PEPTIDES IN PLASMA AS A POTENTIAL TOOL FOR THE EARLY DIAGNOSIS OF ALZHEIMER´S DISEASE: A MULTICENTER STUDY
|
|
LEZCANO, L.B.
|
EFFECT OF THE SNC LESION ON NEUROCHEMICAL CHANGES IN PPN FROM HEMIPARKINSONIAN RATS
|
|
LI, A.
|
PATHOLOGICAL FINDINGS IN FOUR NEUROAXONAL DYSTROPHY CASES WITH PLA2G6 MUTATIONS
|
|
LI, L.
|
SIMVASTATIN PRESERVES COGNITIVE FUNCTION AND ENHANCES SYNAPTIC PLASTICITY IN A MOUSE MODEL OF ALZHEIMER'S DISEASE
|
|
LI, W.
|
N-METHYL-D-ASPARTATE RECEPTOR-BASED PATHOLOGICALLY ACTIVATED NEUROPROTECTION OF BIS(PROPYL)-COGNITIN
|
|
LI, X.
|
SUBSEQUENT PARKINSON DISEASE RISKS IN PATIENTS WITH AUTOIMMUNE DISORDERS: A NATION-WIDE EPIDEMIOLOGICAL STUDY FROM SWEDEN
|
|
LI, Y.
|
COMBINED SNP AND COPY NUMBER VARIATION HAPLOTYPES AT THE MAPT LOCUS
|
|
LIAO, C.-H.
|
HEME BINDS ALZHEIMER'S AMYLOID-Β PEPTIDE AND INTERFERES ITS DEGRADATION
|
|
LIM, J.
|
BAK ATTENUATES NIGERICIN-INDUCED CELL DEATH VIA MAINTAINING AUTOPHGIC FLUX
|
|
LIM, Y.-A.
|
AMYLOID-Β AND HUMAN AMYLIN SHARE COMMON NEUROTOXIC MECHANISMS
|
|
LIMA, M.
|
REM SLEEP DEPRIVATION MODULATES TYROSINE HYDROXYLASE EXPRESSION IN THE NIGROSTRIATAL PATHWAY: BEHAVIORAL AND MOLECULAR ALTERATIONS
|
|
LIMÓN, I.D.
|
NITRIC OXIDE AS A WAY OF TOXICITY OF Aß25-35 INJECTED INTO TEMPORAL CORTEX OF RAT
|
|
LINGOR, P.
|
REGULATION OF SURVIVAL AND REGENERATION IN PRIMARY DOPAMINERGIC NEURONS BY DIFFERENT C-JUN-N-TERMINAL KINASE ISOFORMS
|
|
LIOU, L.-M.
|
LEFT INSULAR CORTEX INFARCTION WITH WERNICKE'S APHASIA
|
|
LIOU, L.-M.
|
AUTONOMIC DYSFUNCTION IN PARKINSON'S DISEASE
|
|
LIPPENS, G.
|
(DE)PHOSPHORYLATION OF TAU - AN IN VITRO NMR STUDY
|
|
LIRAZ, O.
|
DEVELOPMENT OF AN IN-VITRO SYSTEM FOR STUDYING THE MECHANISMS UNDERLYING THE PATHOLOGICAL SYNERGY BETWEEN APOE4 AND AΒ
|
|
LISCIC, R.M.
|
GENETIC MARKERS IN ALS PATIENTS WITH COGNITIVE IMPAIRMENT
|
|
LITVINENKO, I.
|
HIGHER LEVEL CORTICAL DYSFUNCTION IS MOST ORIGIN OF PROGRESSIVE GAIT DISORDERS IN ADVANCED PARKINSON'S DISEASE
|
|
LIU, C.-F.
|
MPP+ IMPAIR AUTOPHAGIC CLEARANCE OF Α-SYNUCLEIN BY INTERFERING THE ACTIVITY OF DYNEIN
|
|
LIU, G.
|
HIGH MAGNESIUM REVERSES COGNITIVE DEFICITS AND SYNAPTIC LOSS IN ALZHEIMER'S MOUSE MODEL
|
|
LIU, H.
|
EVALUATION OF THE BLOOD-BRAIN BARRIER PERMEATION CHARACTERISTICS OF D-ENATIOMERIC PEPTIDES THAT BIND TO AMYLOID PEPTIDE Aß (1-42)
|
|
LIU, S.
|
THE POLYUNSATURATED FATTY ACIDS DOCOSAHEXAENOIC ACID REDUCES Β-AMYLOID INDUCED PROINFLAMMATORY CYTOKINES EXPRESSION WHILE MAINTAINS THE CLEARANCE CAPABILITY OF Β-AMYLOID IN BMDMS
|
|
LIU, X.-A.
|
PP2A ACTIVATES THE ANTI-APOPTOTIC FUNCTION OF BCL-2, WHILE THE DEPHOSPHORYLATION OF TAU BY PP2A FACILITATES APOPTOSIS
|
|
LOBBESTAEL, E.
|
PRODUCTION AND CHARACTERISATION OF NEW ANTI-LRRK2 ANTIBODIES
|
|
LÖKK, J.
|
A PROSPECTIVE STUDY ON THE DEVELOPMENT OF ALZHEIMER´S DISEASE WITH REGARD TO TSH AND HOMOCYSTEINE
|
|
LONGATO, N.
|
EMOTIONAL EXPERIENCE AND PROCESSING OF FACIAL EMOTIONS IN MULTIPLE SCLEROSIS
|
|
LOSSO, M.A.
|
FRONTOTEMPORAL DEMENTIA SPORADIC CASE ASSOCIATING TWO NOVEL TAU MUTATIONS. PART TWO: MOLECULAR EFFECT ON EXON 10 ALTERNATIVE SPLICING
|
|
LOURENCO VENDA, L.
|
THE ROLE OF Α-SYNUCLEIN IN DOPAMINE HOMEOSTASIS: INSIGHTS FROM HUMAN DOPAMINERGIC CELLS
|
|
LUO, J.J.
|
THE DOUBLE FACES OF AMYLOID PRECURSOR PROTEIN PROCESSING: THE ROLES OF AMYLOID-BETA AND SECRETED FORMS OF AMYLOID PRECURSOR PROTEIN
|
|
LUO, Y.
|
MAGNESIUM CONCENTRATION IN RBC AND EXTRACELLUAR FLUID OF MIDBRAIN SUBSTANTIA NIGRA OF RAT MODEL OF PARKINSON'S DISEASE
|
|
LUPO, F.
|
NEUROPSYCHIATRIC SYMPTOMS AS PREDICTORS OF FUNCTIONAL DECLINE IN ALZHEIMER'S DISEASE
|
|
MA, G.
|
DIAZOXIDE REVERSES THE ENHANCED EXPRESSION OF KATP SUBUNITS IN CHOLINERGIC NEURONS CAUSED BY EXPOSURE TO AΒ1-42
|
|
MAALOUF, M.
|
THE KETONES Β-HYDROXYBUTYRATE AND ACETOACETATE PREVENT THE INHIBITION OF HIPPOCAMPAL LONG-TERM POTENTIATION BY AMYLOID AΒ1-42
|
|
MAAT-SCHIEMAN, M.
|
CEREBRAL AMYLOID ANGIOPATHY-RELATED INFLAMMATION IN HEREDITARY CEREBRAL HEMORRHAGE WITH AMYLOIDOSIS-DUTCH TYPE (HCHWA-D)
|
|
MADINE, J.
|
DESIGN OF AN N-METHYLATED PEPTIDE INHIBITOR OF Α-SYNUCLEIN AGGREGATION GUIDED BY SOLID-STATE NMR
|
|
MAERZ-BERBERICH, J.
|
OPTIMIZATION OF A NEW LEAD STRUCTURE FOR ALZHEIMER´S PEPTIDE LIGANDS
|
|
MAGEROVA, H.
|
SMELL IDENTIFICATION DEFICIT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT PREDICTS ALZHEIMER´S DISEASE
|
|
MAJERCAK, J.
|
RATIONAL DESIGN OF SIRNA SCREENS THAT FILL A NEUROSCIENCE PIPELINE
|
|
MAJLESSI, N.
|
ASSOCIATION BETWEEN NOS3 GENE G894T POLYMORPHISM AND LATE-ONSET ALZHEIMER´S DISEASE IN A SAMPLE FROM IRAN
|
|
MALEK, M.
|
EFFECT OF INTRAHIPPOCAMPAL INJECTION OF GROWTH HORMONE (GH) ON MEMORY IMPAIRMENT IN ANIMAL MODEL OF ALZHEIMER'S DISEASE
|
|
MALER, J.M.
|
ACTIVATION ALTERS THE Β-AMYLOID RELEASE SIGNATURES OF HUMAN MONONUCLEAR PHAGOCYTES
|
|
MALINOWSKA, A.
|
DIFFERENTIAL PROTEOMICS OF SYNAPTOSOMES IN ALZHEIMER´S DISEASE
|
|
MAMO, J.
|
SATURATED FATS DISRUPT BLOOD-BRAIN BARRIER INTEGRITY RESULTING IN BLOOD-TO-BRAIN DELIVERY OF LIPOPROTEIN-AMYLOID-BETA; IMPLICATIONS FOR ALZHEIMER'S DISEASE RISK.
|
|
MANDLER, M.
|
THE MIMOVAX VACCINE: A NOVEL AD-TREATMENT STRATEGY TARGETING TRUNCATED Aß40/42 BY ACTIVE IMMUNISATION
|
|
MANDREKAR, S.
|
PPARY ACTIVATION PROMOTES THE PROTEOLYTIC DEGRADATION OF AΒ
|
|
MAO, C.-J.
|
RELATIONSHIP BETWEEN AUTONOMIC DYSFUNCTION AND DEPRESSION IN PARKINSON'S DISEASE
|
|
MAO, C.-J.
|
COMPARISION OF DEPRESSION BETWEEN PARKINSON'S DISEASE AND ESSENTIAL TREMOR
|
|
MARCELLINO, D.
|
TREATMENT WITH ADENOSINE A2A RECEPTOR ANTAGONIST COUNTERACT SYMPTOMS AND PREVENT THE DEVELOPMENT OF DYSKINESIA IN THE MITOPARK MOUSE MODEL
|
|
MARCON, G.
|
ALPHA SYNUCLEIN PATHOLOGY IN FAMILIAL ALZHEIMER´S DISEASE WITH PSEN2 MUTATIONS
|
|
MARIN, R.
|
OESTROGEN RECEPTOR ALPHA IS INTEGRATED INTO CAVEOLAE OF HUMAN NEURONS ASSOCIATED WITH A VOLTAGE-DEPENDENT ANION CHANNEL (VDAC)
|
|
MARTÍ, J.
|
THE HOMOZYGOUS WEAVER MOUSE AS AN ANIMAL MODEL OF PARKINSON'S DISEASE
|
|
MARTIN, E.
|
GENE-GENE INTERACTION BETWEEN PARKIN AND NOS2A IN PARKINSON DISEASE
|
|
MARTIN, L.
|
TAU PHOSPHORYLATION AND NEURONAL APOPTOSIS INDUCED BY THE BLOCKADE OF PP2A INVOLVE GSK3Β
|
|
MARTÍN, V.
|
POLYUNSATURATED FATTY ACID ENRICHMENT SPECIFICALLY PREVENTS AMYLOID-Β TOXICITY IN HT22 AND SN56 NEURONAL-DERIVED CELL LINES
|
|
MARTINEZ, A.
|
PDE7 INHIBITORS AS NOVEL POTENTIAL DRUGS FOR NEURODEGENERATIVE DISORDERS
|
|
MARTINEZ-MARTOS, J.M.
|
INSULIN-REGULATED AMINOPEPTIDASE (IRAP) AND ANGIOTENSIN IV-FORMING ACTIVITIES IN MEN AND WOMEN WITH EARLY STAGE ALZHEIMER TYPE DEMENTIA
|
|
MARTORANA, A.
|
DOPAMINE MODULATES ACETYLCHOLINE CORTICAL EXCITABILITYI IN ALZHEIMER'S PATIENTS
|
|
MARUSZAK, A.
|
PIN1 GENETIC VARIANTS IN ALZHEIMER'S DISEASE
|
|
MASELLIS, M.
|
DEPRESSIVE SYMPTOMS IN AN EXTENDED SAMPLE OF CORTICOBASAL SYNDROME: CORRELATION WITH LEFT ANTERIOR CINGULATE HYPOPERFUSION
|
|
MASMAN, M.
|
IN SILICO STUDY OF FULL LENGTH AMYLOID Β1-42 OLIGOMERS IN SOLUTION: TOWARDS AN EFFECTIVE Β-SHEET-BREAKER DESIGN
|
|
MASSICOT, F.
|
COMPARATIVE CENTRAL MITOCHONDRIAL DAMAGE AND MNESIC DEFICIT IN LIPOPOLYSACCHARIDE-TREATED YOUNG AND AGED SWISS MICE
|
|
MATEOS, L.
|
ESTROGEN REDUCES DAXX TRANSLOCATION CAUSED IN PRESENCE OF AMYLOID-Β IN HUMAN NEUROBLASTOMA CELLS
|
|
MATRONE, C.
|
P75 AND TRK INVOLVEMENT IN THE ACTIVATION OF AMYLOIDOGENESIS FOLLOWING NGF REMOVAL
|
|
MATSUI, M.
|
KNOWLEDGE REGARDING ALZHEIMER´S DISEASE AND COPING STRATEGY AMONG OLDER ADULTS
|
|
MAYER, S.
|
SCREENING FOR PARKINSONIAN SUBJECTS AT RISK OF DEVELOPING COGNITIVE IMPAIRMENT
|
|
MAYES, J.
|
HYDROGEN PEROXIDE FORMATION FROM OLIGOMERIC FORMS OF Β‑AMYLOID
|
|
MAZALAN, S.
|
THE AVIAN CILIARY GANGLION: A USEFUL MODEL FOR STUDY OF BETA AMYLOID EFFECTS ON NEUROTRANSMITTER RELEASE
|
|
MC DONALD, J.
|
DETECTION OF AΒ SDS-STABLE DIMER IS A RELIABLE PREDICTOR OF ALZHEIMER-TYPE DEMENTIA
|
|
MC QUILLAN, K.
|
MODULATION OF AMYLOID-BETA INDUCED MICROGLIAL ACTIVATION BY T CELLS: IMPLICATIONS FOR PLAQUE CLEARANCE IN ALZHEIMER'S DISEASE
|
|
MCCAMPBELL, A.
|
MANIPULATION OF VASCULAR RISK FACTORS IN ALZHEIMER´S MOUSE MODELS
|
|
MCCAMPBELL, A.
|
ALLOSTERIC POTENTIATION OF THE M1 MUSCARINIC RECEPTOR PROVIDES RELIEF FROM COGNITIVE DEFICIT IN TWO ANIMAL MODEL OF ALZHEIMER´S DISEASE
|
|
MCFARLAND, K.
|
ANTIPSYCHOTIC-LIKE ACTIVITY OF PIMAVANSERIN, A 5-HT2A INVERSE AGONIST, IN ANIMAL MODELS OF ALZHEIMER'S DISEASE PSYCHOSIS
|
|
MCFARLAND, K.
|
ANTIPSYCHOTIC-LIKE ACTIVITY OF PIMAVANSERIN, A 5-HT2A INVERSE AGONIST, IN AN ANIMAL MODEL OF PARKINSON'S DISEASE PSYCHOSIS
|
|
MCLAUGHLIN, T.
|
INCREASING DEPENDENCE ON OTHERS IS ASSOCIATED WITH INCREASED RESOURCE USE IN DEMENTIA
|
|
MECO, G.
|
URINARY DYSFUNCTIONS AND INCONTINENCE IN PARKINSON'S DISEASE - USE OF THE OVERACTIVE BLADDER QUESTIONARY IN A COHORT OF PATIENTS
|
|
MECO, G.
|
INFLAMMATORY CYTOKINES INTERLEUKIN-10 AND INTERLEUKIN-1Β GENE POLYMORPHISMS AND PARKINSON'S DISEASE IN ITALIAN PATIENTS
|
|
MECO, G.
|
GASTRIC EMPTING HAS NO RELATIONSHIP WITH L-DOPA PLASMATIC LEVELS AFTER ORAL SOMMINISTRATION OF L-DOPA IN PARKINSON'S DISEASE
|
|
MECO, G.
|
ITALIAN OLFACTORY IDENTIFICATION TEST (IOIT): A NEW OLFACTIVE TEST FOR ITALIAN POPULATION. RESULTS IN PATIENTS WITH PARKINSON'S DISEASE
|
|
MECO, G.
|
INCIDENCE OF DEMENTIA IN A COHORT OF PATIENTS WITH PARKINSON'S DISEASE
|
|
MECOCCI, P.
|
POST-HOC ANALYSES OF ADAS-COG AND SIB TOTAL AND SINGLE-ITEM SCORES IN PATIENTS WITH MODERATE-TO-SEVERE AD TREATED WITH MEMANTINE
|
|
MEDINA, M.
|
MARINE NATURAL PRODUCTS AS AΒ MODULATORS
|
|
MEEUS, B.
|
PARK11 GENE GIGYF2 IN SPORADIC PARKINSON DISEASE IN A BELGIAN POPULATION
|
|
MELCHERS, A.
|
GLUCOCEREBROSIDASE MUTATIONS IN 108 NEUROPATHOLOGICALLY CONFIRMED MULTIPLE SYSTEM ATROPHY CASES
|
|
MELELEO, D.
|
CHOLESTEROL MODULATES AMYLOID BETA PEPTIDE1-42 CHANNEL FORMATION IN PLANAR LIPID MEMBRANES
|
|
MENDES, T.
|
MEMORY COMPLAINTS ARE FREQUENT BUT QUALITATIVELY DIFFERENT IN YOUNG AND OLD HEALTHY PEOPLE
|
|
MENDONÇA, N.
|
UNCOMMON PRESENTATION OF CORTICOBASAL DEGENERATION - CASE REPORTS
|
|
MENG, Y.
|
EFFECT OF APP 5-MER PEPTIDE ON PRODUCTION AND DIFFERENTIATION OF CULTURED EMBRYO HIPPOCAMPAL NEURAL STEM CELLS ORIGINATED FROM SD RATS
|
|
MENGEL, D.
|
THE ANTI-INFLAMMATORY DRUG CNI-1493 REGULATES THE INTRACELLULAR PROCESSING OF AΒ IN DIFFERENT CELL TYPES OF THE BRAIN
|
|
MERCADO, M.L.
|
DISSECTING NEURONAL MACROAUTOPHAGY PATHWAYS IN RESPONSE TO ALPHA-SYNUCLEIN OLIGOMERS
|
|
MEREDITH, J.
|
GAMMA-SECRETASE INHIBITORS CAN DIFFERENTIALLY INHIBIT CLEAVAGE OF AMYLOID PRECURSOR PROTEIN AND NOTCH PROTEINS IN CULTURED CELLS
|
|
MERLINI, M.
|
EXTRACELLULAR BRAIN GLUCOSE IN TRANSGENIC ARCABETA MICE: AN IN VIVO BRAIN MICRODIALYSIS STUDY
|
|
MERVIS, R.F.
|
DENDRITIC PLASTICITY IN THE FRONTAL CORTEX IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT
|
|
MERVIS, R.F.
|
NEUROTOXIC CONSEQUENCES OF INTRANEURONAL AB OLIGOMERIC AGGREGATES ON HIPPOCAMPAL DENDRITIC MORPHOLOGY IN THE 3 MONTH OLD ARCAΒ TRANSGENIC MOUSE
|
|
MIETELSKA-POROWSKA, A.
|
MODELING TAUOPATHIES USING PORE-FORMING AGENT POLY-APS FOR EFFECTIVE INTRANEURONAL DELIVERY OF EXOGENOUS TAU PROTEIN
|
|
MIKHAYLOVA, N.
|
MIXED DEMENTIA AND APOLIPOPROTEIN E POLIMORPHISM
|
|
MIKHAYLOVA, N.
|
MIXED DEMENTIA: CLINICAL AND NEUROPSYCHOLOGICAL FEATURES
|
|
MILANOVIC, D.
|
TEMPORAL AND REGIONAL PROFIL OF ALPHA-II-SPECTRIN BEAKDOWN PRODUCTS AFTER REPEATED PROPOFOL EXPOSURE IN IMMATURE RAT BRAINS
|
|
MILLS, R.
|
AN OPEN-LABEL EXTENSION STUDY TO DETERMINE THE SAFETY OF PIMAVANSERIN IN PATIENTS WITH PARKINSON'S DISEASE AND PSYCHOSIS
|
|
MINNITI, A.
|
EFFECTS OF COPPER ON AΒ-INDUCED PATHOLOGICAL FEATURES IN CAENORHABDITIS ELEGANS
|
|
MITITELU, A.
|
ENVIRONMENTAL XENOBIOTICS EXERTS SOME NEUROPROTECTIVE EFFECTS ON ALZHEIMER"S DISEASE NEURODEGENERATIVE PROCESS
|
|
MITSUYAMA, F.
|
MICROTUBULES TO FORM MEMORY AND ALZHEIMER'S DISEASE
|
|
MIYAJI, Y.
|
EYE DROP TESTS FOR PARKINSONISM
|
|
MLADENOVIC DJORDJEVIC, A.
|
EXPRESSION OF CHOLESTEROL HOMEOSTASIS GENES IN THE RAT BRAIN IS AFFECTED BY AGE AND DIETARY RESTRICTION
|
|
MOHANAKUMAR, K.P.
|
FUNCTIONAL ASSESSMENT OF MOUSE ES CELLS DERIVED DOPAMINERGIC NEURONAL TRANSPLANTS IN HEMIPARKINSONIAN MODELS
|
|
MOISEENOK, A.
|
MODEL OF NEURODEGENERATIVE PATHOLOGY COMNINED WITH COENZYME A DEFICIENCY IN CNS STRUCTURES
|
|
MOLDZIO, R.
|
THYMOQUINONE SHOWS RESCUEING EFFECTS ON MURINE MESENCEPHALIC CULTURE NEURONS AFFECTED BY COMPLEX I INHIBITION
|
|
MOMIYAMA, T.
|
DEVELOPMENTAL CHANGES IN THE CALCIUM CHANNEL AND D1-LIKE RECEPTORS INVOLVED IN THE GLUTAMATERGIC TRANSMISSION ONTO RAT BASAL FOREBRAIN CHOLINERGIC NEURONS
|
|
MONACO, D.
|
MULTIPLE SYSTEM ATROPHY PROJECT: A MULTIDISCIPLINARY DIAGNOSTIC APPROACH
|
|
MONTEIRO, M.
|
UBIQUILIN AND ERASIN FUNCTION IN ERAD AND REGULATE ER STRESS AND LIFESPAN IN CAENORHABDITIS ELEGANS
|
|
MORAIS, V.A.
|
ROLE OF PINK1 IN PARKINSON'S DISEASE AND MITOCHONDRIAL FUNCTION: MUTATIONS IN PINK1 AFFECT SYNAPTIC FUNCTION VIA DISTURBED COMPLEX I ACTIVITY
|
|
MORGENSTERN, N.
|
EFFECTS OF AGEING ON ADULT HIPPOCAMPAL NEUROGENESIS
|
|
MOROZOVA-ROCHE, L.
|
NEUROIMMUNE MARKERS OF NEURODEGENERATION IN ALZHEIMER'S AND PARKINSON'S DISEASE MEASURED BY ELISA
|
|
MOSCA, L.
|
BETA-AMYLOID INDUCES AN ENHANCEMENT OF PARP ACTIVITY IN A CELLULAR MODEL OF NEURODEGENERATION
|
|
MOSIMANN, U.
|
VISUAL SYMPTOMS IN PARKINSON'S DISEASE
|
|
MÖßNANG, C.
|
FMRI INVESTIGATION OF OLFACTORY IMPAIRMENT IN PATIENTS WITH IDIOPATHIC PARKINSON'S DISEASE
|
|
MOUSAVI, M.
|
NICOTINIC RECEPTOR AGONISTS AND ANTAGONISTS INCREASE SAPPΑ SECRETION AND DECREASE AΒ LEVELS IN VITRO
|
|
MOZHEYKO, E.
|
NEURODYNAMIC SPEECH IMPAIRMENTS AS A VARIANT OF REVERSIBLE COGNITIVE DISORDERS
|
|
MRUTHINTI, S.
|
RAGE+BETA AMYLOID, AGE+RAGE, PARKIN+BETA AMYLOID AND NGF+BETA AMYLOID SPECIFIC ANTIGEN/ANTIBODY IGG LEVELS IN ALZHEIMER´S AND PARKINSON´S DISEASES
|
|
MUKHAMEDYAROV, M.
|
PERIPHERAL EFFECTS OF Β-AMYLOID PEPTIDE: IMPLICATION TO MOTOR DYSFUNCTION IN ALZHEIMER'S DISEASE
|
|
MUKHAMEDYAROV, M.
|
MEMBRANE-STABILIZING EFFECT OF NOVEL NEUROPROTECTIVE PHARMACOLOGICAL COMPOUND CAPAH: IMPLICATION TO TREATMENT OF ALZHEIMER'S DISEASE
|
|
MÜLLER, T.
|
THE AFT COMPLEX - INTRACELLULAR DOMAIN OF APP IN CONCERT WITH FE65 AND TIP60
|
|
MÜLLER-SCHIFFMANN, A.
|
IN SILICO AFFINITY MATURATION OF A SINGLE-CHAIN ANTIBODY FRAGMENT (SCFV) AGAINST ABETA
|
|
MÜNCH, A.
|
TMEM59 - A NOVEL MODULATOR OF APP SHEDDING
|
|
MUNTANÉ, G.
|
REGIONAL Α-SYNUCLEIN EXPRESSION LEVELS IN AGED HUMAN BRAIN AND IN PARKINSON'S DISEASE
|
|
MURA, E.
|
BRAIN AREA-SELECTIVE NEUROMODULATORY ACTION OF BETA-AMYLOID
|
|
MURAD, A.
|
IDENTIFICATION OF NOVEL COMPONENTS OF THE PARKINSON'S DISEASE PINK1/PARKIN PATHWAY
|
|
MURATA, M.
|
OLFACTORY DYSFUNCTION IS CORRELATED WITH REDUCED CARDIAC MIBG UPTAKE IN PARKINSON'S DISEASE
|
|
MURESAN, Z.
|
TRANSPORT OF PROTEOLYTICALLY PROCESSED AMYLOID-Β PRECURSOR PROTEIN USES KINESIN AND MYOSIN MOTORS AND A PLETHORA OF SCAFFOLDING PROTEINS
|
|
MURESANU, D.
|
DIABETES AGGRAVATES HEAT STRESS INDUCED BLOOD-BRAIN BARRIER BREAKDOWN, EDEMA FORMATION AND BRAIN PATHOLOGY - POSSIBLE NEUROPROTECTION WITH CEREBROLYSIN
|
|
MUSELLA, O.
|
ADARTE VISUAL ART IN ALZHEIMER DISEASE
|
|
MUSGROVE, R.
|
ΑLPHA-SYNUCLEIN IS A POTENTIAL NEUROPROTECTANT IN BOTH WILD-TYPE CORTICAL AND DOPAMINERGIC NEURONS, BUT NOT A53T MUTANT NEURONS
|
|
MUSHA, T.
|
DISCRIMINATION OF MCI WITH NEURONAL ABNORMALITY IMAGING
|
|
MUSILEK, K.
|
IN VITRO SCREENING OF SMALL ABAD (ERAB) INHIBITORS AS POTENTIAL AD TREATMENT
|
|
MUSTAFAYEVA, N.
|
MOLECULAR DYNAMICS OF THE N-TERMINAL DOMAIN OF TYROSINE HYDROXYLASE
|
|
MWAMBU, M.
|
CLINICAL FEATURES OF THE HEAD INJURY
|
|
NACMIAS, B.
|
NO IMPLICATION OF CALHM1 P86L COMMON VARIATION IN ITALIAN ALZHEIMER 'S DISEASE
|
|
NAJLERAHIM, A.
|
RECOGNIZING FACIAL EMOTIONAL EXPRESSIONS IN AD COMPARED TO MCI (MILD MEMMORY IMPAIRMENT) AND HEALTHY NON DEMENTED CASES
|
|
NAKAE, Y.
|
“APPLAUSE SIGN” IS USEFUL FOR DIAGNOSIS OF NOT ONLY PROGRESSIVE SUPRANUCLEAR PALSY (PSP) BUT ALSO DEMENTIA WITH LEWY BODIES (DLB)
|
|
NAKAMURA, S.
|
EFFECT OF ANM176TM CONTAINING FERULIC ACID AND GARDEN ANGELICA EXTRACT ON ALZHEIMER´S DISEASE
|
|
NAKAMURA, S.
|
THE EFFECT OF COMBINATION THERAPY OF DOPAMINE AGONISTS FOR PARKINSON´S DISEASE
|
|
NARDONE, R.
|
DYSFUNCTION OF CENTRAL CHOLINERGIC CIRCUITS IN EARLY ALZHEIMER´S DISEASE: A TRANSCRANIAL MAGNETIC STIMULATION STUDY
|
|
NÄSSTRÖM, T.
|
CROSS-LINKING OF ALPHA-SYNUCLEIN WITH REACTIVE ALDEHYDES CAUSE RAPID FORMATION OF STABLE OLIGOMERS
|
|
NAUDÉ, P.
|
THE ROLE OF NEUROINFLAMMATION ON BDNF PRODUCTION IN MILD COGNITIVE DISORDER AND ALZHEIMER'S DISEASE
|
|
NAVARRO-SÁNCHEZ, L.
|
GENETIC SUSCEPTIBILITY FACTORS IN PARKINSON DISEASE
|
|
NEGRO, A.
|
DJ-1 IS PHOSPHORYLATED BY MEMBERS OF THE SRC FAMILY OF PROTEIN-TYROSINE KINASES
|
|
NESTOR, S.
|
VENTRICLE SUB-REGION VOLUME AT BASELINE PROVIDES DISCRIMINATION BETWEEN NORMAL CONTROLS, MILD COGNITIVE IMPAIRMENT AND ALZHEIMER DISEASE USING DATA FROM ADNI
|
|
NEUMANN, U.
|
THE EXPERIMENTAL BACE INHIBITOR NB-216 SHIFTS APP PROCESSING FROM THE AMYLOIDOGENIC TO THE NON-AMYLOIDOGENIC PATHWAY IN AN APP-TRANSGENIC MOUSE MODEL
|
|
NICOLIA, V.
|
METHYLATION METABOLISM ALTERATION MODULATES A SMALL NUMBER OF CNS GENES BESIDES PS1 AND BACE
|
|
NICOSIA, F.
|
CARDIAC AUTONOMIC DYSFUNCTION IS ASSOCIATED WITH WHITE MATTER LESIONS IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
|
|
NICOSIA, F.
|
DIAGNOSTIC PROCEDURES FOR CARDIOVASCULAR COMORBIDITIES IN HOSPITALIZED ELDERLY IN RELATION TO DEMENTIA
|
|
NIEDOWICZ, D.
|
THE EFFECT OF A KETOGENIC DIET ON MOTOR PERFORMANCE AND AMYLOID Β ACCUMULATION IN APP TRANSGENIC MICE
|
|
NIEHAUS, I.
|
LEU-ENKEPHALIN AS A TREATMENT OF INFLAMMATORY PARKINSONISM (A CASE REPORT)
|
|
NIZRI, E.
|
NEUROINFLAMMATION SUPPRESSION AND IMPROVED COGNITIVE FUNCTION BY THE ACETYLCHOLINESTERASE INHIBITOR RIVASTIGMINE
|
|
NODEL, M.
|
FATIGUE IN PARKINSON´S DISEASE - EFFECT OF DOPAMINE AGONIST PRAMIPEXOLE
|
|
NOLAN, R.
|
AXONAL TRANSPORT DEFECTS LEAD TO CHANGES IN APP METABOLISM AND TAU CONFORMATION IN HUMAN EMBRYONIC STEM CELL-DERIVED NEURONAL CULTURES
|
|
NOLAN, Y.
|
THE EFFECT OF PHARMACOLOGICAL AND ENDOGENOUS P38 INHIBITION ON 6-HYDROXYDOPAMINE-TREATED RAT VENTRAL MESENCEPHALIC NEURONS IN VITRO
|
|
NORDLUND, A.
|
THE ASSOCIATION BETWEEN ALZHEIMER-TYPICAL BIOMARKERS, VASCULAR DISEASE AND COGNITION IN MCI
|
|
NOTARACHILLE, G.
|
EFFECT OF CALCIUM AND CADMIUM IONS ON AMYLOID BETA PEPTIDE1-42 CHANNEL ACTIVITY
|
|
NURMI, A.
|
THE EFFECT OF SAN-61 ON BETA AMYLOID (AΒ1-42) TOXICITY IN RAT MIXED CORTICAL CULTURES
|
|
NUYTEMANS, K.
|
COMPREHENSIVE ANALYSIS OF SEQUENCE AND COPY NUMBER VARIATIONS IN THE 5 MAJOR PD GENES IN A BELGIAN PD PATIENT GROUP
|
|
O' NEILL, C.
|
AMYLOID-Β ASSOCIATED INCREASES IN AKT ACTIVATION AND TAU PATHOGENESIS IN THE 3 X TG-AD MODEL: IMPLICATIONS FOR AD
|
|
OCHUDLO, S.
|
EXECUTIVE DYSFUNCTION IN FOCAL DYSTONIA
|
|
O'CONNOR, M.
|
ARE PARKSINONS PATIENTS SAFE TO DRIVE? HOW CAN THE CLINICIAN DECIDE?
|
|
OH, C.K.
|
IDENTIFICATION OF E3 LIGASE ACTIVITY IN THE RING FINGER PROTEIN 166 DURING DOPAMINERGIC NEURONAL CELL DEATH
|
|
OH, Y.
|
SCREENING OF POTENTIAL NEURONAL CELL DEATH MODULATORS IN DYRK1A-OVEREXPRESSING HIPPOCAMPAL CELLS
|
|
OHM, T.
|
THE NPC1/P301L-MOUSE
|
|
OKOCHI, M.
|
CHARACTERIZATION OF A NOVEL APLP1-DERIVED AΒ-LIKE PEPTIDE
|
|
OLAS, K.
|
INTRAVENOUS IMMUNOGLOBULIN PREPARATION CONTAINING NATURAL ANTI-AMYLOID BETA ANTIBODIES ATTENUATES AMYLOID BETA-INDUCED NEUROTOXICITY IN VITRO
|
|
OMIDI, H.
|
CORRELATION BETWEEN VITAMIN E AND STATIN LEVELS AND THE DEVELOPMENT OF ALZHEIMERS DISEASE IN A MOUSE
|
|
O'NEILL, M.
|
A LASER CAPTURE MICRODISSECTION STUDY OF GENE EXPRESSION FOLLOWING A RETROGRADE 6-HYDROXYDOPAMINE LESION OF THE SUBSTANTIA NIGRA IN RATS
|
|
OPARA, J.
|
POSTUROGRAPHY SUPPORTS BALANCE PHYSICAL THERAPY IN INDIVIDUALS WITH PARKINSON´S DISEASE
|
|
ORIMO, S.
|
AXONAL Α-SYNUCLEIN AGGREGATES HERALD CENTRIPETAL DEGENERATION OF THE CARDIAC SYMPATHETIC NERVE IN PARKINSON´S DISEASE
|
|
OSMANOVIC, J.
|
ENVIRONMENTAL ENRICHMENT AND MENTAL TRAINING IMPROVE COGNITION IN RAT MODEL OF SPORADIC ALZHEIMER'S DISEASE
|
|
OSSOLA, M.
|
CAPGRAS DELUSION ALONG WITH VISUAL HALLUCINATIONS IN LEWY BODY DEMENTIA: A SUPPORTIVE CRITERION FOR DIAGNOSIS? A CASE REPORT
|
|
PALEY, E.
|
NEW MAPPED MONOCLONAL ANTIBODIES FOR DISAGGREGATION OF FIBRILS
|
|
PALEY, E.
|
NON-TRANSGENIC METABOLIC MODELS FOR AND ARREST OF NEURODEGENERATION
|
|
PALLAS, M.
|
LITHIUM REDUCES NEURODEGENERATION MARKERS IN EXPERIMENTAL MODELS OF AGEING
|
|
PALMQVIST, S.
|
AQT - TESTS YOUR COGNITIVE SPEED! A REVIEW OF A VALIDATED SCREENING TOOL FOR DEMENTIA WITH MANY POTENTIAL APPLICATIONS
|
|
PAN, C.
|
IDENTIFICATION OF PROTEINS WITH OXIDATION AND/OR PHOSPHORYLATION IN HUMAN CEREBROSPINAL FLUID OF PATIENTS WITH ALZHEIMER´S AND PARKINSON´S DISEASE
|
|
PANDEY, M.
|
EXPRESSION CHANGES IN PROFILIN IN 3-NITROPROPIONIC ACID-INDUCED ANIMAL MODEL OF HUNTINGTON'S DISEASE: A SUBTRACTIVE HYBRIDIZATION STUDY
|
|
PAPADOPOULOS, V.
|
OXIDATIVE STRESS-MEDIATED DHEA FORMATION IN PATIENTS' SERUM: THE BIOCHEMICAL BASIS FOR A DIAGNOSIS OF ALZHEIMER'S DISEASE
|
|
PAPALEXI, E.
|
EFFECTS OF MEMANTINE ON INSTRUMENTAL ACTIVITIES OF DAILY LIVING IN A LARGE GREEK OBSERVATIONAL STUDY
|
|
PAQUET, D.
|
A NOVEL TAU TRANSGENIC ZEBRAFISH MODEL FOR DRUG DISCOVERY
|
|
PARK, J.
|
NEUROPATHOLOGICAL FEATURES OF DOWN SYNDROME SHOWN IN DYRK1A-OVEREXPRESSING IMMORTALIZED HIPPOCAMPAL NEURONS
|
|
PARK, K.W.
|
SUBTYPE ANALYSIS AND PATTERN OF CEREBRAL HYPOPERFUSION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
|
|
PARK, M.H.
|
PLASMA HOMOCYSTEINE IS ASSOCIATED WITH COGNITIVE DECLINE IN THE ELDERLY KOREAN
|
|
PARKIN, E.
|
FLAG-TAGGED CONSTRUCTS FOR THE STUDY OF ADAM10 ECTODOMAIN SHEDDING
|
|
PARKIN, E.
|
EXCLUSIVELY TARGETING ADAM10 TO LIPID RAFTS BY GPI ANCHOR ADDITION REDUCES Β-SITE PROCESSING OF THE AMYLOID PRECURSOR PROTEIN
|
|
PARKKINEN, L.
|
DOES L-DOPA HAVE TOXIC EFFECTS IN PARKINSON'S DISEASE BRAIN?
|
|
PARRA, M.
|
WHAT MEMORY BINDING DEFICITS CAN TELL US ABOUT ALZHEIMER'S DISEASE?
|
|
PASBAKHSH, P.
|
THE PROTECTIVE EFFECT OF VITAMIN E ON LOCUS COERULEUS IN EARLY MODEL OF PARKINSONُS DISEASE IN RAT: IMMUNOREACTIVITY EVIDENCE
|
|
PATRICIO, A.
|
EFFECT OF THE C-TERMINAL CHAIN OF TETANUS TOXIN IMPROVES MOTOR BEHAVIORS IN HEMIPARKINONIAN RATS
|
|
PAVEL, M.
|
EARLY DETECTION OF COGNITIVE DECLINE USING UNOBTRUSIVE AND CONTINUOUS MONITORING
|
|
PEARSON, H.A.
|
AMYLOID ß PRODUCTION IS IMPORTANT FOR CELL VIABILITY AND NEURITE OUTGROWTH
|
|
PEDROSA, R.
|
SPORADIC EARLY-ONSET ALZHEIMER´S DISEASE
|
|
PEIFFER, J.J.
|
THE RELATIONSHIP BETWEEN LEAN BODY MASS, COGNITION AND BLOOD BIOMARKERS IN A HEALTHY ELDERLY POPULATION
|
|
PENNINGTON, K.
|
PROTEOMIC ANALYSIS OF THE EFFECTS OF Α-SYNUCLEIN ON MITOCHONDRIAL PROTEIN EXPRESSION
|
|
PÉREZ-TUR, J.
|
HOMOCYSTEINE AND COGNITIVE IMPAIRMENT IN PARKINSON DISEASE: A GENETIC STUDY
|
|
PEROVIC, M.
|
EXPRESSION OF PROBDNF AND P75 IN THE AGING RAT HIPPOCAMPUS
|
|
PERREAU, V.M.
|
DOMAIN LEVEL PROTEIN INTERACTION NETWORK OF AMYLOID PRECURSOR PROTEIN AND AΒ, IMPLICATIONS FOR INVESTIGATIONS INTO ALZHEIMER'S DISEASE
|
|
PESIC, V.
|
POTENTIAL MECHANISM OF CELL DEATH IN THE DEVELOPING RAT BRAIN INDUCED BY PROPOFOL ANESTHESIA
|
|
PESINI, P.
|
BLOOD LEVELS OF AΒ-40 AND AΒ-42 PEPTIDES IN PEOPLE WITHOUT DEMENTIA THROUGHOUT LIFESPAN - ANALYSES IN PEOPLE OF AYERBE (HUESCA, SPAIN)
|
|
PETIT, A.
|
GSK-3BETA MEDIATES MPTP (N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE) - INDUCED DOPAMINERGIC NEURONAL CELL DEATH THROUGH MITOCHONDRIAL MEMBRANE DEPOLARIZATION
|
|
PETTERSSON, C.
|
LPS-INDUCED NO PRODUCTION IN MURINE BV-2 CELLS IS DEPENDENT ON THE JNK PATHWAY
|
|
PEURALINNA, T.
|
AMYLOID PRECURSOR PROTEIN (APP) VARIATION IN ELDERLY FINNISH POPULATION: ASSOCIATION WITH ALZHEIMER TYPE PATHOLOGY
|
|
PIAZZA, F.
|
TISSUE FACTOR PATHWAY INHIBITOR AND HOMOCYSTEINE: EVIDENCE FOR ENDOTHELIAL DAMAGE IN ALZHEIMER´S DISEASE
|
|
PINEDA, D.
|
TISSUE PLASMINOGEN ACTIVATOR (TPA) INDUCES MICROGLIA ACTIVATION THROUGH A MOLECULAR MECHANISM INVOLVING ERK1/2 ACTIVATION
|
|
PIPLANI, P.
|
RATIONAL DESIGN OF ACETYLCHOLINESTERASE INHIBITORS IN THE TREATMENT OF ALZHEIMER´S DISEASE
|
|
PIRSCOVEANU, D.
|
STUDY ABOUT THE COGNITIVE IMPAIRMENT AFTER ISCHEMIC STROKE COMPARATIVE WITH HEMORRHAGIC STROKE
|
|
PISCOPO, P.
|
HYPOXIA INDUCES PROGRANULIN UP-REGULATION IN A NEURON-LIKE MODEL
|
|
PLACANICA, L.
|
Γ-SECRETASE ACTIVITY IN MOUSE BRAIN EXHIBITS AGE AND SEX SPECIFIC DIFFERENCES IN THE PROCESSING OF APP AND NOTCH1
|
|
PLUCINSKA, K.
|
FUNCTIONAL REORGANIZATION OF THE MESOLIMBIC DOPAMINERGIC SYSTEM AFTER ITS TERMINAL AREA DESTRUCTION
|
|
POCOCK, J.
|
INHIBITION OF P53 PATHWAYS IN MICROGLIA ATTENUATES MICROGLIAL-EVOKED NEUROTOXICITY FOLLOWING EXPOSURE TO ALZHEIMER PEPTIDES
|
|
POLITO, C.
|
COGNITIVE, STRUCTURAL AND METABOLIC CHANGES IN PRECLINICAL FAMILIAL ALZHEIMER'S DISEASE WITH AN AUTOSOMAL DOMINANT MUTATION
|
|
POLITO, C.
|
BEYOND THE FRONTOSTRIATAL CIRCUIT: EXECUTIVE FUNCTIONS DEFICIT AND LIMBIC HYPOMETABOLISM IN EARLY PARKINSON'S DISEASE
|
|
POMARA, N.
|
THE RELATIONSHIP BETWEEN RISK FACTORS FOR AD AND SERIAL POSITION EFFECTS
|
|
POOLER, A.
|
PHOSPHORYLATION REGULATES THE ASSOCIATION OF TAU WITH MEMBRANES
|
|
POPESCU, B.O.
|
EFFECTS OF THE NEUROTROPHIC DRUG CEREBROLYSIN ON BEHAVIORAL TESTS IN A RAT MODEL OF PARKINSON'S DISEASE
|
|
PÖSCHL, P.
|
POSTURAL INSTABILITY IN PARKINSON´S DISEASE IS NOT ASSOCIATED WITH DEPRESSED VESTIBULOSPINAL REFLEX
|
|
POURCHER, E.
|
OFF-LINE LEARNING IN IDIOPATHIC PARKINSON'S DISEASE DO VASCULAR RISK FACTORS MAKE A DIFFERENCE?
|
|
PRAKASAM, A.
|
APP PROCESSING IN LIGHT-INDUCED RETINAL DEGENERATION: COMMON MECHANISM OF NEURODEGENERATION WITH ALZHEIMER'S DISEASE
|
|
PREOBRAZHENSKAYA, I.
|
THE EFFECT OF MEMANTINE ON COGNITION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
|
|
PREOBRAZHENSKAYA, I.
|
ESTIMATION OF THE INFLUENCE OF LEVODOPA AND CHOLINESTERASE INHIBITORS ON HEART RATE VARIABILITY
|
|
PRIETO, G.A.
|
DOPAMINE D3 RECEPTOR SUPERSENSITIVITY FOLLOWING DOPAMINERGIC DENERVATION
|
|
PROCTOR, D.
|
REGIONAL POST-SYNAPTIC SCAFFOLD PROTEIN LOSS IN ALZHEIMER´S DISEASE
|
|
PROTTER, A.
|
NEURITE OUTGROWTH AND MITOCHONDRIAL FUNCTION IN DIMEBON TREATED RAT CORTICAL CULTURES
|
|
PUSTOKHANOVA, L.
|
LIPID DELIVERY LEUKOCYTE ABILITY IN EARLY DIAGNOSIS OF ALZHEIMER´S DISEASE
|
|
PUSTOKHANOVA, L.
|
COGNITIVE STATUS IN "ACUTE" ISCHEMIC STROKE PATIENTS
|
|
RABL, R.
|
BEHAVIOURAL PHENOTYPING OF R6/2 MICE, A MODEL FOR HUNTINGTON´S DISEASE
|
|
RACIC, M.
|
PREVENTION OF COGNITIVE IMPAIRMENTS IN PRIMARY HEATH CARE
|
|
RAMBERG, V.
|
MICROTUBULE DIRECTED CASPASE SENSORS FOR LIVE CELL IMAGING OF NEURITEDEGENERATION AND CELL DEATH
|
|
RAMIREZ, M.J.
|
PROPRANOLOL TREATMENT INCREASES INSULIN DEGRADING ENZYME (IDE) LEVELS IN HUMAN AND RATS
|
|
RAMIREZ-EXPOSITO, M.J.
|
PYRROLIDONE CARBOXYL PEPTIDASE PROTECTS AGAINST NEUROTOXICITY INDUCED BY PYROGLUTAMYL-ENDED FORMS OF BETA-AMYLOID
|
|
RANGAPPA, K.S.
|
MUSCARINIC RECEPTOR 1 AGONIST ACTIVITY OF NOVEL ARECOLINE DERIVATIVES IN ALZHEIMER'S DEMENTIA MODELS
|
|
RAPPLEY, I.
|
ALPHA-SYNUCLEIN EFFECTS ON PHOSPHOLIPID MEMBRANES AND CELL HEALTH
|
|
RASCOL, O.
|
THE ADAGIO DELAYED-START STUDY DEMONSTRATES THAT EARLY RASAGILINE TREATMENT SLOWS UPDRS DECLINE
|
|
RAUSCH, W.
|
POACYNUM HENDERSONII (HOOK.F) WOODSON EXTRACTS PROTECT DOPAMINERGIC NEURONS IN CULTURE
|
|
RAVI, S.K.
|
LINGUISTIC DEFICITS IN INDIVIDUALS WITH DAT - A CROSS LANGUAGE COMPARISON
|
|
REALE, M.
|
POLYMORPHISMS OF CHEMOKINE AND CHEMOKINE RECEPTOR GENES IN AD AND PD PATIENTS
|
|
REBELO, S.
|
THE ROLE OF PKCEPSILON ON APP EXPRESSION AND ABETA PRODUCTION
|
|
REED-GEAGHAN, E.
|
CD14 MEDIATES MICROGLIAL ACTIVATION BY FIBRILLAR AΒ
|
|
RHEIN, V.
|
PROTECTIVE EFFECTS OF GINKGO BILOBA EXTRACT ON MITOCHONDRIAL ABNORMALITIES IN APP OVEREXPRESSING HUMAN NEUROBLASTOMA CELLS
|
|
RHODES, C.H.
|
TRANSCRIPTIONAL REGULATION IN THE MAPT H1/H2 HAPLOTYPE BLOCK
|
|
RIDDELL, D.
|
IMPACT OF APOLIPOPROTEIN E (APOE) POLYMORPHISM ON BRAIN APOE LEVELS
|
|
RIEDINGER, K.
|
INVESTIGATIONS OF THE CONTEXT DEPENDENCY OF CATALEPSY-SENSITIZATION IN A RAT MODEL OF PARKINSON PATHOLOGY
|
|
RILEY MCCARTEN, J.
|
MOTOR SYMPTOMS AND SIGNS IN PATIENTS REFERRED TO A DEMENTIA CLINIC: INCIDENCE AND ETIOLOGY
|
|
RIOS, R.M.
|
EFFECT OF PROTEASOME INHIBITION IN GOLGI APPARATUS AND CENTROSOME STRUCTURE - RELEVANCE IN PARKINSON´S DISEASE PATHOPHYSIOLOGY
|
|
ROCKENSTEIN, E.
|
NEUROPROTECTIVE EFFECTS OF CEREBROLYSIN ON NEUROFIBRILLARY PATHOLOGY IN APP-TRANSGENIC MICE THAT RECEIVED NEURONAL GENE TRANSFER WITH AAV2-TAU
|
|
RODRIGUEZ-OROZ, M.C.
|
PATTERN OF BRAIN METABOLISM IN ALZHEIMER´S DISEASES AND PARKINSON'S DISEASES WITH DEMENTIA: DIFFERENCES AND SIMILARITIES
|
|
ROESLER, R.
|
A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST ENHANCES VIABILITY AND PROLIFERATION OF NEUROBLASTOMA CELLS: PREVENTION BY A HISTONE DEACETYLASE INHIBITOR
|
|
ROESLER, R.
|
BOMBESIN-INDUCED ENHANCEMENT OF MEMORY CONSOLIDATION IN THE HIPPOCAMPUS REQUIRES PHOSPHATIDYLINOSITOL 3-KINASE
|
|
ROH, J.H.
|
QUANTITATIVE ANALYSIS OF ELECTROENCEPHALOGRAPHY IN PATIENTS WITH ALZHEIMER´S DISEASE AND MILD COGNITIVE IMPAIRMENT
|
|
ROHN, S.
|
DEVELOPMENT OF A NEURON-SPECIFIC NONVIRAL GENE TRANSFER SYSTEM AS A NOVEL THERAPEUTICAL TOOL FOR NEURODEGENERATIVE DISORDERS
|
|
ROHRER, J.
|
THE HERITABILITY AND GENETICS OF FRONTOTEMPORAL LOBAR DEGENERATION
|
|
ROJO, A.I.
|
THE TRANSCRIPTION FACTOR NRF2 IS A NEW THERAPEUTIC TARGET FOR NEUROPROTECTION IN PARKINSON'S DISEASE
|
|
ROMAN, F.
|
ANTI-AMNESIC AND NEUROPROTECTIVE ACTIVITIES OF ANAVEX2-73, A NEW AMINOTETRAHYDROFURAN DERIVATIVE ACTING AS A MIXED MUSCARINIC/SIGMA-1 LIGAND, IN PHARMACOLOGICAL AND PATHOLOGICAL MODELS OF AMNESIA
|
|
RONICKE, R.
|
AΒ MEDIATED DIMINUTION OF MTT REDUCTION- AN ARTEFACT OF SINGLE CELL CULTURE?
|
|
RÖNNEMAA, E.
|
MIDLIFE CARDIOVASCULAR RISK FACTORS, SMOKING, APOE STATUS AND RISK OF DEMENTIA AND COGNITIVE IMPAIRMENT
|
|
RORIS-CRUZ, M.
|
SERUM NEURON SPECIFIC ENOLASE PREDICTS COGNITIVE DECLINE AMONG BASELINE NON-DEMENTED COMMUNITY-DWELLING ELDERLY: A 2-YEAR FOLLOW-UP STUDY
|
|
ROSI, M.C.
|
INHIBITION OF GSK-3Β BY LITHIUM IMPROVES AMYLOID PATHOLOGY AND LEARNING AND MEMORY FUNCTIONS IN A HUMAN APP TRANSGENIC MOUSE MODEL
|
|
ROSI, S.
|
THERAPEUTIC POTENTIAL OF TNF-Α SYNTHESIS INHIBITORS IN RODENT MODELS OF NEUROINFLAMMATION
|
|
ROSSI, C.
|
“PARKINSON-DEMENTIA” DISEASES: A COMPARISON BY DOUBLE TRACER SPECT STUDIES
|
|
ROUILLARD, C.
|
NUR77 IS INVOLVED IN DOPAMINE CELL DEATH AND NEUROPROTECTION
|
|
RUBIO DE LA TORRE, E.
|
COMBINED KINASE INHIBITION MODULATES PARKIN INACTIVATION
|
|
RUDRA, A.
|
PARKINSON´S DISEASE AND ANAESTHESIA
|
|
RUIZ-MARTÍNEZ, J.
|
VERBAL SEMANTIC FLUENCY IN ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE
|
|
RUSINA, R.
|
MULTIPLE SYSTEM ATROPHY AND ALZHEIMER'S DISEASE IN ASSOCIATION: COINCIDENCE OR COMORBIDITY?
|
|
RUSSO, C.
|
APP OVEREXPRESSION AND PROCESSING MODULATES MAPK SIGNALING AND CELL CYCLE
|
|
RUZDIJIC, S.
|
THE EXPRESSION OF APOE, APP, GFAP AND SYNAPTOPHYSIN FOLLOWING REPEATED CORTICAL INJURIES IN ADULT RATS DURING THE RECOVERY PERIOD
|
|
RYE, P.
|
A BLOOD BASED GENE EXPRESSION TEST FOR THE EARLY DETECTION OF ALZHEIMER'S DISEASE
|
|
SABLONNIERE, B.
|
ASSOCIATION OF CORTICOBASAL DEGENERATION AND HUNTINGTON'S DISEASE: CAN TAU AGGREGATES PROTECT HUNTINGTIN TOXICITY?
|
|
SAEMANN, J.
|
THE KINASES LRK-1 AND PINK-1 HAVE ANTAGONISTIC FUNCTIONS IN C. ELEGANS
|
|
SÁEZ-VALERO, J.
|
THE Β-AMYLOID PROTEIN OF ALZHEIMER´S DISEASE ALTERS REELIN EXPRESSION AND GLYCOSYLATION
|
|
SAFCIUC, F.
|
IMPLICATIONS OF THE CEREBRAL BLOOD VESSELS IN HYPERLIPEMIA, AS RISK FACTORS FOR NEURODEGENERATION
|
|
SAHBAEI ROY, F.
|
NURSE´S ROLE IN PREVENTION OF DEPRESSION OF PSYCHOTIC STATES IN PARKINSON´S PATIENTS
|
|
SALKOVIC-PETRISIC, M.
|
NEUROPROTECTIVE POTENTIAL OF NOVEL MULTIFUNCTIONAL, LIPOPHYLIC IRON-CHELATORS M-30 AND HLA-20 IN RAT MODEL OF SPORADIC ALZHEIMER´S DISEASE
|
|
SALMON, D.
|
DIFFERENCES IN COGNITIVE PROFILES ASSOCIATED WITH PARKINSON'S DISEASE WITH DEMENTIA, DEMENTIA WITH LEWY BODIES, AND ALZHEIMER'S DISEASE
|
|
SALMON, E.
|
DISTINCT METABOLIC CORRELATES OF IMPAIRED CONTROLLED MEMORY PROCESSES IN STABLE QUESTIONABLE ALZHEIMER'S DISEASE AND IN VERY EARLY ALZHEIMER'S DISEASE
|
|
SALMON, E.
|
MULTIVARIATE ANALYSIS OF COGNITIVE PROFILES IN ALZHEIMER'S DISEASE
|
|
SAMORÌ, B.
|
CATCHING AT THE SINGLE MOLECULE LEVEL THE PATHOLOGICAL CONFORMATIONS OF ALPHA SYNUCLEIN: A NEW TOOL FOR DRUG DISCOVERY
|
|
SANDEBRING, A.
|
MAMMALIAN PINK1 DEFICIENCY RESULTS IN DEPHOSPHORYLATION OF DRP1 LEADING TO ALTERATIONS IN MITOCHONDRIAL DYNAMICS
|
|
SANZ-BLASCO, S.
|
NEUROTOXICITY OF AΒ OLIGOMERS IN HIPPOCAMPAL NEURONS: ROLE OF CALCIUM AND NEUROPROTECTION BY NSAIDS
|
|
SARAJÄRVI, T.
|
EFFECTS OF SELADIN-1 KNOCK-DOWN ON APP PROCESSING DURING APOPTOSIS
|
|
SARANTSEVA, S.
|
OVEREXPRESSION OF HUMAN AMYLOID PRECURSOR PROTEIN CAUSES NEURODEGENERATION AND LOSS OF SYNAPTIC PROTEINS IN NEURAL CELLS IN TRANSGENIC DROSOPHILA
|
|
SARESELLA, M.
|
NAÏVE (PD1NEG) AND ACTIVATED (PD1POS) CD4+ T REGULATORY CELLS IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD)
|
|
SARKAKI, A.
|
PREVENTIVE EFFECT OF GRAPE SEED EXTRACT ON SPATIAL MEMORY AND LONG-TERM POTENTIATION (LTP) IN ANIMAL MODEL OF ALZHEIMER'S DISEASE
|
|
SATHEESH KUMAR, N.
|
IN VITRO ACETYLCHOLINESTERASE INHIBITORY ACTIVITY OF MAHANIMBINE IN MURRAYA KOENIGII
|
|
SCHAEFER, S.
|
BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF STABILIZED AΒ OLIGOMERS
|
|
SCHEININ, M.
|
ASSESSMENT OF BRAIN MAO-B OCCUPANCY BY EVT 302, A NOVEL MAO-B INHIBITOR, WITH PET AND [11C]-L-DEPRENYL-D2
|
|
SCHEPER, W.
|
ENDOPLASMIC RETICULUM STRESS IN ALZHEIMER'S DISEASE
|
|
SCHERZER, R.
|
QUINONE-BASED SMALL MOLECULES INHIBIT Β-AMYLOID AGGREGATION AND ALLEVIATE ITS NEURODEGENERATIVE EFFECTS IN FLIES
|
|
SCHLOSSMACHER, M.
|
QUANTIFICATION OF A-SYNUCLEIN IN CSF AND VENOUS BLOOD FOR PD BIOMARKER EXPLORATION
|
|
SCHMIDT, C.
|
A RAPIDLY PROGRESSIVE SUBTYPE OF ALZHEIMER´S DISEASE
|
|
SCHNEEBERGER, A.
|
DEVELOPMENT OF AFFITOPE VACCINES FOR AD - FROM CONCEPT TO CLINICAL TESTING
|
|
SCHÖLL, M.
|
LONGITUDINAL PET STUDY IN A FAMILY HARBOURING A PRESENILINE 1 GENE MUTATION
|
|
SCHOMBURG, R.
|
MICROGLIAL UPTAKE OF AMYLOID-ß AND INFLAMMATORY ACTIVITY ARE DETERMINED BY AMYLOID-ß AGGREGATION STATE AND EXPRESSION OF INNATE IMMUNITY RECEPTORS
|
|
SCHRÖDER, N.
|
AGENTS THAT ENHANCE CHOLINERGIC NEURAL TRANSMISSION REVERSE COGNITIVE IMPAIRMENT ASSOCIATED WITH BRAIN IRON ACCUMULATION IN RATS
|
|
SCHRÖTTER, A.
|
KNOCKDOWN OF THE APP/FE65/TIP60-COMPLEX USING SHRNA EXPRESSION VECTORS IN HUMAN CELL CULTURE - RELEVANCE FOR ALZHEIMER'S DISEASE
|
|
SCHUETTE, S.
|
THE ROLE OF 5-HT1B RECEPTORS ON THE ANTI-PARKINSONIAN ACTIVITY OF MDMA IN THE RESERPINE-INDUCED AKINESIA MODEL IN MICE
|
|
SCHUUR, M.
|
COGNITIVE FUNCTION IS IMPAIRED IN PEOPLE WITH METABOLIC SYNDROME
|
|
SCHWAB, C.
|
TDP-43 PATHOLOGY IN FAMILIAL BRITISH DEMENTIA AND HUNTINGTON'S DISEASE
|
|
SCHWARZMAN, A.
|
PRESENILIN 1 MEDIATES CELL-CELL ADHESION IN TRANSFECTED L-FIBROBLASTS
|
|
SCHWEINZER, C.
|
METABOLISM OF AMYLOID-ß PRECURSOR PROTEIN AT THE BLOOD-BRAIN BARRIER
|
|
SCHWIELER, L.
|
DIFFERENTIAL EXPRESSION OF BACE AND BACE2 IN THE RODENT HIPPOCAMPAL FORMATION
|
|
SCOYNI, R.M.
|
THREE PATIENTS COULD BE LABELLED AS HAVING A DEMENTIA PUGILISTICA (BOXER´S ENCEPHALOPATHY)
|
|
SEÇIL, Y.
|
ALZHEIMER'S DISEASE AND THYROID DYSFUNCTION
|
|
SEDIGHI, M.
|
THE COMPARATIVE EVALUATION OF SERUM HOMOCYSTEIN LEVEL IN THE PATIENT WITH PARKINSON DISEASE (PD) AND HEALTHY PEOPLE
|
|
SEEGER-ARMBRUSTER, S.
|
ELECTROPHYSIOLOGICAL EVIDENCE FOR THE ANTIPARKINSONIAN EFFECT OF R- AND S-MDMA
|
|
SEGERS, K.
|
WHAT BELGIAN GERIATRICIANS TELL THEIR PATIENTS WITH ALZHEIMER´S DISEASE (AND WHY)
|
|
SEHLIN, D.
|
FRACTIONATION OF SOLUBLE AΒ WITH DENSITY GRADIENT ULTRACENTRIFUGATION
|
|
SENGUPTA, S.
|
ALZHEIMER´S DISEASE AND ANAESTHESIA
|
|
SENGUPTA, T.
|
A SYNTHETIC DERIVATIVE OF A TETRAHYDROISOQUINOLINE ALKALOID FROM MUCUNA PRURIENS IS NEUROPROTECTIVE IN MPTP MODEL OF PARKINSON'S DISEASE
|
|
SERRANO GIL, A.
|
ASSESSMENT OF LEGAL INCAPACITY IN DEMENTIAS
|
|
SETH, K.
|
COTRANSPLANTATION WITH OLFACTORY ENSHEATHING CELLS PROTECTS NEURAL PROGENITOR CELLS IN 6-OHDA LESIONED RATS: MODULATION OF PHOSPHATIDYLINOSITOL 3-KINASE/AKT SIGNALING
|
|
SEVLEVER, D.
|
ROLES OF CATHPESIN D AND CALPAIN I IN Α-SYNUCLEIN DEGRADATION
|
|
SHAFIEE ARDESTANI, M.
|
DEXAMETHASONE SIGNIFICANTLY MODIFIED STRIATAL DOPAMINERGIC, GLUTAMATERGIC AND GABAERGIC NEUROTRANSMISSIONS IN NORMAL AND RAT MODEL OF PARKINSON'S DISEASE
|
|
SHAFIEE ARDESTANI, M.
|
PARKINSON´S DISEASE, RADIOLOGY AND MOLECULAR IMAGING; AN OVERVIEW ON THE RECENT RESEARCHES
|
|
SHALTIEL KARYO, R.
|
INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION AND OLIGOMERIZATION IN PARKINSON´S DISEASE
|
|
SHAMS, A.
|
THE ROLE OF CO- TRANSPLANTATION TREATMENT IN THE PARKINSONIAN RAT MODEL
|
|
SHAO, W.
|
UP-REGULATED GENES IN THE SUBSTANTIA NIGRA FOLLOWING 6-OHDA-INDUCED LESION IN ADULT RATS
|
|
SHARMA, H.
|
AN INHIBITOR OF HEME OXYGENASE ATTENUATES CLOSED HEAD INJURY INDUCED BRAIN PATHOLOGY AND SEROTONIN LEVELS IN THE RAT
|
|
SHARMA, N.
|
SEQUENTIAL CHANGES BIOCHEMICAL PARAMETERS IN ROTENONE INDUCED PARKINSON'S DISEASE MODEL: THERAPEUTIC POTENTIALS OF VITAMIN E
|
|
SHEARDOVA, K.
|
MANAGEMENT OF DEMENTIA IN THE CZECH REPUBLIC, STRUCTURED QUESTIONNAIRE BASED STUDY
|
|
SHELTON, S.B.
|
LACK OF GENOTYPIC DIFFERENCES IN BRAIN PATHOLOGY IN HUMAN APOE-TARGETED-REPLACEMENT MICE
|
|
SHIE, F.-S.
|
REGULATION OF MICROGLIA-MEDIATED NEURO-INFLAMMATION BY A NOVEL SYNTHETIC COMPOUND
|
|
SHIM, I.
|
EFFECT OF GINSENG TOTAL SAPONIN ON THE IMPAIRMENT OF LEARNING AND MEMORY AFTER CEREBRAL ISCHEMIA IN RATS
|
|
SHIN, E.-H.
|
EFFECTS OF TOXOPLASMA GONDII INFECTION ON THE PROGRESS OF ALZHEIMER'S DISEASE
|
|
SHIN, J.H.
|
COUNTERCLOCKWISE ROTATION IN REY COMPLEX FIGURE AFTER ACUTE CAUDATE INFARCTION
|
|
SHUGHRUE, P.
|
OLIGOMERS OF AMYLOID-Β ARE SEQUESTERED INTO EXISTING PLAQUES AND SEED NEW PLAQUES IN THE BRAIN OF HAPP OVER-EXPRESSING TRANSGENIC MICE
|
|
SHUKLA, S.
|
ENHANCED SURVIVAL AND FUNCTION OF NEURAL STEM CELLS DERIVED DOPAMINERGIC NEURONS UNDER INFLUENCE OF OLFACTORY ENSHEATHING CELLS IN PARKINSONIAN RATS
|
|
SHULMAN, R.
|
MAINTENANCE ELECTROCONVULSIVE THERAPY IN THE TREATMENT OF PARKINSON´S DISEASE
|
|
SIAPERA, M.
|
DEPRESSION, EXTRAPYRAMIDAL SYMPTOMS, DEMENTIA AND AN UNEXPECTED OUTCOME, CASE REPORT
|
|
SIDHU, A.
|
PROTECTIVE EFFECT OF Β-CAROTENE ON 3-NITROPROPIONIC ACID (3-NP)-INDUCED NEUROTOXICITY IN EXPERIMENTAL HUNTINGTON'S DISEASE (HD)
|
|
SIHA, M.
|
OVER EXHAUSTION AND EARLY DEMENTIA AT THE WORKPLACE
|
|
SILVA, W.
|
SORLA/LR11 IN GLIA: RELATION TO THE MEMBRANE RAFT PROTEIN CAVEOLIN-1
|
|
SIMON, D.
|
PROTECTIVE EFFECT OF PUTATIVE DRUG CANDIDATES ON THE AMYLOID-BETA OLIGOMER-INDUCED ASTROCYTE ACTIVATION IN RAT ENTORHINAL CORTEX
|
|
SINGH, C.M.
|
CHARACTERIZATION OF DROSOPHILA MODELS OF ALZHEIMER'S DISEASE
|
|
SIQUEIRA-NETO, J.I.
|
ETIOLOGIC SPECTRUM FOR VASCULAR DEMENTIA IN A BRAZILIAN PUBLIC HEALTH CARE SERVICE SPECIALIZED IN COGNITIVE DISORDERS
|
|
SISKOVA, Z.
|
ULTRASTRUCTURAL ANALYSIS OF SYNAPTIC LOSS IN MURINE PRION DISEASE: EVIDENCE FOR PHAGOCYTOSIS BY PYRAMIDAL CELL DENDRITIC SPINES
|
|
SITKIEWICZ, E.
|
IMPACT OF THE DITYROSINE CROSS-LINKS ON ABETA PEPTIDE OLIGOMERIZATION
|
|
SKOGAR, O.
|
TACTILE STIMULATION - AN ALTERNATIVE IN PARKINSONS DISEASE WITH PAIN?
|
|
SLEEGERS, K.
|
SERUM PROGRANULIN IS A NONINVASIVE BIOMARKER FOR FRONTOTEMPORAL LOBAR DEGENERATION
|
|
SLIFER, M.
|
ELAVL4 VARIATION ASSOCIATED WITH DEPRESSION IN ALZHEIMER DISEASE AND PARKINSON DISEASE
|
|
SOBOW, T.
|
APOE AND PRNP GENOTYPES AND NEUROPSYCHIATRIC SYMTOMS IN ALZHEIMER"S DISEASE
|
|
SOBOW, T.
|
MORTALITY DIFFERENCES IN DLB VERSUS AD AS RELATED TO DIABETES AND OTHER VASCULAR RISK FACTORS
|
|
SOFIC, E.
|
BIOCHEMICAL POSTMORTEM DIAGNOSIS OF PARKINSON´S DISEASE
|
|
SOFOLA, O.
|
A ROLE FOR THE INSULIN PATHWAY IN AN INDUCIBLE DROSOPHILA MODEL OF ALZHEIMER'S DISEASE
|
|
SOLAS, M.
|
RELATIONSHIP BETWEEN PERIPHERAL INSULIN LEVELS, CORTISOL AND COGNITIVE STATUS
|
|
SONG, W.
|
VALPROIC ACID INHIBITS NEURITIC PLAQUE FORMATION AND MEMORY DEFICITS IN ALZHEIMER'S DISEASE MODELS
|
|
SONG, W.
|
INHIBITION OF APP PROCESSING AND AMYLOID Β PROFUCTION BY VALPROIC ACID
|
|
SORENSEN, K.
|
APOE COUNTERACTS THE IMPAIRMENT OF MITOCHONDRIAL ACTIVITY INDUCED BY OLIGOMERIC Aß-(1-42)
|
|
SORS- MIREUX, I.
|
MANAGEMENT OF PATIENTS WITH DEMENTIA: ASSESSMENT OF NON PHARMACOLOGIC INTERVENTIONS IN DAY-CARE HOSPITAL
|
|
SOTIROPOULOS, I.
|
GENDER-DEPENDENT NEUROGENERATIVE ROLE OF CHRONIC STRESS IN P301L TAU TG MICE
|
|
SPENCER, B.
|
LENTIVECTOR DELIVERY OF A SINGLE CHAIN ANTIBODY DIRECTED AGAINST OLIGOMERIC FORMS OF Α-SYNUCLEIN REDUCE Α-SYNUCLEIN ACCUMULATION AND IMPROVE SYNAPTIC DENSITY
|
|
SPENGER, C.
|
THE INNOMED/ADDNEUROMED FRAMEWORK FOR MULTI-CENTRE MRI ASSESSMENT OF LONGITUDINAL CHANGES IN ALZHEIMER´S DISEASE
|
|
SPIRU, L.
|
GENDER ASPECTS IN MILD COGNITIVE IMPAIRMENT (MCI) TO ALZHEIMER'S DISEASE (AD) CONVERSION. A ROMANIAN EPIDEMIOLOGICAL STUDY
|
|
SPIRU, L.
|
A PILOT, COMPARATIVE EPIGENOMIC AND METHYLOMIC STUDY IN HEALTHY ELDERLY, ADULT AND YOUNG PEOPLE
|
|
SREDNI, B.
|
MULTIFUNCTIONAL TELLURIUM MOLECULE PROTECTS AND RESTORES DOPAMINERGIC NEURONS IN PARKINSON´S DISEASE MODELS
|
|
SROVNALOVA, H.
|
EFFECTS OF HIGH FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) OF THE DLPFC ON EXECUTIVE FUNCTIONS IN PATIENTS WITH PN
|
|
STAAL, R.
|
Α-SYNUCLEIN OLIGOMERS ALTER THE CELL MEMBRANE POTENTIAL IN DIFFERENTIATED SH-SY5Y CELLS
|
|
STAUFENBIEL, M.
|
EFFECT OF BACE1 GENE DISRUPTION ON APP METABOLISM AND BEHAVIOR OF APP TRANSGENIC MICE WITH AND WITHOUT THE SWEDISH MUTATION
|
|
STEPKINA, D.
|
THE PROGRESSION OF COGNITIVE DYSFUNCTIONS IN PATIENTS WITH PARKINSON'S DISEASE
|
|
STOMRUD, E.
|
LONGITUDINAL CSF BIOMARKER LEVELS AND COGNITION IN HEALTHY ELDERLY
|
|
STROSZNAJDER, J.
|
GLYCOGEN SYNTHASE KINASE 3Β (GSK-3Β) AND ITS ACTIVE FORM IN PARKINSON DISEASE
|
|
SUBHANI, F.U.H.
|
CURRENT DRUG TARGET SITES IN CLINICAL PRACTICE OR CLINICAL TRAIL, EXTENT OF DISEASE MODIFICATION FOR ALZHEIMER'S DISEASE
|
|
SUGAMATA, M.
|
PRENATAL DIESEL EXHAUST EXPOSURE CAUSES NEURODEGENERATIVE DISEASES IN ADULTS
|
|
SUGIYAMA, M.
|
CLINICAL CHARACTERIZATION OF ELDERLY-ONSET AMYOTROPHIC LATERAL SCLEROSIS
|
|
SVEDBERG, M.
|
COMPARISON OF 18F- AND 11C-LABELED BF-168 AND PIB IMAGING OF Β-AMYLOID USING IN VITRO AUTORADIOGRAPHY
|
|
SZOCS, I.
|
RISK FACTORS OF MILD COGNITIVE IMPAIRMENT IN A NEUROLOGICALLY VARIED POPULATION
|
|
TACKENBERG, C.
|
ABETA CAUSES SPINE PATHOLOGY AND INDUCES TAU-DEPENDENT NEURODEGENERATION IN AN EX VIVO MODEL OF ALZHEIMER'S DISEASE
|
|
TAKADA, M.
|
PREVENTION OF MPTP-INDUCED PARKINSONISM BY CALBINDIN RECRUITMENT INTO NIGRAL DOPAMINERGIC CELLS
|
|
TAKAHASHI, M.
|
SELECTIVE ANTI-INFLAMMATORY THERAPY FOR ALZHEIMER'S DISEASE
|
|
TAKAHASHI, T.
|
THE RAPHE NUCLEI IN PARKINSON DISEASE
|
|
TAKEDA, K.
|
POTENTIATION OF ACETYLCHOLINE-MEDIATED FACILITATION OF SYNAPTIC TRANSMISSION BY AN AZAINDOLIZINONE DERIVATIVE, ZSET1446 (ST101), IN THE RAT HIPPOCAMPUS
|
|
TAKIGAWA, H.
|
ASSOCIATION WITH THE BODY MASS INDEX (BMI) AND NEUROLOGICAL SYMPTOMS WITH PARKINSON'S DISEASE
|
|
TAMBOLI, I.Y.
|
ACCUMULATION OF SPHINGOLIPIDS INCREASES SECRETION OF THE AMYLOID ß-PEPTIDE BY STABILIZATION OF THE ß-AMYLOID PRECURSOR PROTEIN
|
|
TAN, L.
|
GENETIC ASSOCIATION OF INTERLEUKIN-18 PROMOTER POLYMORPHISMS WITH LATE ONSET ALZHEIMER'S DISEASE IN THE HAN CHINESE POPULATION
|
|
TAN, X.
|
DIETARY CHARACTERIZES OF CHINESE PD PATIENTS: FOOD INTAKE SURVEY RESULTS
|
|
TAN, X.
|
THE TRACE ELEMENTS CHANGE IN CHINESE PD PATIENTS: A CASE-CONTROL ANALYSIS
|
|
TAN, X.
|
THE ROLES OF IRON, MN, ZINC ON THE PD DEVELOPMENT? RELATIONSHIP BETWEEN FOOD INTAKE AND SERUM CONCENTRATIONS
|
|
TANAKA, K.
|
AMYLOID BETA42 FIBRIL MIMIC PEPTIDES INHIBITING AΒ42 FIBRILLATION BY BINDING TO THE PREFIBRILLAR SOLUBLE OLIGOMERS
|
|
TAYEBI, M.
|
ANTI-PRION BINDERS AS CARRIER FOR CNS DRUGS
|
|
TAYLOR, J.
|
CHARACTERISATION OF THE FUNCTIONAL SIGNIFICANCE OF THE INTERACTION BETWEEN PARKIN AND PARKIN CO-REGULATED GENE (PACRG)
|
|
TEDDE, A.
|
NEDD9 IS GENETICALLY ASSOCIATED WITH INCREASED RISK FOR LATE-ONSET ALZHEIMER'S DISEASE IN THE ITALIAN POPULATION
|
|
TELECKA, S.
|
ONE YEAR AFTER DBS FOR PARKINSON´S DISEASE: NEUROPSYCHOLOGICAL RESULTS
|
|
TERNI, B.
|
MITOCHONDRIAL ATP-SYNTHASE IN THE ENTORHINAL CORTEX IS A TARGET OF OXIDATIVE STRESS AT STAGES I/II OF ALZHEIMER'S DISEASE PATHOLOGY
|
|
TERTAN, D.
|
EXTRAPONTINE MYELINOLYSIS WITH PARKINSONISM
|
|
TESIC, V.
|
EXPRESSION OF PRO-BDNF AND P75 IN MESENCEPHALON AND STRIATUM IN 6-OHDA RAT MODEL OF PD
|
|
THANOPOULOU, K.
|
SR-BI REGULATES CNS APOE LEVELS AND AGGRAVATES MEMORY DEFICITS WITHOUT MODIFYING AMYLOID PLAQUE FORMATION IN ALZHEIMER TRANSGENIC MICE
|
|
THATCHER, G.
|
HARNESSING NITRIC OXIDE MIMETIC ACTIVITY IN DRUG CHIMERAS FOR ALZHEIMER'S
|
|
THATHIAH, A.
|
THE ORPHAN G PROTEIN-COUPLED RECEPTOR 3 IS A NOVEL MODULATOR OF AMYLOID-BETA PEPTIDE GENERATION IN NEURONS
|
|
THERESA, R.M.
|
THE DIFFERENCES OF CAREGIVER´S QUALITY OF LIFE AT DEMENTIA PATIENT BASED ON THE SEVERITY OF DEMENTIA
|
|
THOMANN, P.
|
MRI-DERIVED ATROPHY OF THE OLFACTORY BULB AND TRACT IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
|
|
THOMANN, P.
|
ASSOCIATION OF CSF TOTAL TAU AND PHOSPHO-TAU (181) WITH CEREBRAL ATROPHY IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
|
|
THOMANN, P.
|
APOLIPOPROTEIN E POLYMORPHISM AND BRAIN MORPHOLOGY IN MILD COGNITIVE IMPAIRMENT
|
|
THOMPSON, S.
|
IMPROVING VISUAL MEMORY WITH ARICEPT
|
|
TIAN, J.
|
THE STUDY OF GEPT ACTIVE IN THE PREVENTION OF BETA-AMYLOID42 PRODUCTION IN A MOUSE MODEL OF ALZHEIMER'S DISEASE
|
|
TKACHENKO, S.
|
DISCOVERY AND PRECLINICAL STUDIES OF AVN-322 HIGHLY SELECTIVE AND POTENT 5-HT6 ANTAGONIST FOR COGNITION ENHANCEMENT IN TREATING NEURODEGERATIVE DISEASES
|
|
TOCCO, M.
|
EFFECTS OF MEMANTINE ON LANGUAGE AND FUNCTIONAL COMMUNICATION IN PATIENTS WITH MODERATE TO SEVERE ALZHEIMER´S DISEASE: A POOLED ANALYSIS
|
|
TODMAN, D.
|
ARNOLD PICK (1851-1924) AND PICK´S DISEASE: AN HISTORICAL PERSPECTIVE
|
|
TOLEDO, E.M.
|
LITHIUM AND ROSIGLITAZONE PROTECTS AGAINST COGNITIVE AND HISTOPATHOLOGICAL CHANGES IN A DOUBLE TRANSGENIC MODEL OF ALZHEIMER DISEASE
|
|
TOMLINSON, J.J.
|
THE REGULATION OF Α-SYNUCLEIN EXPRESSION BY GATA TRANSCRIPTION FACTORS
|
|
TORIYA, R.
|
EFFECT OF BLUE LIGHT THERAPY ON COGNITIVE FUNCTION AND SERUM INSULIN-LIKE GROWTH FACTOR I (IGF-I) LEVEL IN ALZHEIMER'S DISEASE
|
|
TORO, P.
|
PHYSICAL ACTIVITY AS A PROTECTIVE FACTOR IN A PROSPECTIVE AGEING STUDY IN GERMANY
|
|
TORO, P.
|
PREVALENCE AND NATURAL COURSE OF MILD COGNITIVE IMPAIRMENT IN A LONGITUDINAL POPULATION BASED STUDY IN GERMANY
|
|
TORO, P.
|
EARLY VERSUS LATE-ONSET DEPRESSION: LIFETIME PREVALENCE AND ASSOCIATION TO MILD COGNITIVE IMPAIRMENT IN A REPRESENTATIVE COMMUNITY SAMPLE
|
|
TOULOUSE, A.
|
NEUROTROPHIC EFFECTS OF GROWTH/DIFFERENTIATION FACTOR 5 IN A NEURONAL CELL LINE
|
|
TRAMUTOLI, R.G.
|
ATYPICAL PARKINSONISM AND DEMENTIA: FUNCTIONAL NEUROIMAGING DIFFERENCES AMONG LEWY BODY DEMENTIA, CORTICOBASAL DEGENERATION AND PROGRESSIVE SUPRANUCLEAR PALSY
|
|
TSAI, S.-Y.
|
ANTI-NOGO-A IMMUNOTHERAPY IMPROVES SPATIAL MEMORY AFTER STROKE IN THE AGED RAT
|
|
TURCU, I.
|
ARGUMENTS FOR THE RECONSIDERATION OF PROCAINE AS A POTENT THERAPEUTIC MOLECULE IN AD/PD
|
|
TURNER, L.
|
NOVEL ALZHEIMER'S DISEASE TARGETS: AN SIRNA SCREEN TO IDENTIFY GENETIC MODIFIERS OF ABETA PRODUCTION
|
|
TURUNEN, M.
|
SINGLE NUCLEOTIDE POLYMORPHISM IN HTRA1 GENE AFFECTS AGE-AT-ONSET OF ALZHEIMER´S DISEASE IN FINNISH POPULATION
|
|
UBERTI, D.
|
CHARACTERIZATION OF P53 CONFORMATIONAL STATUS, AND OXIDATIVE PROFILE IN BLOOD OF FAMILIAL ALZHEIMER DISEASE PATIENTS
|
|
UBHI, K.
|
THE ROLE OF GLIAL-DERIVED NEUROTROPHIC FACTOR IN MULTIPLE SYSTEM ATROPHY
|
|
UCHIDA, S.
|
EFFECTS OF Α5GABAA RECEPTOR INVERSE AGONISTS IN SEVERAL ANIMAL MODELS OF COGNITIVE FUNCTION
|
|
UEBERHAM, U.
|
DIFFERENT EXPRESSION OF SMAD ISOFORMS DURING BRAIN DEVELOPMENT AND AGING
|
|
UEDA, N.
|
EVALUATION OF MOTOR DYSFUNCTION IN PARKINSON´S DISEASE BY ANALYSIS OF SRIRAL DRAWING AND TAPPING
|
|
UGOLINO, J.
|
CHARACTERIZATION OF WILD TYPE AND MUTANT ATP13A2 (PARK9) PROTEINS
|
|
UPPU, R.M.
|
INTRACELLULAR OXIDATIVE STRESS AND CYTOTOXICITY IN RAT PRIMARY CORTICAL NEURONAL CELLS EXPOSED TO CHOLESTEROL OZONATION PRODUCTS
|
|
VAN BUGGENHOUT, M.
|
BEHAVIOURAL DISTURBANCES IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
|
|
VAN BUGGENHOUT, M.
|
IS THE GERIATRIC DEPRESSION SCALE A RELIABLE SCREENING TOOL FOR DEPRESSIVE SYMPTOMS IN ELDERLY PATIENTS WITH COGNITIVE IMPAIRMENT?
|
|
VAN DAM, A.-M.
|
MICROGLIOSIS IN THE ANTERIOR OLFACTORY NUCLEUS OF PARKINSON AND ALZHEIMER PATIENTS
|
|
VAN DEN EEDEN, S.
|
THE EFFECT OF CAFFEINE AND ALCOHOL USE ON SURVIVAL IN PARKINSON'S DISEASE
|
|
VAN DER ELST, M.
|
TOWARDS OPTIMIZATION OF THE PROCEDURE OF PRIMING FOR L-DOPA INDUCED DYSKINESIA IN 6-OHDA LESIONED RATS
|
|
VAN DER PERREN, A.
|
COMPARATIVE STUDY OF DIFFERENT RAAV SEROTYPES FOR TRANSDUCTION OF DOPAMINERGIC NEURONS IN RODENT BRAIN
|
|
VAN DOOREN, T.
|
BIOLOGY-DRIVEN IDENTIFICATION OF HIGHLY POTENT DRUGS WITH NEUROPROTECTIVE PROPERTIES IN PD AND AD MOUSE MODELS
|
|
VAN EERSEL, J.
|
PROTEASOME INHIBITION INDUCED RE-LOCALIZATION AND AGGREGATION OF TDP-43 IN NEURONAL CELLS
|
|
VAN LEEUWEN, F.W.
|
PROTEASOMAL DYSFUNCTION AND NEURODEGENERATION: A NOVEL VIEW ON ALZHEIMER'S DISEASE
|
|
VANCE, J.
|
ASSOCIATION OF VITAMIN D RECEPTOR (VDR) IN PARKINSON DISEASE: A GENETIC RISK FACTOR FOR NEURODEGENERATION
|
|
VANCE, J.
|
GENOME WIDE ASSOCIATION STUDIES (GWAS) IN TWO PARKINSON DATASETS
|
|
VANDENBERGHE, W.
|
THE TYPE 1 CANNABINOID RECEPTOR IN PARKINSON´S DISEASE: AN IN VIVO BRAIN IMAGING STUDY
|
|
VANDROVCOVA, J.
|
MAPT AND SNCA GENETIC VARIATION AND PARKINSON'S DISEASE
|
|
VANMIERLO, T.
|
PLANT STEROLS IN THE BRAIN, GOOD OR BAD?
|
|
VARJASSYOVÁ, A.
|
RECOGNITION OF EMOTIONAL EXPRESSION IS IMPAIRED IN MILD COGNITIVE IMPAIRMENT
|
|
VARVEL, N.
|
THE ROLE OF BETA-AMYLOID AND INFLAMMATION IN TRIGGERING ABERRANT NEURONAL CELL CYCLE EVENTS
|
|
VASANTHAKUMAR, V.
|
PREVALENCE OF IDIOPATHIC PARKINSON´S DISEASE (IPD) IN MILTON KEYNES, UNITED KINGDOM (UK)
|
|
VÁZQUEZ, M.C.
|
INHIBITION OF C-ABL KINASE MODULATES NEPRILYSIN EXPRESSION IN VITRO AND DECREASES MEMORY IMPAIRMENT IN VIVO
|
|
VEKRELLIS, K.
|
INDUCIBLE OVER-EXPRESSION OF WILD TYPE ALPHA-SYNUCLEIN IN HUMAN NEURONAL CELLS LEADS TO CASPASE-DEPENDENT NON-APOPTOTIC DEATH
|
|
VEKRELLIS, K.
|
EFFECTS OF Α-SYNUCLEIN ON LYSOSOMAL DEGRADATION IN NEURONS
|
|
VELAYUDHAN, L.
|
OLFACTORY IDENTIFICATION TEST AS A TREATMENT RESPONSE MARKER IN PATIENTS WITH ALZHEIMER´S DISEASE RECEIVING CHOLINESTERASE INHIBITOR
|
|
VELAYUDHAN, L.
|
RISK OF DEVELOPING DEMENTIA WITH DIABETES IN MILD COGNITIVE IMPAIRMENT
|
|
VELLA, L.J.
|
A ROLE FOR APP GXXXG MOTIFS IN THE PROCESSING OF APP AND APPARENT MODULATION OF APP N-TERMINAL FRAGMENTS
|
|
VENKATARAMANI, V.
|
A SIMPLE CELL CULTURE SYSTEM AS NEW SCREENING MODEL IN ALZHEIMER'S DISEASE
|
|
VEPSÄLÄINEN, S.
|
COMBINED RISK EFFECTS OF IDE AND NEP GENE VARIANTS ON ALZHEIMER´S DISEASE ADDITIVELY INCREASE THE SUSCEPTIBILITY TO DISEASE
|
|
VERHAAR, R.
|
TISSUE TRANSGLUTAMINASE (TTG) AND NEURODEGENERATION: ADDED VALUE OF A CELL BASED ASSAY FOR SELECTION OF EFFECTIVE INHIBITORS IN PRECLINICAL DEVELOPMENT
|
|
VERKAIK, R.
|
THE EFFECTS OF INTRODUCING A NURSING GUIDELINE ON DEPRESSION IN PSYCHOGERIATRIC NURSING HOME RESIDENTS
|
|
VERNON, A.
|
DYNAMIC SERIAL INVESTIGATION OF NEUROPATHOLOGY IN A RODENT MODEL OF PARKINSON'S DISEASE USING T2-WEIGHTED MAGNETIC RESONANCE IMAGING
|
|
VEROFF, A.
|
DEVELOPMENT AND VALIDATION OF NEW MEASURES OF LONG TERM MEMORY CONSOLIDATION
|
|
VEROFF, A.
|
AN ALTERNATIVE SCREENING AND OUTCOME MEASURE FOR AD AND MCI CLINICAL TRIALS: THE COMPUTERIZED NEUROPSYCHOLOGICAL TEST BATTERY (CNTB)
|
|
VIANA, G.
|
DOXYCYCLINE, A 2ND GENERATION TETRACYCLINE, PROTECTS NEURONAL CELLS AGAINST GLUTAMATE- BUT NOT AGAINST 6-OHDA-INDUCED CYTOTOXICITY
|
|
VIANA, R.
|
TAUROURSODEOXYCHOLIC ACID PREVENTS E22Q ALZHEIMER'S AΒ TOXICITY IN HUMAN CEREBRAL ENDOTHELIAL CELLS
|
|
VIEIRA, S.
|
PKCALPHA REGULATES APP VESICULAR TRAFFIC AND STIMULATES SAPP RELEASE
|
|
VIGNINI, A.
|
ENHANCED EXPRESSION OF APP ISOFORMS IN PLATELETS FROM ALZHEIMER DISEASE PATIENTS
|
|
VILLAREJO, A.
|
ALZHEIMER´S DISEASE ASSOCIATED MORTALITY IN THE NEDICES COHORT STUDY
|
|
VILLEMAGNE, V.L.
|
QUANTIFICATION OF STRIATAL VESICULAR MONOAMINE TRANSPORTERS TYPE 2 IN THE HUMAN BRAIN WITH 18F-AV-133
|
|
VILLEMAGNE, V.L.
|
AMYLOID IMAGING RESULTS FROM THE AUSTRALIAN BIOMARKER, IMAGING AND LIFESTYLE (AIBL) STUDY
|
|
VIRTA, J.
|
EFFECTS OF DONEPEZIL AND RIVASTIGMINE MEDICATION ON BRAIN BUTYRYLCHOLINESTERASE ACTIVITY IN PATIENTS WITH ALZHEIMER'S DISEASE
|
|
VIRTA, J.J.
|
VOXEL-BASED ANALYSIS OF CEREBRAL GLUCOSE METABOLISM IN MONO- AND DIZYGOTIC TWINS DISCORDANT FOR ALZHEIMER'S DISEASE
|
|
VISWANATHAN, J.
|
OVER-EXPRESSION OF UBQLN1 AFFECTS APP MATURATION AND G-SECRETASE ACTIVITY IN HUMAN NEUROBLASTOMA SH-SY5Y CELLS
|
|
VITAL, A.
|
PARKINSONISM IN CREUTZFELDT-JAKOB DISEASE
|
|
VITAL, M.
|
MINOCYCLINE ADMINISTRATION REVERSED THE HYPOFUNCTION OBSERVED IN THE OPEN FIELD TEST IN MPTP-LESIONED RATS
|
|
VITAL, M.
|
MELATONIN ATTENUATES TYROSINE HYDROXYLASE LOSS AND HYPOLOCOMOTION IN MPTP-LESIONED RATS
|
|
VITAL, M.
|
DIFFERENT PARKINSONISM MODELS: BEHAVIOURAL AND NEUROCHEMICAL COMPARISONS
|
|
VITAL, M.
|
NEUROPROTECTIVE EFFECT OF NEURONAL NOS INHIBITION IS ATTRIBUTED TO BCL2 EXPRESSION IN THE SUBSTANTIA NIGRA PARS COMPACTA
|
|
VITNER, E.
|
ALTERATIONS IN ALPHA-SYNUCLEIN IN NEURONS THAT ACCUMULATE GLUCOSYLCERAMIDE
|
|
VLAD, C.
|
STRUCTURAL CHARACTERISATION AND AFFINITY- MASS SPECTROMETRIC IDENTIFICATION OF Α- SYNUCLEIN EPITOPES RELATED TO PARKINSON'S DISEASE
|
|
VOLBRACHT, C.
|
EFFECTS OF HSP90 INHIBITORS ON TAU HYPERPHOSPHORYLATION IN NEURONS
|
|
VON BERNHARDI, R.
|
GLIAL DYSFUNCTION IN ALZHEIMER'S DISEASE: THE TGFΒ CONNECTION
|
|
WAHLBERG, T.
|
IS ALPHA-SYNUCLEIN MODIFIED IN VIVO BY ALDEHYDES INVOLVED IN OXIDATIVE STRESS?
|
|
WALDMAN, M.
|
INCIDENCE OF ALZHEIMER´S FROM 1906 TO THE PRESENT
|
|
WALDMAN, M.
|
AN INVESTIGATION INTO THE INCIDENCE OF ALZHEIMER'S AND OTHER DEMENTIAS BETWEEN 1920 AND 2008: ARE WE WITNESSING A NEW EPIDEMIC?
|
|
WALKER, W.P.
|
STUDIES IN ATTRACTIN AND MAHOGUNIN MUTANT MICE ILLUMINATE A CHARACTERISTIC NEUROPATHOLOGICAL FEATURE OF PROTEIN AGGREGATION DISORDERS
|
|
WAN, H.
|
THE POSSIBLE MECHANISMS OF HFS-STN IN PARKINSON'S DISEASE
|
|
WAN, H.
|
RELATIONSHIP OF STRIATAL 99TCM-TRODAT-1 SPECIFIC UPTAKE AND MOTOR'S SEVERITY IN PATIENTS WITH PARKINSON'S DISEASE
|
|
WAN, H.
|
PET STUDIES OF THE DOPAMINE D2 RECEPTORS IN SUBCLINICAL AND CLINICAL HEMI-PARKINSONISM MONKEYS WITH 11C-RACLOPRIDE
|
|
WAN, H.
|
SPECT STUDIES OF THE DOPAMINE TRANSPORTERS IN SUBCLINICAL AND CLINICAL HEMI-PARKINSONISM MONKEYS WITH 99TCM-TRODAT-1
|
|
WAN, H.
|
CLINICAL STUDIES OF 18F-FDG AND 18F-FP-ΒCIT PET IMAGING IN HEMI-PARKINSON'S DISEASE
|
|
WAN, H.
|
1H-MAGNETIC RESONANCE SPECTROSCOPY ANALYSIS ON ALZHEIMER'S DISEASE AND DEMENTIA WITH LEWY BODY
|
|
WAN, H.
|
ANALYSIS ON THE METABOLISM OF HIPPOCAMPUS IN NON-DEMENTED PARKINSON DISEASE PATIENTS WITH MAGNETIC RESONANCE SPECTROSCOPY
|
|
WAN, H.
|
PRELIMINARY CLINICAL STUDY ON 18F-FP-Β-CIT PET DOPAMINE TRANSPORTER IMAGING IN PARKINSON'S DISEASE
|
|
WAN, H.
|
EFFECT OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON VESICULAR MONOAMINE TRANSPORTER-2 AND SYNAPTOPHYSIN EXPRESSIONS IN STRIATUM OF PARKINSON'S DISEASE
|
|
WAN, H.
|
FOLLOW-UP WITH SPECT IN PATIENTS WITH PARKINSON'S DISEASE HAVE DEEP BRAIN STIMULATION OF THE SUBTHALAMIC NUCLEUS
|
|
WAN, H.
|
EFFECT OF TRANSCRANIAL MAGNETIC STIMULATION ON DOPAMINERGIC NEURONS OF MOUSE WITH PARKINSON'S DISEASE
|
|
WAN, H.
|
THERAPEUTIC EFFECT OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON MOTOR FUNCTION AND MOTOR EVOKED POTENTIALS IN PARKINSON'S DISEASE
|
|
WAN, H.
|
THE VALUES OF 99TCM-TRODAT-1 DAT SPECT IN THE EARLY DIAGNOSIS AND ASSESSING THE SEVERITY OF PATIENTS WITH PD
|
|
WAN, H.
|
DEEP BRAIN STIMULATION OF SUBTHALAMIC NUCLEUS IN THE HEMIPARKINSONIAN MONKEYS
|
|
WAN, H.
|
STUDY OF SUSCEPTIBILITY-WEIGHTED IMAGING IN DIFFERENTIATION OF MULTIPLE SYSTEM ATROPHY AND IDIOPATHIC PARKINSON DISEASE
|
|
WAN, H.
|
APPLICATION OF NEAR-INFRARED SPECTROSCOPY TECHNOLOGY IN STUDYING THE DAMAGE OF RATS WITH PARKINSON DISEASE BY RADIOFREQUENCY
|
|
WANG, B.
|
SUPPRESSION OF ANTIGEN SPECIFIC INFLAMMATORY RESPONSES BY IN VIVO INDUCTION OF REGULATORY DC AND TREG CELLS
|
|
WANG, H.
|
EXPRESSION OF INSULIN SIGNALING-RELATED PROTEINS IN CHOLINERGIC NEURONS
|
|
WANG, L.
|
ASSOCIATION BETWEEN TH GENE AND PARKINSON DISEASE REVEALED BY A POOLED ANALYSIS
|
|
WANG, L.
|
MONITORING AGGREGATED AMYLOID-Β PEPTIDE FOR DIAGNOSIS OF ALZHEIMER'S DISEASE
|
|
WANG, T.-F.
|
RUNNING EXERCISE PROTECTS DOPAMINERGIC NEURONS AGAINST NEUROINFLAMMATION-INDUCED DEGENERATION
|
|
WANG, X.
|
THE NEUROPROTECTIVE EFFECT OF HIGH FREQUENCY ELECTRO-ACUPUNCTURE STIMULATION ON DOPAMINERGIC NEURONS OF SUBSTANTIA NIGRA IN PARKINSONISN RAT
|
|
WANG, Y.
|
OVERACTIVATION OF GLYCOGEN SYNTHASE KINASE-3 DECREASES ACH LEVEL IN NUCLEUS BASALIS OF MEYNERT AND FRONTAL CORTEX
|
|
WARD, M.
|
THE EVALUATION OF CANDIDATE MARKERS OF ALZHEIMER 'S DISEASE USING TANDEM MASS TAGS AND SRM MASS SPECTROMETRY
|
|
WARD, M.
|
MULTI-SITE PHOSPHORYLATION ASSAYS FOR TAU PROTEIN
|
|
WATANABE, C.
|
REGIONAL CEREBRAL BLOOD FLOW PATTERNS IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT AND SUSPECTED ALZHEIMER DISEASE
|
|
WATANABE, T.
|
GDNF INDUCED METALLOTHIONEIN I AND II ON ASTROCYTES, AND PROTECTS MPP+-INDUCED DEPAMINERGIC NEURODEGENERATION
|
|
WATTMO, C.
|
RISK FACTORS FOR NURSING HOME PLACEMENT IN CHOLINESTERASE INHIBITOR TREATED NATURALISTIC ALZHEIMER PATIENTS
|
|
WATTS, R.
|
LONG-TERM EFFICACY AND SAFETY OF THE ROTIGOTINE TANSDERMAL PATCH IN EARLY-STAGE PD
|
|
WEBB, R.L.
|
BACE1 AND BACE2 IN DOWN SYNDROME AND AGING
|
|
WEBER, A.
|
ANTI-BETA-AMYLOID (AΒ) IGG LEVELS IN PLASMA OF HEALTHY PEOPLE MEASURED WITH A RELIABLE IMMUNOASSAY
|
|
WELLINGTON, C.
|
GW3965 REQUIRES ABCA1 FOR BENEFICIAL BIOCHEMICAL AND COGNITIVE OUTCOMES IN THE APP/PS1 MOUSE MODEL OF ALZHEIMER'S DISEASE
|
|
WELT, T.
|
MODULATION OF HIPPOCAMPAL ABETA MEASURED BY IN VIVO MICRODIALYSIS IN AWAKE AND FREELY MOVING TRANSGENIC MICE
|
|
WENINGER, H.
|
ALPHA-SYNUCLEIN SPECIFIC IMMUNOTHERAPY FOR TREATMENT OF PARKINSON´S DISEASE IN A TRANSGENIC MOUSE MODEL
|
|
WESTERLUND, M.
|
ASSOCIATION AND LOCALIZATION STUDIES OF OMI/HTRA2 IN ALZHEIMER'S AND PARKINSON'S DISEASE
|
|
WHITE, L.R.
|
CHANGES IN INTRATHECAL METABOLIC PROFILES IN SPORADIC AND LRRK2 G2019S PARKINSON´S DISEASE
|
|
WILKINSON, J.
|
INVESTIGATION OF P2X7 AS A POTENTIAL TARGET FOR AMYLOID Β
|
|
WILLBOLD, D.
|
A NOVEL D-AMINO ACID PEPTIDE REDUCES ALZHEIMER'S DISEASE AMYLOID PLAQUE LOAD IN TRANSGENIC MICE AND IMPROVES COGNITION UPON ORAL TREATMENT
|
|
WILLIAMS, H.
|
A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-ESCALATION TRIAL OF PIMAVANSERIN IN PARKINSON´S DISEASE AND PSYCHOSIS
|
|
WINKLHOFER, K.F.
|
LOSS OF PARKIN FUNCTION IMPAIRS MITOCHONDRIAL DYNAMICS IN HUMAN CELLS
|
|
WIRTH, Y.
|
BENEFITS OF MEMANTINE TREATMENT TRANSLATE INTO A REDUCTION OF HEALTH-ECONOMIC COSTS
|
|
WIRTHS, O.
|
ENVIRONMENTAL ENRICHMENT IMPROVES MOTOR ABILITIES BUT FAILS TO RESCUE MEMORY FUNCTIONS AND NEUROGENESIS IN THE APP/PS1KI MICE
|
|
WIRTHS, O.
|
INFLAMMATORY CHANGES ARE TIGHTLY ASSOCIATED WITH NEURODEGENERATION IN THE BRAIN AND SPINAL CORD OF APP/PS1KI MICE
|
|
WOLF, H.
|
CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) TAQ1B POLYMORPHISM IS NOT ASSOCIATED WITH COGNITIVE PHENOTYPE IN A MEMORY CLINIC SAMPLE
|
|
WOLOZIN, B.
|
USE OF ANGIOTENSIN RECEPTOR BLOCKERS IS ASSOCIATED WITH A LOWER INCIDENCE AND PROGRESSION OF DEMENTIA
|
|
WREDE, A.
|
CAMPTOCORMIA IN PD IS CAUSED BY A MYOPATHY
|
|
WRIGHT, J.
|
ALPHA-SYNUCLEIN NEUROTOXICITY REQUIRES COPPER
|
|
WU, Y.
|
AMYLOID-BETA CAUSES PSD-95 AND SYNAPTOPHYSIN DEGRADATION VIA CASPASE CASCADE THAT IS INFLUENCED BY NMDA RECEPTOR SUBUNIT COMPOSITION
|
|
WU, Y.-R.
|
UCHL S18Y POLYMORPHISM AND UBIQUITIN SPECIFIC PROTEASES HAD SYNERGIC EFFECTS ON THE RISK OF PARKINSON´S DISEASE IN TAIWAN
|
|
WÜLLNER, U.
|
DIFFERENTIAL DNA METHYLATION DETERMINES TNF ALPHA EXPRESSION LEVELS IN PARKINSON'S DISEASE PATIENTS BRAINS
|
|
WUNDERLICH, P.
|
AMINO ACID SEQUENCE OF BACE1 AND BACE2 DETERMINE DIFFERENT SUBCELLULAR TRANSPORT AND LOCALISATION
|
|
XIROMERISIOU, G.
|
SEVERE DEMENTIA ASSOCIATED WITH SJÖGREN SYNDROME
|
|
XU, J.
|
C-REACTIVE PROTEIN INDUCES COGNITIVE DEFICITS AND MOLECULAR BIOLOGICAL ALTERATION IN RAT: IMPLICATIONS FOR ALZHEIMER'S DISEASE
|
|
YAMAGUCHI, Y.
|
COMBINATION OF ZSET1446 (ST101) WITH DONEPEZIL SYNERGISTICALLY AMELIORATES COGNITIVE DEFICITS MEDIATED BY INCREASE IN THE EXTRACELLULAR LEVEL OF ACETYLCHOLINE
|
|
YAN, R.
|
THE IMPACT OF AGE-DEPENDENT PREFORMED DESTROPHIC NEURITES ON AMYLOID DEPOSITION
|
|
YANG, D.-I.
|
PROTECTIVE EFFECTS OF NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) AGAINST AMYLOID BETA-PEPTIDE NEUROTOXICITY
|
|
YENER, G.G.
|
VISUAL EVOKED OSCILLATORY RESPONSES OF ALZHEIMER PATIENTS
|
|
YEZDIMER, E.
|
DEVELOPMENT OF NATURAL, PEPTIDE BASED, SMART CONTRAST AGENTS FOR THE IMAGING OF TRANSITION METALS IN NEUROLOGICAL DISORDERS
|
|
YI, S.-H.
|
ENHANCED SURVIVAL AND DIFFERENTIATION IN MASH1- AND NGN2-TRANSDUCED NEURAL PRECURSOR CELLS AFTER TRANSPLANTATION VIA SHH AND NT-3 SIGNALING
|
|
YOKOCHI, F.
|
A PARKINSONIAN PATIENT WITH MENTAL DETERIORATION AFTER STARTING BILATERAL SUBTHALAMIC STIMULATION
|
|
YOKOE, M.
|
QUANTITATIVE ANALYSIS OF THE FINGER-TAPPING CONTACT FORCE IN PARKINSON'S DISEASE BY ACCELEROMETER
|
|
YOON, W.T.
|
CEREBRAL WHITE MATTER INVOLVEMENT IN EARLY STAGE OF DENTATORUBROPALLIDOUYSIAN ATROPHY
|
|
YOON, W.T.
|
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION (PKAN) WITH A NOVEL PANTOTHENATE KINASE 2 GENE MUTATION AND ATYPICAL PHENOTYPE
|
|
YOUDIM, M.B.H.
|
NOVEL THERAPEUTIC APPROAHES CONSTITUTING MULTIMODAL NEUROPROTECTIVE AND NEURORESTORATIVE DRUGS FOR ALZHEIMER'S DISEASE
|
|
YOUN, Y.C.
|
URINE NEURAL THREAD PROTEIN MEASUREMENTS IN ALZHEIMER´S DISEASE AND PARKINSON´S DISEASE
|
|
YRJANHEIKKI, J.
|
TEMPORAL CEREBRAL METABOLIC PROFILE AND VOLUMETRY IN TG2576 MOUSE MODEL OF ALZHEIMER'S DISEASE BY 1H-MR SPECTROSCOPY AND T2-MRI
|
|
YU, P.
|
INVOLVEMENT OF CEREBRAL VASCULAR SURFACE SEMICARBAZIDE-SENSITIVE AMINE OXIDASE IN B-AMYLOID OLIGOMERIZATION, CLEARANCE AND INFLAMMATION: IMPLICATIONS TO ALZHEIMER'S DISEASE
|
|
ZABŁOCKA, A.
|
PROLINE-RICH POLYPEPTIDE COMPLEX (PRP) FROM OVINE COLOSTRUM REGULATES ACTIVITY OF INDUCIBLE NITRIC OXIDE SYNTHASE
|
|
ZABŁOCKA, A.
|
A NONAPEPTIDE COMPONENT OF PROLINE-RICH POLYPEPTIDE COMPLEX FROM OVINE COLOSTRUM INHIBITS AGGREGATION OF AMYLOID Β AND DISASSEMBLES PREFORMED AGGREGATES
|
|
ZAHARIA, C.
|
STUDY ABOUT RELATIONSHIP OF COGNITIVE IMPAIRMENT AND DEPRESSION IN PATIENTS WITH PARKINSON DISEASE
|
|
ZAMANI, B.
|
PREVALENCE OF RLS IN ORTHOPEDICS AND NEUROLOGIC CLINICS
|
|
ZAMANI, M.
|
STUDY OF THE ACE GENE I/D POLYMORPHISM IN LATE-ONSET ALZHEIMER´S DISEASE
|
|
ZATTA, P.
|
ALUMINUM MODULATES EFFECTS OF Β-AMYLOID1-42 ON NEURONAL CALCIUM HOMEOSTASIS AND MITOCHONDRIA FUNCTIONING
|
|
ZDAROVA KARASOVA, J.
|
IN VITRO STUDY OF PASSIVE DRUG TRANSPORT THROUGH BLOOD-BRAIN BARRIER USING HPLC TECHNIQUES
|
|
ZHANG, J.
|
PROTECTIVE EFFECTS OF DHB ON ISCHEMIA-INDUCED NEURONAL DEATH AND COGNITIVE IMPAIRMENT IN RATS
|
|
ZHANG, J.
|
LYSOSOMAL ENZYME CATHEPSIN D PROTECTS AGAINST Α-SYNUCLEIN AGGREGATION AND TOXICITY
|
|
ZHANG, Y.
|
IDENTIFICATION OF TWO NEW GENES THAT REGULATE ABETA GENERATION, TAU PHOSPHORYLATION AND GSK-3 ACTIVITY
|
|
ZHEN, X.
|
RECENT DEVELOPMENT AND MECHANISM OF STEPHOLIDINE (L-SPD) IN PARKINSONS DISEASE TREATMENT
|
|
ZHENG, L.
|
THE ROLE OF AUTOPHAGY AND APP PROCESSING IN OXIDANT INDUCED DAMAGE TO CULTURED NEUROBLASTOMA CELLS
|
|
ZHENG, Y.
|
NEUROPROTECTIVE EFFECTS OF TYRO3 AND AXL KINASES ON HIPPOCAMPAL NEURONS AND DIFFERENTIATED PC12 CELLS
|
|
ZHOU, F.
|
REDOX REACTIONS OF COPPER COMPLEXES FORMED WITH AMYLOID-BETA PEPTIDES AND THEIR ROLES IN OXIDATIVE STRESS ASSOIATED WITH ALZHEIMER´S DISEASE
|
|
ZHOU, J.-N.
|
ESTROGEN BIOSYNTHESIS IN CENTRAL NERVOUS SYSTEM AND PERIPHERY WERE DIFFERENTLY AFFECTED BY APOE GENOTYPE
|
|
ZHOU, J.-W.
|
IDENTIFICATION OF NIGRAL DOPAMINERGIC NEURON-ENRICHED GENES IN ADULT RATS
|
|
ZHOU, J.-W.
|
CRUCIAL ROLES OF MZF-1 IN THE TRANSCRIPTIONAL REGULATION OF APOMORPHINE-INDUCED MODULATION FGF-2 EXPRESSION IN ASTROCYTIC CULTURES
|
|
ZHOU, J.-W.
|
DEFICIENCY IN NEUROFILAMENT-ASSOCIATED PROTEIN P43 CAUSES MOTOR NEURON AXON PATHOLOGY
|
|
ZHOU, J.-W.
|
VENTRAL MESENCEPHALON-ENRICHED GENES THAT REGULATE THE DEVELOPMENT OF DOPAMINERGIC NEURONS IN VIVO
|
|
ZHOU, J.-W.
|
IDENTIFICATION OF CEREBROSPINAL FLUID PROTEOMIC BIOMARKERS FOR PARKINSON'S DISEASE
|
|
ZIMMERMANN, R.
|
NEUROCHEMICAL DEMENTIA DIAGNOSTICS: STATE OF THE ART AND A SIMPLE ALGORITHM FOR INTERPRETATION OF CSF BIOMARKERS
|
|
ZINSER, E.G.
|
THE ROLE OF GANGLIOSIDE METABOLISM IN ALZHEIMER`S DISEASE AND APP PROCESSING
|
|
ZOVO, K.
|
MALDI MS-BASED HIGH-THROUGHPUT SCREENING METHOD FOR SUBSTANCES INHIBITING AGGREGATION OF ALZHEIMER'S AΒ PEPTIDES
|
|
ZUCHNER, S.
|
COMPREHENSIVE ASSESSMENT OF MTDNA VARIATION BY APPLYING NEXT-GENERATION SEQUENCING
|
|
ZUSSY, C.
|
TIME-COURSE EFFECTS OF AMYLOID TOXICITY INDUCED BY A SINGLE ICV INJECTION OF Aß (25-35) ON BDNF SYSTEM IN RATS
|
|
ZWECKSTETTER, M.
|
STRUCTURAL POLYMORPHISM OF 441-RESIDUE TAU AT SINGLE RESIDUE RESOLUTION
|
